UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2016

 

OR
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                          to                         .

 

Commission file number 001-34529

 

 

 

STR Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware
(State or other jurisdiction of
incorporation or organization)
27-1023344
(I.R.S. Employer
Identification No.)
   
10 Water Street, Enfield, Connecticut
(Address of principal executive offices)
06082
(Zip code)
   

Registrant’s telephone number, including area code: (860) 272-4235

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Securities Registered Pursuant to Section 12(g) of the Act:

 

Title of each class

Common Stock $0.01 par value per share

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. YES ☐   NO ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. YES ☐   NO  ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES ☒   NO ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES ☒   NO ☐

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☒

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☐
(Do not check if a
smaller reporting company)
Smaller reporting company ☒

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). YES ☐   NO ☒

 

The aggregate market value of the registrant’s voting and non-voting common equity held by non-affiliates of the registrant as of June 30, 2016 was $2,546,331 based on the price of the last reported sale of $0.29 per share on the OTCQX Marketplace on that date.

 

On February 28, 2017, the registrant had 19,307,482 outstanding shares of Common Stock, $0.01 par value per share.

 

DOCUMENTS INCORPORATED BY REFERENCE:

 

Portions of the registrant’s Proxy Statement for the 2017 Annual Meeting of Stockholders, to be filed by the registrant on or prior to 120 days following the end of the registrant’s fiscal year ended December 31, 2016, are incorporated by reference into Part III of this Annual Report on Form 10-K.

 

 

 

 

 

TABLE OF CONTENTS

 

PART I    
ITEM 1. Business 2
ITEM 1A. Risk Factors 10
ITEM 1B. Unresolved Staff Comments 26
ITEM 2. Properties 26
ITEM 3. Legal Proceedings 26
ITEM 4. Mine Safety Disclosures 26
PART II    
ITEM 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 27
ITEM 6. Selected Financial Data 27
ITEM 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 28
ITEM 7A. Quantitative and Qualitative Disclosures about Market Risk 48
ITEM 8. Financial Statements and Supplementary Data 49
ITEM 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 77
ITEM 9A. Controls and Procedures 77
ITEM 9B. Other Information 78
PART III    
ITEM 10. Directors, Executive Officers and Corporate Governance 78
ITEM 11. Executive Compensation 78
ITEM 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 78
ITEM 13. Certain Relationships and Related Transactions, and Director Independence 78
ITEM 14. Principal Accounting Fees and Services 78
PART IV    
ITEM 15. Exhibits and Financial Statement Schedule 79

 

 

1
 

PART I

 

ITEM 1. Business

 

Forward-Looking Statements

 

This Annual Report on Form 10-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. For a discussion of forward-looking statements, see the section captioned “Forward-Looking Statements” in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Reverse Stock Split

 

On January 30, 2015, we effected a reverse stock split of our common stock at a ratio of one share-for-every three shares of the outstanding common stock. The change in the number of shares resulting from the reverse stock split has been applied retroactively to all shares and per share amounts presented in this report, including the financial statements and accompanying notes included herein.

 

Overview

 

STR Holdings, Inc. and its subsidiaries (“we”, “us”, “our” or the “Company”) commenced operations in 1944 as a plastics and industrial materials research and development company. Based upon our expertise in polymer science, we evolved into a global provider of encapsulants to the solar industry. Encapsulant is a critical component used to protect and hold solar modules together.

 

We were the first to develop ethylene-vinyl acetate (“EVA”) based encapsulants for use in commercial solar module manufacturing. Our initial development effort was conducted while under contract to the predecessor of the U.S. Department of Energy in the 1970s. Since that time, we have expanded our solar encapsulant business, by investing in research and development and global production capacity.

 

In September 2011, we sold our Quality Assurance (“QA”) business, which provided consumer product development, inspection, testing and audit services that enabled our retail and manufacturing clients to determine whether products met applicable safety, regulatory, quality, performance and social standards, to Underwriters Laboratories, Inc. (“UL”) for $275.0 million in cash, plus assumed cash. The historical results of operations of our former QA business have been recast and presented as discontinued operations in this Annual Report on Form 10-K. Further information about our divestiture of the QA business is included in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, and Note 4, Discontinued Operations, of the Notes to Consolidated Financial Statements, included in Item 8, Financial Statements and Supplementary Data, of this Annual Report on Form 10-K.

 

Our net sales and profitability have declined significantly in recent years. We attribute these declines primarily to a rapid shift of solar module production from the United States and Europe to Asia, particularly China, the loss of our largest customer in 2013, financial distress of certain of our key customers, intensified competition and steep price declines resulting from cyclical or periodic excess capacity throughout the solar manufacturing industry.

 

Recent Developments

 

Manufacturing Facility Fire

 

During October 2016, a portion of the production facility within our manufacturing plant located in Shajiabang, Jiangsu, China was damaged by a fire. No employee injuries have been reported. As of the date of this report, our China facility has 50% of its on-site, pre-fire production capacity available. The damage was mainly to certain ancillary equipment and related systems as well as one production line, which has been determined to be a total loss. Through the date of this report, we have been able to continue to fulfill customer orders utilizing our alternative capacity. However, we have recorded a $0.9 million loss related to the fire. We carry both casualty and property insurance for our facilities and equipment, as well as business interruption insurance, and we continue to work with our insurance carriers to complete the filing of our claims.

 

Zhenfa Module-for-Encapsulant Swap Transaction

 

During the second quarter of 2015, we entered into a module-for-encapsulant swap transaction with Zhenfa
Energy Group Co. Ltd. (“Zhenfa”) and Zhejiang ReneSola Jiangsu Co., Ltd. (“ReneSola”) to settle outstanding accounts receivable due from ReneSola. As part of this three-party transaction, we agreed to accept solar modules as settlement of approximately $7.5 million of outstanding receivables from ReneSola, and Zhenfa agreed to purchase these modules from us for $7.5 million. During the third quarter of 2016, we increased the amount due by approximately $1.2 million to reflect an inadvertent overpayment of modules made by ReneSola to Zhenfa. In October 2016, we received bank acceptance notes and cash from Zhenfa for approximately $3.2 million as full payment of the balance due under these arrangements.

 

2
 

2014 Transaction with Zhenfa

 

In 2014, we entered into certain definitive agreements with Zhenfa and its indirect wholly-owned subsidiary, Zhen Fa New Energy (U.S.) Co., Ltd., a Nevada corporation (“Zhenfa U.S.”).

 

Purchase Agreement and Special Dividend

 

On August 11, 2014, we entered into a Stock Purchase Agreement (the “Purchase Agreement”) with Zhenfa U.S., pursuant to which we agreed to issue and sell to Zhenfa U.S., and Zhenfa U.S. agreed to purchase from us, an aggregate of approximately 9.2 million shares (the “Purchased Shares”) of our common stock for an aggregate purchase price (“Purchased Price”) of approximately $21.7 million, or $2.35 per share (the “Transaction”). The Purchased Shares represented approximately 51% of our outstanding shares of common stock upon the closing of the Transaction (the “Closing”) , which occurred on December 15, 2014.

 

In connection with the Closing, we declared a special dividend (the “Special Dividend”) on December 11, 2014 to be paid to all of our stockholders of record (other than Zhenfa U.S.) in an amount equal to $2.55 per common share on January 2, 2015. The cash used to fund the Special Dividend was paid to our transfer agent as of December 31, 2014.

 

Sales Service Agreement

 

In connection with the execution of the Purchase Agreement, Specialized Technology Resources, Inc., our wholly owned subsidiary, entered into a sales service agreement (the "Sales Service Agreement") with Zhenfa, whereby Zhenfa agreed, among other things, to assist us in a number of endeavors, including, without limitation, marketing and selling our products in China, acquiring local raw materials, hiring and training personnel in China, and complying with Chinese law. The Sales Service Agreement also provides us an option to lease a Zhenfa-owned manufacturing facility rent free for a period of five years, which option expired on December 15, 2016. The Sales Service Agreement became effective on the date of the Closing, had an an initial term of two years, and is automatically extended for one year periods unless terminated earlier. The Sales Service Agreement may also be terminated by either party at such time as Zhenfa and its affiliates own less than 10% of our outstanding Common Stock. As of the date of this filing, the Sales Service Agreement has not been terminated by either party.

 

Execution with Zhenfa and Assessment of Strategic Alternatives

 

Our net sales from our China operations were essentially flat in 2016 compared to 2015, with an increasing amount of such sales to India, despite our ongoing efforts to increase our share in the strategically important Chinese market. Within China, we have experienced difficulty attracting large, creditworthy customers on acceptable pricing and payment terms for volumes necessary to achieve profitable scale, even with Zhenfa’s assistance. As a result of these challenges, we have continued to operate at a loss in China.

 

Encapsulant Business Restructuring

 

In light of continued difficulties in the China market, we have decided to wind down our China manufacturing operations substantially by the end of the first quarter of 2017. We plan to keep a small staff in our China factory for some time beyond that date to manage an orderly wind down, which may include limited continued production for the purpose of servicing local creditworthy customers who may rely on our products, and to consume our remaining inventory of raw materials. We are currently working with our tolling partners to assure uninterrupted supply to our valued customers in the local market.

 

Given that our China factory has been manufacturing encapsulants for sale outside of China, we are currently working to accommodate production in the primary export market, namely India.

 

Our customers in India have generally paid according to terms. Although pricing in India is also very aggressive, we believe that the India market represents opportunity of sufficient scale to support profitable production operations within India, though we cannot assure that this will be the case. We have been working for several months to qualify a tolling partner in India and plan to launch commercial-scale production of our products within India during the second quarter of 2017.

 

We expect to continue to operate our Spanish facility in 2017 and to continue to occupy our headquarters in Enfield, Connecticut.

 

3
 

Since ceasing production in Malaysia in 2015, we have sold certain production and ancillary equipment, and have entered into a Purchase and Sale Agreement (“P&S”) to sell the building and related property rights. Our P&S, having been duly executed by both buyer and seller as of November 18, 2016, is subject to the approval of the Johor Port Authority (“JPA”), pending their review to be held at a meeting of the JPA Board of Directors. The timing of such review is subject to inclusion on the agenda of said meeting. We are not able to accurately predict the date of such review or the likelihood or timing of JPA approval.

 

In summary, we are considering the reorganization of our encapsulant business to better align with customer geography, to reduce the cash burn related to unprofitable locations and to convert assets to cash for potential redeployment into more profitable endeavors.

 

Assessment of Entry into Downstream Solar

 

We have recently made a detailed assessment of the solar downstream market and may consider participation in this field, if given a reasonable entry point, among our other strategic options. Our immediate focus, however, is on reducing our operating losses and positioning assets for redeployment.

Compliance With OTCQX Marketplace Listing Standards

 

Our common stock trades on the OTCQX Marketplace (“OTCQX”) under the symbol “STRI.” On December 1, 2016, we were notified by the OTCQX that the Company did not meet the OTCQX Requirements for Continued Qualification found in Section 3.2 of the OTCQX Rules for U.S. Companies due to the Company failing to maintain a market capitalization of at least $5.0 million for at least one of every 30 consecutive calendar days. The OTCQX has granted us a 60 day extension beginning on January 3, 2017 with a re-evaluation on or after February 28, 2017. Following that re-evaluation, if our market capitalization has not returned to at least $5.0 million, our stock will move to trading on the OTCQB market. As of the date hereof, our stock continues to trade on the OTCQX.

 

Solar Energy Market Overview

 

Solar energy has emerged as one of the most rapidly growing sources of renewable energy. A number of different technologies have been developed to harness solar energy. The most prevalent technology comprises interconnected photovoltaic (“PV”) cells to generate electricity directly from sunlight. Solar energy has many advantages over other renewable and non-renewable electricity sources relative to environmental impact, delivery risk, distributed generation, matching of peak generation with demand, predictable generation costs without fuel-cost volatility, low maintenance and installation cost at competitive prices in many global markets.

 

PV systems have been used to produce electricity for several decades. However, technological advances and production efficiencies combined with the rising costs of conventional/carbon-based electricity and the availability of government subsidies and incentives, have led to solar becoming one of the fastest growing renewable energy technologies.

 

Government incentive programs, which make solar-generated electricity more price competitive with that of other energy sources, are among the key demand drivers for PV. Historically, the largest growth in the demand for PV was in the European Union, driven by its goal of generating 20% of its electricity from renewable sources by 2020. However, Europe’s share of global demand has recently declined and is expected to continue to decline as many European Union countries, such as Germany and Italy, continue to reduce their subsidy programs in light of financing constraints, overall fiscal policy, precipitous reductions in PV system and related electricity costs, and saturation due to cumulative installed capacity. The reduction in subsidies and increased competition in the solar industry have been accompanied by a reduction in selling prices throughout the supply chain that is expected to yield future unit volume growth in new end markets as grid-parity is achieved and a price-elastic model continues to develop. We anticipate continued growth in installations of PV modules in the United States, China, India, South America, Africa and the Middle East.

 

Despite our expectations for favorable conditions for the adoption of solar electricity generation, solar energy continues to represent only a small fraction of the world’s electricity supply.

 

Solar Energy Systems

 

Solar electricity is primarily generated by PV systems comprised of solar modules, mounting structures and electrical components. PV systems are either grid-connected or off-grid. Grid-connected systems are tied to the transmission and distribution grid and feed electricity into the end-user’s electrical system and/or the grid. Such systems are commonly mounted on the rooftops of buildings, integrated into building facades or installed on the ground using support structures, and range in size from a small number of kilowatts to hundreds of megawatts. Off-grid PV systems are typically much smaller and are frequently used in remote areas where they may be the only source of electricity for the end-user.

 

4
 

Solar Modules

 

PV cells are semiconductor devices that convert sunlight directly to electricity by a process known as the photovoltaic effect. A solar module is an assembly of PV cells that are electrically interconnected, laminated and framed in a durable and weatherproof package.

 

There are two primary commercialized categories of solar cells: crystalline silicon and thin-film. PV devices can be manufactured using different semiconductor materials, including mono-and poly-crystalline silicon for silicon cells, and amorphous silicon, gallium arsenide, copper indium gallium selenide and cadmium telluride, among others, for thin-film cells. Crystalline silicon cells typically operate at higher conversion efficiency. Historically, crystalline silicon cells have been higher in cost due to a more complex production process and the need for more expensive raw materials. In recent years, the price of polysilicon has declined rapidly, eroding the cost advantage of thin-film cells, while the gap in conversion efficiency narrows due to more rapid improvements in the thin-film sector.

 

During the last five years, the production of solar modules has migrated rapidly from the U.S. and Europe to Asia, primarily China.

 

Encapsulants

 

Regardless of the technology used to create solar energy from a PV system, the core component of the solar cell is the semiconductor circuit. To protect and preserve that circuit, solar module manufacturers typically use an encapsulant. Encapsulants are critical to the function of solar modules, as they protect cells from the elements, bond the multiple layers of a module together and provide electrical isolation. Encapsulants must incorporate high optical transparency, stability at high temperatures and high levels of ultraviolet radiation, good adhesion to different module materials, adequate mechanical compliance to accommodate stresses induced by differences in thermal expansion and contraction between glass and cells, good dielectric properties (electrical isolation) and resistance to potential induced degradation. Even slight deterioration of any of these properties over time could significantly impair the electrical output of the solar module, which is of critical importance in the solar industry, where solar module manufacturers typically provide 20 to 25-year warranties for their products.

 

Over the years, various encapsulant materials have been used in solar modules, including EVA, polyvinyl butyral (“PVB”), polyolefin elastomer (“POE”) and poly dimethyl siloxane or silicone. We currently use EVA to make substantially all of our encapsulant products, although we are currently commercializing a range of POE encapsulants. Our encapsulants are modified with additives to increase stability for long-term outdoor applications, such as solar modules. We have also begun selling EVA interlayer to the laminated glass market to further expand our product offering.

 

During solar module assembly, encapsulation is typically accomplished by vacuum lamination, wherein a “pre-lam” stack (as depicted in the following diagram) is fashioned into a singular part comprising multiple layers. Thin sheets of EVA are positioned on either side of the PV cells, top and bottom. Heating the “sandwich” then causes the EVA to melt and then to cure, or crosslink, bonding the module into one piece. This step occurs towards the end of the manufacturing process and is critical to the entire solar module, as there is only one opportunity to laminate correctly.

 

5
 

Solar Module Component Stack—Crystalline Silicon

 

 

Excessive shrinkage or inadequate adhesion (associated with improperly formulated encapsulants) can occur during lamination and may result in voids or holes in the encapsulant, which are considered defects and cause for rejection of the entire panel. Upon direct exposure to the elements, encapsulants are susceptible to several performance failures, which may jeopardize the integrity and performance of the entire solar module and lead to significant warranty costs for solar module manufacturers. The most significant failures include:

 

Loss of clarity - the propensity of an encapsulant to “brown” after long-term exposure to ultraviolet (“UV”) light, leading to a permanent loss of transparency. If an encapsulant positioned above the cells loses its transparency, the power output of the module will be reduced.
     
Module delamination - the loss of adhesion between the encapsulant and other module layers. Delamination in the field could occur in cases where the encapsulant was improperly cured or where incompatibilities between the encapsulant and other module components exist. Most delamination observed in the field has occurred at the interface between the encapsulant and the front surface of the solar cells. Delamination is more frequent and more severe in hot and humid climates, sometimes occurring after less than five years of exposure. Delamination first causes a performance loss due to optical de-coupling of the encapsulant from the cells. Of greater concern from a module lifetime perspective is the likelihood that the void resulting from the delamination will provide a preferential location for moisture accumulation, greatly increasing the possibility of corrosion failures in metallic contacts and resulting in module failure.
     
Potential Induced Degradation (“PID”) - the loss of electrical output caused by sodium ion migration from the cover glass, through the encapsulant to the cell, is a factor that could adversely impact the energy yield of crystalline silicon solar modules. PID can occur in some solar module installations where a transformerless inverter is used in combination with a high negative voltage bias applied to the solar cells. The magnitude of the power loss depends upon many factors, including the applied voltage bias and the type of surface coatings on the solar cells. Specific encapsulant chemistry, such as in our recent product introductions, has been demonstrated to help inhibit power loss due to PID.
     

Despite the critical nature of encapsulant to solar cell applications, the encapsulant represents a small percentage of the total manufacturing cost of the solar module.

 

We typically sell our encapsulants in square meters. However, because the solar industry’s standard measurement for production volume and capacity is watts, megawatts (“MW”), or gigawatts (“GW”), we convert our capacity and production volume from square meters to approximate MW depending on the applicable conversion efficiencies specific to our customers. The conversion rate is approximately 12,500 square meters of encapsulant per MW. This rate is based on our calculations using publicly available information, our industry experience and assumptions that our management believes to be appropriate and reasonable. Certain production capacity and market metrics included in this Annual Report on Form 10-K are based on these calculations. Our calculations may not be accurate, and we may change the methodology of our calculations in the future as new information becomes available. In that case, period-to-period comparisons of such metrics may not be perfectly comparable.

 

Financial Information About Our Segment and Geographic Areas

 

Financial information about our segment and geographical areas of operation is included in Item 7,-Management’s Discussion and Analysis of Financial Condition and Results of Operations, and Note 19-Reportable Segment and Geographical Information, of the Notes to Consolidated Financial Statements, included in Item 8, Financial Statements and Supplementary Data, of this Annual Report on Form 10-K.

 

Our Products

 

Drawing upon our considerable experience, we develop our formulations internally and work in conjunction with our customers to meet their varying requirements. Our encapsulant formulations offer a range of properties and processing attributes, including various curing times and temperatures that align with the requirements of our customers’ individual lamination processes and module constructions. Our formulations can be used in both crystalline silicon and thin-film modules.

 

6
 

Our Markets and Customers

 

Our customers are solar module manufacturers located primarily in North America, Europe and Asia. We typically sell our encapsulants on a purchase order basis that specifies price and delivery parameters, but can be cancelled or postponed prior to production. We also provide technical support and assist our customers when they are qualifying solar modules that utilize our products, which can take from two months to more than two years. Historically, our sales strategy has focused on developing long-term relationships with solar module manufacturers and working collaboratively during their product development efforts.

 

Over the past several years, many of our Western customers continued to lose market share to lower-cost Chinese module manufacturers, with many being forced into bankruptcy or exiting the solar business as module production migrated rapidly to Asia, primarily China. We have been actively trying to enhance our presence and improve our competitiveness in China, however, in light of the obstacles detailed herein relating to the Chinese market, we have decided to conduct an orderly wind down of our China-based manufacturing operations. Given that our China factory has been manufacturing encapsulants for sale outside of China, we are currently working to accommodate production in the primary export market, namely India.

 

Global Wedge, Inc. and Heckert Solar, each accounted for at least 10% of our net sales, and in the aggregate accounted for approximately 33% of our net sales, for the year ended December 31, 2016. In 2015, ReneSola and Global Wedge, Inc. each accounted for at least 10% of our net sales, and in the aggregate accounted for approximately 28% of our net sales, for the year ended December 31, 2015. Our top five customers accounted for approximately 51% and 49% of our net sales in 2016 and 2015, respectively.

 

Our Operations

 

Facilities and Equipment

 

We currently operate production facilities in Llanera, Asturias, Spain and Shajiabang, Changshu, Jiangsu Province, China. These production facilities are augmented by our research, development and testing laboratory in Enfield, Connecticut, which is co-located with our corporate headquarters and our pilot production facility.

 

We also own a dormant production facility in Johor, Malaysia, for which we have executed a Purchase and Sale Agreement effective November 18, 2016. The completion of the sale is subject to the approval of the Johor Port Authority.

 

Our factories currently have total annual production capacity of approximately 3.0 GW, with 2.5 GW at our Spain location and 0.5 GW at our China facility. In addition, we have informal arrangements with third-parties to augment our manufacturing capacity in China.

 

In addition to our production capacity, we have pilot production lines based in Connecticut that are operational and could be used for production to address demand within North America.

 

Our production lines incorporate our proprietary technology and processes. We rely on third-party equipment manufacturers to produce our manufacturing lines to our specifications, which we then further customize in-house. Most of our production lines are functionally equivalent, having the ability to manufacture all of our formulations and providing us with flexibility in meeting shifting trends in global demand.

 

Encapsulant Production Process

 

Our production process typically begins by mixing EVA pellets with several additives to give the encapsulant its desired properties. The mixture is then melted, homogenized, pressurized and forced through a die to create an “EVA curtain,” forming a continuous encapsulant sheet. The sheet then progresses downstream in a proprietary process and ultimately wound into rolls, slit to the desired width, and packaged for shipment to customers.

 

Our manufacturing quality program is ISO 9001 certified. We have a high level of automation at each of our facilities that includes real-time computerized monitoring of the manufacturing process. Such automation provides consistency across our facilities so we can satisfy customer orders at all of our manufacturing locations. In addition, our enterprise resource planning system allows us to efficiently plan our production by location with global, real-time visibility.

 

We test our products in real-time and at a high frequency after production. The Quality Department at all of our manufacturing facilities follows our global quality assurance program and has a mandate to disposition products that do not meet required standards.

 

7
 

Raw Materials

 

Resin is the primary raw material used in our process, accounting for more than half of our manufacturing costs. A number of additives as well as packaging materials represent the remainder of our raw material costs.

 

We have multiple vendors for resin. Our objective has been to carry at least a five-week supply of resin to provide protection against supply interruptions resulting from inclement weather, natural disasters and strikes. The stock is distributed among our production facilities and warehouses so that a disruptive event at one location would not affect our ability to continue production. We have qualified resin suppliers local to each of our manufacturing facilities and continue to pursue qualification of additional resin suppliers.

 

Seasonal Trends

 

Our business could be adversely affected by seasonal trends, holiday seasons and weather patterns. See Item 1A,-Risk Factors for more information.

 

Our Competition

 

We face intense competition in the solar encapsulant market and have experienced a significant decline in our global market share from approximately 30% in 2010 to 2% in 2016. We compete with a number of encapsulant manufacturers, including Bridgestone Corporation, Hangzhou First PV Material Co., Ltd., Mitsui Chemicals Group, Inc. and SK Chemical Ltd. We have also faced competition from suppliers of non-EVA encapsulants including 3M Company, Dow Chemical Corporation, Dow Corning Corporation, Dai Nippon Printing Co., Ltd., and E.I. DuPont De Nemours and Company (“DuPont”). Over the years, various alternative encapsulant materials have been used in solar modules, including POE, PVB and silicone. Many of our competitors are large, global companies with substantially more financial, manufacturing and logistical resources. Also, low-cost solar module manufacturers have emerged in Asia, primarily in China, who compete with our legacy customers in Western markets. As the China solar market matures, additional encapsulant providers from China and the greater Asian markets may compete with us. We compete on the basis of various factors, including:

 

price;
     
product performance, including quality and technology;
     
product innovations;
     
customer service and technical support; and
     
delivery timing and logistics.

 

We expect competition in the encapsulant space to continue to be intense.

 

Qualification and Certification

 

Design certification programs for solar modules measure performance under simulated or advanced environmental conditions. In certifying their solar modules, our customers must qualify the encapsulant utilized within their product. The certification and qualification tests related to solar modules are defined in the following standards: IEC 61215 (crystalline silicon), IEC 61646 (thin-film) and UL 1703.

 

A successful qualification test program typically means that the tested models/types of solar modules have been subjected to and have passed the minimum requirements of the relevant standards. In addition, many PV module manufacturers often use internal validation tests that are beyond the scope and requirements of IEC and UL. These tests require suppliers to spend more time and investment to become approved suppliers for the module manufacturer’s bill of materials. Qualification or certification does not guarantee any performance, but is designed to provide reasonable assurance that the solar modules of the tested model or type will perform reliably under field conditions.

 

Under guidelines developed by the IEC/TC82/WG2 committee in 2000, modifications to the encapsulation system for solar modules can require retesting of the solar module. Such guidelines call for various retesting if there is any change in the chemistry of the encapsulant used in the solar module.

 

8
 

Employees

 

As of December 31, 2016, we employed approximately 135 people on a full or part-time basis. We maintain a non-unionized workforce, with the exception of some employees in our manufacturing facility in Spain, where unions are statutory. We have not experienced any significant work stoppages during the past five years.

 

Executive Officers

 

The following table sets forth the names and ages, as of March 1, 2017, of our executive officers. The descriptions below include each such person’s service as a board member or an executive officer of STR Holdings, Inc. and our predecessor.

 

Name   Age   Position
Robert S. Yorgensen     53     Chairman, President and Chief Executive Officer
Thomas D. Vitro     56     Vice President, Chief Financial Officer and Chief Accounting Officer

 

Robert S. Yorgensen. Mr. Yorgensen has been our Chairman since December 2014 and our President and Chief Executive Officer and a director of our board since January 2012. Prior to becoming our Chief Executive Officer, Mr. Yorgensen was Vice President of STR Holdings, Inc., and President of our Solar Division since 2007, and has been employed with us for over 31 years. Mr. Yorgensen has held a variety of positions with us, including Extruded Products Manager and Senior Technical Specialist of Materials RD&E and Specialty Manufacturing, Technical Specialist of Materials RD&E and Specialty Manufacturing and Project Leader of Development Engineering and Specialty Manufacturing. He holds a Bachelor of Technology, Mechanical Engineering degree from the University of Connecticut and an A.S. from Hartford State Technical College.

 

Thomas D. Vitro. Mr. Vitro has been our Vice President and Chief Financial Officer since December 2015 and is responsible for all finance and accounting functions of the Company. Previously, Mr. Vitro served in various positions with us between 1982 and 2013, most recently as Vice President, Finance from 2009 to 2013. Prior to that, he was the Corporate Controller from 1988 to 2009. Mr. Vitro has a Bachelor of Science in Accountancy from Bentley University and is a Certified Management Accountant.

 

Each executive officer holds office for a term of one year and until his successor is duly elected and qualified, in accordance with our bylaws.

 

Intellectual Property

 

Our intellectual property consists of multiple encapsulant formulations, as well as several processes and sub-processes, and our trademarks “STR ® ”, “PhotoCap ® ” and “STR Protected ® .” As appropriate, we require employees, suppliers and customers to execute confidentiality agreements.

 

We own a number of trademarks, trade secrets and other intellectual property rights that relate to our products. We typically rely on trade secrets rather than patents to protect our proprietary manufacturing processes, proprietary encapsulant formulations, methods, documentation and other technology, as well as certain other business information. Patent protection requires a costly and uncertain federal registration process that would place our confidential information in the public domain. While we enter into confidentiality agreements with our employees and third parties to protect our intellectual property rights, such confidentiality provisions related to our trade secrets could be breached and may not provide meaningful protection for our trade secrets. Also, others may independently develop technologies or products that are similar or identical to ours. In such case, our trade secrets would not prevent third parties from competing with us. See Item 1A.-Risk Factors and Item 3,-Legal Proceedings.

 

Environmental Regulation

 

We are subject to a variety of environmental, health and safety and pollution-control laws and regulations in the jurisdictions in which we operate. The cost of compliance with these laws and regulations is not material and we do not believe the cost of compliance with these laws and regulations will be material. We use, generate and discharge hazardous substances, chemicals and wastes at some of our facilities in connection with our product development and manufacturing activities. Any failure by us to restrict adequately the discharge of such substances, chemicals or wastes could subject us to potentially significant liabilities, clean-up costs, monetary damages, fines or suspensions in our business operations. In addition, some of our facilities are located on properties with a history of use involving hazardous substances, chemicals and wastes and may be contaminated. For example, our 10 Water Street, Enfield, Connecticut location was found to contain a presence of volatile organic compounds, and we have removed contaminated soil to remediate these conditions. The estimated remaining cost we expect to pay to monitor the property is approximately $0.1 million. If we elect to sell, transfer or change the use of the facility, additional environmental testing would be required. We cannot assure that we will not discover further environmental contamination or that we would not be required to incur significant expenditures for environmental remediation in the future.

 

9
 

Available Information

 

Information regarding us, including corporate governance policies, ethics policies and charters for the committees of the Board of Directors can be found on our internet website at http://www.strsolar.com and copies of these documents are available to stockholders, without charge, upon request to Investor Relations, STR Holdings, Inc., 10 Water Street, Enfield, Connecticut 06082. The information contained in our website is not intended to be incorporated into this Form 10-K. In addition, our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) are made available free of charge on our internet website on the same day that we electronically file such material with, or furnish it to, the SEC. Information filed with the SEC may be read or copied at the SEC’s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. Information on operation of the Public Reference Room may be obtained by calling the SEC at 1-800-SEC-0330. These filings are also available to the public from commercial document retrieval services and at the internet website maintained by the SEC at http://www.sec.gov that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.

 

ITEM 1A. Risk Factors

 

An investment in our common stock involves a very high degree of risk. You should carefully consider the following risks, as well as the other information in this Annual Report on Form 10-K, before making an investment in us. If any of these risks, or other events that we do not currently anticipate or that we currently deem immaterial, actually occur, our business, results of operations or financial condition may be materially adversely affected. In such an event, the trading price of our common stock could decline and you could lose part or all of your investment.

 

Risks Related to Our Business

 

We have recently incurred substantial losses and we may not be able to achieve or sustain profitability in the future.

 

We incurred net losses from continuing operations of $15.9 million and $13.4 million for the years ended December 31, 2016 and 2015, respectively. Although we are pursuing plans to improve our financial results, such plans contemplate significant changes to our existing operations and activities. Failure to successfully manage such changes may result in continued substantial net losses and could have a material adverse effect on our business, prospects and financial condition.

 

We continue to explore options for reorganizing of our encapsulant business to better align with customer geography, to reduce the cash burn related to unprofitable locations and to convert assets to cash for potential redeployment into more profitable endeavors, and possible business opportunities in potentially more profitable parts of the solar supply chain, as well as other strategic alternatives. We cannot assure that we will be able to successfully pursue any such potential transactions. If we are successful in pursuing any such transactions we may be required to expend significant funds, incur additional debt or other obligations or issue additional securities, any of which could significantly dilute our current stockholders and may negatively affect our operating results and financial condition. We cannot assure that any such strategic transactions, or any financing in connection therewith, would be available on favorable terms, if at all, or that we will realize any anticipated benefits from any such transactions that we complete. In the event that we are not successful in restructuring our encapsulant business or pursuing opportunities in the downstream solar market or other strategic transactions, we also intend to consider alternatives, including without limitation, the acquisition of another business, the divestiture of all or certain of our assets, joint ventures and other transactions outside the ordinary course of business.

 

If we are not successful in executing on our strategic plans to reorganize our encapsulant business and achieve profitability, we may decide to wind down or cease any or all of our operations.

 

In addition, any further wind-down or dissolution of us may be a lengthy and complex process, yield unexpected results and delay any potential distributions to our stockholders. Such process may also require the further expenditure of our resources, such as legal, accounting and other professional fees and expenses and other related charges, which would decrease the amount of assets available for distributions to our stockholders.

 

10
 

We have a limited amount of cash, a limited factoring arrangement and may not be able to obtain credit.

 

As of the date of this report, we had no credit facilities other than a limited factoring arrangement in Spain. Until we return to profitability, it is not likely that we will be able to obtain debt or other financing on reasonable terms, or at all. Furthermore, tight credit in the solar manufacturing industry may delay or prevent our customers from securing funding adequate to operate their businesses and purchase our products and could lead to an increase in our bad debt levels.

 

As of December 31, 2016, our principal source of liquidity was $12.4 million of cash and $3.4 million of Chinese bank acceptance notes. Our principal needs for liquidity have been, and for the foreseeable future will continue to be, for working capital and capital investments. Payment terms are currently longer in China than in many other locations, which results in delayed cash receipts from certain of our customers. If we are unable to collect our receivables, fail to receive payment in a timely fashion, or have limited access to the $2.1 million of cash and $3.4 million of bank acceptance notes located in China, our financial condition and results of operations may be negatively affected .

 

We currently rely on a single product line for nearly all of our net sales.

 

In 2016 and 2015, we derived substantially all of our net sales from solar encapsulant products. For our business to succeed, we will have to achieve broader market acceptance of our products or enter a new business activity or sector. As a result, factors adversely affecting the demand for our solar encapsulants, such as competition, pricing or technological change, could materially and adversely affect our business, financial condition and results of operations.

 

Our encapsulant business is dependent upon securing net sales to new customers, growing net sales to existing key customers and increasing our market share.

 

We estimate that our global market share has declined significantly from approximately 30% in 2010 to 2% in 2016. The future success of our encapsulant business depends on our ability to secure net sales to new customers, to grow net sales to existing key customers and to increase our global market share. Over the last few years, we believe our European and North American customers have lost market share to Asian module manufacturers, primarily from China, who continue to penetrate the global solar market. In order to be successful in the encapsulant business, we believe that we will need to significantly increase our net sales. Our failure to do so could have a material adverse effect on our business, financial condition and results of operations.

 

Our business is dependent on a limited number of customers, which may cause significant fluctuations or result in declines in our net sales.

 

The solar module industry is relatively concentrated, and we expect this concentration to increase with consolidation. As a result, we sell substantially all of our encapsulants to a limited number of solar module manufacturers. We expect that our results of operations will, for the foreseeable future, continue to depend on the sale of encapsulants to a relatively small number of customers. Global Wedge, Inc. and Heckert Solar, each accounted for at least 10% of our net sales, and in the aggregate accounted for approximately 33% of our net sales for the year ended December 31, 2016. ReneSola and Global Wedge, Inc., each accounted for at least 10% of our net sales, and in the aggregate accounted for approximately 28% of our net sales for the year ended December 31, 2015. Our top five customers accounted for approximately 51% and 49% of our net sales in 2016 and 2015, respectively. Furthermore, participants in the solar industry, including our customers, are experiencing pressure to reduce their costs. Since we are part of the overall supply chain to our customers, any cost pressures experienced by them may affect our business and results of operations. Our customers may not continue to generate net sales for us. Conversely, we may be unable to meet the production demands of our customers or maintain these customer relationships. Any one of the following events may cause material fluctuations or declines in our net sales and have a material adverse effect on our business, financial condition and results of operations:

 

reduction in the price that one or more of our significant customers is willing to pay for our encapsulants;
     
reduction, postponement or cancellation of orders from one or more of our significant customers;
     
selection by one or more of our customers of products competitive with our encapsulants;
     
11
 
     
loss of one or more of our significant customers and failure to obtain additional or replacement customers; and
     
failure of any of our significant customers to make timely payment for our products, if at all.

 

We currently outsource the manufacture of a portion of our encapsulants, and our future success may be dependent on the timeliness and effectiveness of the efforts of these third parties.

 

We currently engage third-party manufacturers to supply certain of our proprietary products to us in China, and we are working to qualify a tolling partner in India to launch commercial scale production of our products within India during the second quarter of 2017. If problems develop in our relationship with these manufacturers, or if they fail to perform as expected, it could lead to product defects, manufacturing and shipping delays, significant cost increases, changes in our strategies, and even failure of our initiatives, each of which may have a material adverse effect on our business, financial condition, and results of operations.

 

Technological changes in the solar energy industry or our failure to develop and introduce or integrate new technologies could render our encapsulants uncompetitive or obsolete, which would adversely affect our business.

 

The solar energy market is very competitive, rapidly evolving and characterized by continuous improvements in solar modules to increase efficiency and power output and improve aesthetics. This requires us and our customers to invest significant financial resources to develop new products and solar module technology to enhance existing modules to keep pace with evolving industry standards and changing customer requirements and to compete effectively in the future. During the past few years, we engaged in significant cost-reduction actions, including substantial reductions to our research and development and engineering personnel. The reduction of these resources may limit our ability to introduce new products or manufacturing improvements and may put us at a competitive disadvantage, which could negatively impact our ability to increase or maintain our market share and generate net sales, and negatively impact our financial condition, prospects and results of operations. Consequently, our competitors may develop encapsulant products and technologies that perform better or are more cost-effective than our products. This could cause our encapsulants to become uncompetitive or obsolete, which would adversely affect our business, financial condition and results of operations. Product development activities are inherently uncertain, and we could encounter difficulties and increased costs in commercializing new technologies. As a result, our product development expenditures may not produce corresponding benefits.

 

Moreover, we produce a component utilized in the manufacture of solar modules. New or existing solar technologies that do not require encapsulants as we produce them, or at all, may emerge and/or gain market share. Recently, competitors have introduced new encapsulant products to the market based upon POE. We believe that certain of our former customers are now using POE encapsulant for their modules. Although we have been pursuing the development of POE products, such products are not yet in regular commercial production and it is uncertain as to when or if we will manufacture and sell such products on a regular basis. In the event that solar module manufacturers switch to POE encapsulant products from EVA encapsulants and we do not offer a competitive POE product, such switch could materially and adversely affect our business, financial condition and results of operations.

 

Also, manufacturing methods may emerge that could be more advanced or efficient than our current manufacturing capability. Such manufacturing methods could result in competitive products that are more effective and/or are less expensive to produce, resulting in decreased demand for our encapsulants or render them obsolete, which would adversely affect our business, financial condition and results of operations.

 

We face competition in our business from other companies producing encapsulants for solar modules.

 

The market for encapsulants is highly competitive and continually evolving. We compete with a number of encapsulant manufacturers, many of which are large, global companies with substantially more financial, manufacturing and logistical resources and strong customer relationships. If we fail to attract and retain customers for our current and future products, we will be unable to increase our net sales and market share. Our primary encapsulant competitors include Bridgestone Corporation, Hangzhou First PV Material Co., Ltd., Mitsui Chemicals Group, Inc. and SK Chemical Ltd. We also face competition from suppliers of non-EVA encapsulants including 3M Company, Dow Chemical Corporation, Dow Corning Corporation, Dai Nippon Printing Co., Ltd., and DuPont. We also expect to compete with new entrants to the encapsulant market, including those that may offer more advanced technological solutions or complementary products such as backsheet that possess advanced or more efficient manufacturing capabilities or that have greater financial resources than we do. Some solar module manufacturers have encapsulant production capabilities of their own and this trend may broaden with market consolidation. Further, as the China solar market matures, we expect additional encapsulant providers from China and the greater Asian markets to compete with us. Our competitors may develop and produce or may be currently producing encapsulants that offer advantages over our products. A widespread adoption of any of these technologies could result in a rapid decline in our position in the encapsulant market and adversely affect our net sales and margins.

 

12
 

Excess capacity currently exists throughout the solar supply chain leading to substantial solar module price declines, which has caused cost to become the predominant factor in the encapsulant procurement process.

 

Significant excess capacity currently exists and may exist again in the future throughout the solar supply chain resulting in a further decrease in selling prices of solar modules. Due to many module manufacturers not producing at full capacity as well as being impacted by pricing pressure, our encapsulants’ value proposition has been reduced in the current excess capacity environment. Our customers and potential customers have been increasingly focused on the purchase price of encapsulants. In light of recent declines in our global market share, it is a priority to increase our market share through net sales to existing and new customers, however, we cannot assure that we will be able to do so. In order to remain competitive, we expect to be subject to continuing downward pricing pressures that may negatively impact our net sales and net earnings. In addition, our competitors may reduce the price of their products, which may force us to further reduce the price of our encapsulant products to retain net sales.

 

If demand for solar energy in general and solar modules in particular does not continue to develop or takes longer to develop than we anticipate, net sales in our business may continue to stagnate or decline, which would negatively affect our financial condition and results of operations.

 

Our encapsulants are used in the production of solar modules; therefore our financial condition and results of operations and future growth are tied to a significant extent to the overall demand for solar energy and solar modules. The solar energy market is at a relatively early stage of development and the extent to which solar modules will be widely adopted is uncertain. Many factors may affect the viability and widespread adoption of solar energy technology and demand for solar modules, and in turn, our encapsulants, including:

 

cost-effectiveness of solar modules compared to conventional and non-solar renewable energy sources and products;
     
performance and reliability of solar modules compared to conventional and non-solar renewable energy sources and products;
     
availability and amount of government subsidies and incentives to support the development and deployment of solar energy technology;
     
rate of adoption of solar energy and other renewable energy generation technologies, such as wind, geothermal and biomass;
     
seasonal fluctuations related to economic incentives and weather patterns;
     
impact of fiscal issues experienced by governments, primarily in Europe;
     
fluctuations in economic and market conditions that affect the viability of conventional and non-solar renewable energy sources, such as increases or decreases in the prices of fossil fuels and corn or other biomass materials;
     
changes in global economic conditions including increases in interest rates and the availability of financing and investment capital that is required to fund solar projects.
     
fluctuations in capital expenditures by end users of solar modules, which tend to decrease when the overall economy slows down;
     
the extent to which the electric power and broader energy industries are deregulated to permit broader adoption of solar electricity generation;
     
the cost and availability of polysilicon and other key raw materials for the production of solar modules;
     
construction of transmission facilities in certain areas to transport new solar electricity;
     
saturation in certain markets such as Europe; and
     
rate of adoption of solar energy in growing solar markets such as the United States, China, India, the Middle East and Africa.

 

13
 

If demand for solar energy and solar modules fails to develop sufficiently along our expectations, demand for our customers’ products as well as demand for our encapsulants could decrease, and we may not be able to grow our business or net sales and our financial condition and results of operations may be negatively impacted.

 

Our operations and assets in China and India are subject to significant political and economic uncertainties.

 

For as long as we continue to manufacture our products in China within our own leased manufacturing plant (which we expect to wind down substantially by the end of the first quarter of 2017), and also engage third-party manufacturers located in China and India to toll for us, we are exposed to certain risks. If the manufacture of our products in China or India is disrupted, our overall capacity could be significantly reduced and net sales and/or profitability could be negatively impacted. Furthermore, changes in Chinese or Indian laws and regulations, or their interpretation, or the imposition of confiscatory taxation, restrictions on currency conversion and repatriation, imports and sources of supply, devaluations of currency or the nationalization or other expropriation of private enterprises could have a material adverse effect on our business, results of operations and financial condition.

 

We may have limited legal recourse under the laws of China if disputes arise under our agreements with third parties.

 

The Chinese government has enacted certain laws and regulations dealing with matters such as corporate organization and governance, foreign investment, commerce, taxation and trade. However, their experience in implementing, interpreting and enforcing these laws and regulations is limited, and our ability to enforce commercial claims or to resolve commercial disputes is unpredictable. If our tolling arrangements or other future arrangements are unsuccessful or other adverse circumstances arise from these arrangements, we face the risk that our third-party manufacturers may dishonor our purchase orders or unwritten arrangements. Similarly, if our product sale arrangements with customers are unsuccessful or other adverse circumstances arise from these arrangements, we face the risk that our customers may not honor their obligation to pay us for purchased products. Further, if disputes arise under our agreements with any other parties doing business in China, including Zhenfa, we face the risk that such party may breach any such agreement or otherwise engage in conduct relating to their relationship with us that could otherwise give rise to liability under U.S. law. The resolution of these matters may be subject to the exercise of considerable discretion by agencies of the Chinese government, and forces unrelated to the legal merits of a particular matter or dispute may influence their determination. Any rights we may have to specific performance, or to seek an injunction under Chinese law, in either of these cases, may be limited, and without a means of recourse by virtue of the Chinese legal system, we may be unable to prevent these situations from occurring. The occurrence of any such events could have a material adverse effect on our business, financial condition and results of operations.

 

Our potential inability to adequately protect our intellectual property during the outsource manufacturing of our products in China or India could negatively impact our performance.

 

In connection with our tolling manufacturing arrangements, we rely on third-party manufacturers to implement customary manufacturer safeguards onsite, such as the use of confidentiality agreements with employees, to protect our proprietary information and technologies during the manufacturing process. However, these safeguards may not effectively prevent unauthorized use of such information and technical knowhow, or prevent the manufacturers from retaining them. Although the courts in China are increasing and broadening their protection of intellectual property rights, the legal regime governing intellectual property rights in China is relatively immature and it is often difficult to create and enforce intellectual property rights or protect trade secrets there. We face risks that our proprietary information may not be afforded the same protection in China or India as it is in countries with well-developed intellectual property laws, and local laws may not provide an adequate remedy in the event of unauthorized disclosure of confidential information. Costly and time-consuming litigation could be necessary to enforce and determine the scope of our proprietary rights in China and India, and failure to obtain or maintain trade secret protection could adversely affect our competitive business position. In the event that the third-party tolling manufacturers of our proprietary products misappropriate our intellectual property, our business, prospects and financial condition could be materially and adversely affected.

 

A significant reduction or elimination of government subsidies and economic incentives or a change in government policies that promote the use of solar energy could have a material adverse effect on our business and prospects.

 

Demand for our encapsulants depends on the continued adoption of solar energy and the resultant demand for solar modules. Demand for our products depends, in large part, on government incentives aimed to promote greater use of solar energy. In many countries in which solar modules are sold, solar energy would not be commercially viable without government incentives. This is because the cost of generating electricity from solar energy may exceed the cost of generating electricity from conventional energy sources in some regions of the world and because the capital investment associated with deploying solar modules may have a long payback period or be difficult to finance, making conventional sources available on the grid without capital investment a more widely accessible option.

 

14
 

The scope of government incentives for solar energy depends, to a large extent, on political and policy developments relating to environmental and energy concerns in a given country that are subject to change, which could lead to a significant reduction in, or a discontinuation of, the support for renewable energy in such country. Federal, state and local governmental bodies in many of our customers’ target markets, including Germany, Italy, Spain, the United States, China, France, Japan and South Korea, have provided subsidies and economic incentives in the form of feed-in tariffs, rebates, tax credits and other incentives to end users, distributors, system integrators and manufacturers of solar energy products to promote the use of solar energy and to reduce dependency on other forms of energy. In many cases, the costs of these government subsidy programs are passed on to electricity consumers in the applicable regions. These government economic incentives could be reduced or eliminated earlier than anticipated. For example, in Germany, which was a large solar PV installation market, the government enacted legislation that reduced feed-in tariffs beginning June 30, 2010. In early 2011, the German government enacted further legislation that accelerated the annual year-end feed-in tariff reduction to July 1, 2011 for roof-top systems and September 1, 2011 for ground-mount projects. In 2012, the German government enacted additional legislation that reduced feed-in tariffs by between 20% and 30% depending on the size of the solar energy system. Additional negative changes to solar incentives in 2013 continued to affect the solar markets throughout the European Union. Similarly, in September 2008, the Spanish Parliament decreased the feed-in tariff for solar energy by approximately 27% and capped its subsidized PV installations at 500 MW for 2009. This event drove an over-supply of solar module inventory in the supply chain during the first half of 2009 and was one of the main drivers behind our sales volume decline in 2009 compared to 2008. In addition, numerous other countries have recently reduced solar incentives. A change in government incentives similar to these may result in the pull-in of demand from solar module manufacturers due to increased end-user demand being driven by the incentive to purchase a solar system prior to the enactment of the decreased feed-in tariff incentives.

 

It is our belief that most if not all government solar incentive programs are designed to increase the use of solar energy and are subject to periodic adjustment in light of the rate of installations resulting from the incentive and the economics of solar energy resulting from the price of the installed systems combined with the incentives. As has often happened over the past several years, the rate of incentivized installations has outpaced estimates and the price of solar panels and systems has fallen faster than anticipated. When combined, these dynamics result in a situation where the incentive is more generous than is necessary to drive more installations, and the incentive is subsequently reduced in light of these economics. Adjustments in these incentive programs, which may range from a minor adjustment to a complete shutdown, or in some cases even retroactive action, have resulted in the formation of boom-and-bust cycles within the solar industry.

 

Some European governments have recently experienced sovereign debt issues and a risk exists that some of these governments will continue to reduce current subsidies provided for PV installations in conjunction with generally tighter fiscal policies.

 

Policies relative to solar in China, while generally very supportive, have shifted focus and scope with some regularity over the past few years and may change with little notice again in the future. China is currently the world’s largest consumption market for solar panel installations as well as production. The strength or weakness of China’s economy may cause their domestic solar policy to shift in a positive or negative manner.

 

In the United States, recent solar installation growth has been driven by Renewable Portfolio Standards, regulatory mandates to increase production of energy from renewable sources such as wind, solar, biomass and other alternatives to fossil and nuclear electricity generation, and a 30% federal energy Investment Tax Credit (the “ITC”) for both residential and commercial solar installation through December 31, 2019. The ITC ratchets down to 26% for 2020, 22% for 2021 and 10% for 2022 and later. The ITC also includes a “commence construction” clause that allows system owners to claim the associated tax credit provided construction began within the period and is finished before 2024.

 

Electric utility companies, or generators of electricity from fossil fuels or other energy sources, could also lobby for changes to the relevant legislation in their markets to protect their revenue streams. Reduced growth in or the reduction, elimination or expiration of government subsidies and economic incentives for solar energy, especially those in our customers’ target markets, could cause our net sales to decline and negatively impact our business.

 

Our financial results may be adversely affected by rising commodity costs.

 

We are dependent upon certain raw materials, particularly resin, for the manufacture of our encapsulants. EVA resin comprises approximately 49% of our cost of sales. We do not believe that EVA resin can be effectively hedged with derivatives in the commodity markets. The prices for resin remained fairly constant in 2016 versus 2015 and declined in 2015 over 2014. However, they have been volatile in the past and if raw material prices increase, our gross margins and results of operations may be materially and adversely affected.

 

15
 

Deterioration of our customers’ financial profile may cause additional credit risk on our accounts receivable.

 

A significant portion of our outstanding accounts receivable is derived from sales to a limited number of customers. The accounts receivable from our top five customers represented 27% and 39% of our accounts receivable balance as of December 31, 2016 and December 31, 2015, respectively. The accounts receivable due from our largest customer was 7% of our accounts receivable balance as of December 31, 2016. During the past several years, many solar module manufacturers became insolvent and the number of days outstanding on accounts receivable has increased significantly industry-wide. For example, in 2016, we recorded bad debt expense of approximately $1.2 million for China Sunergy Co Ltd. (“CSUN”). We have won a judgement against CSUN in a China first instance court and are awaiting enforcement from the second instance court, though we cannot assure you that we will be successful in obtaining such enforcement. Moreover, many solar manufacturing companies continue to face significant liquidity and capital expenditure requirements, and as a result, our customers may have trouble making payments owed to us. In addition, payment terms are currently longer in China than in many other locations. We are attempting to obtain bank acceptance notes from financial institutions with respect to the accounts receivable from certain of our customers, however, if we are unable to collect our accounts receivable or obtain bank acceptance notes, or fail to receive payment of accounts receivable in a timely fashion, our financial condition and results of operations may be negatively affected.

 

If we are unable to attract, train and retain key personnel, our business may be materially and adversely affected.

 

Our future success depends, to a significant extent, on our ability to attract, train and retain management, operations and technical personnel. This may be particularly difficult in light of our financial performance and our delisting from the New York Stock Exchange in September 2015. In addition, we have substantially reduced our headcount during the past few years, which limits the resources available to successfully manage and grow our business. The loss of the services of any member of our senior management team or the inability to hire or retain experienced management personnel could adversely affect our ability to execute our business plan and harm our operating results.

 

In periods of cost reduction, there is a risk that employees may voluntarily leave us to pursue other career opportunities. There is substantial competition for qualified technical personnel for our business, and as a result, we may be unable to continue to attract or retain qualified technical personnel necessary for the development of our business or recruit suitable replacement personnel. If we are unable to attract and retain qualified employees, our business may be materially and adversely affected.

 

Our dependence on a limited number of suppliers for raw materials for our encapsulants and other significant materials used in our process could prevent us from timely delivery of encapsulants to our customers in the required quantities, which could result in order cancellations and decreased net sales.

 

We purchase resin, the main component used in our manufacturing process, from a limited number of third-party suppliers. If we fail to develop or maintain our relationships with these suppliers or with our other suppliers, or if the suppliers’ facilities are affected by events beyond our control, we may be unable to manufacture our encapsulants or our encapsulants may be available only for customers in lesser quantities, at a higher cost or after a long delay. If we do not increase our sales volumes, which drive our demand for our suppliers’ product, we may not procure at volumes sufficient to maintain favorable supplier relationships, which could lead to higher costs, lower quality and lack of availability of raw materials. We may be unable to pass along any price increases relating to materials costs to our customers, in which case our gross margins could be adversely affected. In addition, we do not maintain long-term supply contracts with our suppliers. Our inventory of raw materials, including back-up supplies of resin, may not be sufficient in the event of a supply disruption. The failure of a supplier to provide materials and components, or a supplier’s failure to provide materials that meet our quality, quantity and cost requirements in a timely manner, could impair our ability to manufacture our products to specifications, particularly if we are unable to obtain these materials and components from alternative sources on a timely basis or on commercially reasonable terms. If we are forced to change suppliers, our customers may require us to undertake testing to ensure that our encapsulants meet their specifications.

 

16
 

Problems with product quality or product performance, including defects, could result in a decrease in customers and net sales, unexpected expenses and loss of market share.

 

Our encapsulants are complex and must meet stringent quality requirements. Products as complex as our encapsulants may contain undetected defects, especially when first introduced. For example, our encapsulants may contain defects that are not detected until after they are shipped or are installed because we cannot test for all possible scenarios that may arise in our customers’ manufacturing processes. These defects could cause us to incur significant costs, including costs to service or replace products, divert the attention of our engineering personnel from product development efforts and significantly affect our customer relationships and business reputation. If we deliver products with defects or if there is a perception that our products contain errors or defects, our credibility and the market acceptance and sales of our encapsulants could materially decline. In addition, we could be subject to product liability claims and could experience increased costs and expenses related to significant product liability claims or other legal judgments against us, or a widespread product recall by us or a solar module manufacturer.

 

We provide a short-term warranty that we have manufactured our products to our specifications. On limited occasions, we incur costs to service our products in connection with specific product performance matters that do not meet our manufacturing specifications. Also, in isolated occasions, we have offered limited short-term performance warranties relating to our encapsulants not causing module power loss. This type of arrangement may increase in 2016. If we were to ever receive a warranty claim for such matter, we would assess the need for a warranty accrual at that time.

 

The manufacturing process for our encapsulants is complex. Minor deviations in the manufacturing process can cause substantial decreases in yield and, in some cases, cause production to be suspended. We have from time to time experienced lower-than-anticipated manufacturing yields. This typically occurs during the production of new encapsulants or during the installation and start-up of new process technologies or equipment. If we do not achieve planned yields, our cost of sales could increase, and product availability could decrease resulting in lower net sales than expected.

 

Changes to existing regulations and capacity in the utility sector and the solar energy industry may present technical, regulatory and economic barriers to the purchase and use of solar modules, which in turn may significantly reduce demand for our products.

 

The market for power generation products is heavily influenced by government regulations and policies concerning the electric utility industry, as well as the internal policies of electric utility companies. These regulations and policies often relate to electricity pricing and technical interconnection of end-user-owned power generation. In a number of countries, these regulations and policies are being modified and may continue to be modified. End users’ purchases of alternative energy sources, including solar modules, could be deterred by these regulations and policies. For example, utility companies sometimes charge fees to larger, industrial customers for disconnecting from the electricity transmission grid or relying on the electricity transmission grid for back-up purposes. Such fees could increase the costs of using solar modules, which may lead to reduced demand for solar modules and, in turn, our encapsulants.

 

We anticipate that solar modules and their installation will continue to be subject to oversight and regulation in accordance with national and local ordinances relating to building codes, safety, environmental protection, utility interconnection, metering and related matters in various countries. New or revised government regulations or utility policies pertaining to solar modules may result in significant additional expenses to our customers, and their distributors and end users, which could cause a significant reduction in demand for solar modules and, in turn, our encapsulants.

 

The adoption of solar energy in most parts of the world will be dependent on the capacity of applicable electricity transmission grids to instantaneously accept and distribute the increased volume of electricity to end-users. For example, some countries may implement curtailment policies which would limit solar electricity purchases based on transmission congestion or lack of incremental demand in excess of baseload supply, which may be cheaper for utilities to produce and much more difficult to modulate. The lack of available capacity on the transmission grid could substantially impact the adoption of solar energy, which could cause a significant reduction in demand for solar modules and, in turn, our encapsulants.

 

We typically rely upon trade secrets and contractual restrictions, rather than patents, to protect our proprietary rights. Failure to protect our intellectual property rights may undermine our competitive position and protecting our rights or defending against third-party allegations of infringement may be costly.

 

Protection of proprietary processes, methods, documentation and other technology is critical to our business. Failure to protect, monitor and control the use of our intellectual property rights could cause us to lose our ability to compete and to incur significant expenses. We typically rely on trade secrets, trademarks and contractual restrictions to protect our intellectual property rights. However, the measures we take to protect our trade secrets and other intellectual property rights may be insufficient. While we enter into confidentiality agreements with our employees and third parties to protect our intellectual property rights, such confidentiality provisions related to our trade secrets could be breached and may not provide meaningful protection for our trade secrets. Also, others may independently develop technologies or products that are similar or identical to ours. In such case, our trade secrets would not prevent third parties from competing with us.

 

17
 

Third parties or employees may infringe or misappropriate our proprietary technologies or other intellectual property rights, which could harm our business and operating results. Policing unauthorized use of intellectual property rights can be difficult and expensive, and adequate remedies may not be available.

 

The sales cycle for our encapsulants can be lengthy and may result in uncertainty and delays in generating net sales.

 

The integration and testing of our encapsulants with prospective customers’ solar modules or enhancements to existing customers’ solar modules requires a substantial amount of time and resources. A customer may need up to one year and in some cases even longer, to test, evaluate and adopt our encapsulants and qualify a new solar module before ordering our encapsulants. Our customers then need additional time to begin volume production of solar modules that incorporate our encapsulants. As a result, the complete sales cycle for our business can be lengthy. We may experience a significant delay between the time we increase our expenditures for product development, sales and marketing efforts and raw materials inventory and the time we generate net sales, if any, from these expenditures.

 

As a supplier to solar module manufacturers, disruptions in any other component of the supply chain to solar module manufacturers may adversely affect our customers and consequently limit the growth of our business and net sales.

 

We supply a component to solar module manufacturers. If there are disruptions in any other area of the supply chain for solar module manufacturers, it could affect the overall demand for our encapsulants, which in turn would adversely affect our net sales.

 

We generally operate on a purchase order basis with our customers, and their ability to cancel, reduce, or postpone orders could reduce our net sales and increase our costs.

 

Net sales to our customers are typically made through non-exclusive, short-term purchase order arrangements that specify prices and delivery parameters. The timing of placing these orders and the amounts of these orders are at our customers’ discretion. Customers may cancel, reduce or postpone purchase orders with us prior to production on relatively short notice. If customers cancel, reduce or postpone existing orders or fail to make anticipated orders, it could result in the delay or loss of anticipated net sales, which could lead to excess raw materials inventory and unabsorbed overhead costs. Because our encapsulants have a limited shelf life from the time they are produced until they are incorporated into a solar module, we may be required to sell any excess inventory at a reduced price, or we may not be able to sell it at all and incur an inventory write-off, which could reduce our net sales and increase our costs.

 

Our substantial international operations and shift of business focus to emerging markets subject us to a number of risks.

 

Of our total net sales, approximately 100% were generated from outside the United States in each of the years ended December 31, 2016 and 2015. Our international operations are subject to a number of risks that could have a material adverse effect on our business, financial condition, results of operations or cash flow, including:

 

a module manufacturer’s unwillingness to purchase from foreign-owned companies;
     
difficulty in enforcing agreements in foreign legal systems and in the collection of trade accounts receivable;
     
foreign countries may impose additional withholding taxes or otherwise tax our foreign income, impose tariffs or adopt other restrictions on foreign trade and investment, including currency exchange controls;
     
protectionist laws and business practices that favor local companies;
     
difficulties in securing, servicing and increasing net sales to foreign customers;
     
potentially adverse tax consequences;
     
18
 
     
fluctuations in exchange rates may affect product demand and may adversely affect our profitability in U.S. dollars;
     
potential noncompliance with a wide variety of laws and regulations, including the U.S. Foreign Corrupt Practices Act of 1977 (“FCPA”), the Office of Foreign Assets Control and similar non-U.S. laws and regulations;
     
operations in parts of the world where strict compliance with anti-bribery laws may conflict with local practices and customs;
     
inability to obtain, maintain or enforce intellectual property rights and otherwise protect against clone or “knock off” products;
     
labor strikes, especially those affecting transportation and shipping;
     
risk of nationalization of private enterprises;
     
changes in general economic and political conditions in the countries in which we operate, including changes in the government incentives on which our module manufacturing customers and their customers rely;
     
multiple, conflicting and unexpected adverse changes in foreign laws or regulatory requirements, including those with respect to local content rules, environmental protection, export duties, import duties and quotas;
     
disruptions in our business operations or damage to strategic assets that may not be recoverable from applicable insurance policies caused by potential unfavorable weather patterns in certain locations of the world including, but not limited to, nor’easters, blizzards, earthquakes, typhoons and hurricanes;
     
terrorist attacks and acts of violence or war;
     
difficulty with developing staffing and simultaneously managing widespread operations as a result of, among other things, distance, language and cultural differences; and
     
difficulty of and costs relating to compliance with the different commercial and legal requirements of the international markets in which we operate.

 

Our China operations are subject to national, regional and local regulation. The regulatory environment in China is evolving, and officials in the Chinese government exercise broad discretion in deciding how to interpret and apply regulations. It is possible that the Chinese government’s current or future interpretation and application of existing or new regulations will negatively impact our China operations, result in regulatory investigations or lead to fines or penalties. Our planned operations in India will require us to comply with local laws and regulatory requirements, which are complex and of which may not always be aware, and may expose us to foreign currency exchange rate risk. Our planned Indian operations may also subject us to trade restrictions, reduced or inadequate protection for intellectual property rights, security breaches and other factors that may adversely affect our business. Negative developments in any of these areas could increase our costs of operations or otherwise harm our business.

 

We may be subject to claims that we have infringed, misappropriated or otherwise violated the patent or other intellectual property rights of a third party. The outcome of any such claims is uncertain and any unfavorable result could adversely affect our business, financial condition and results of operations.

 

We may be subject to claims by third parties that we have infringed, misappropriated or otherwise violated their intellectual property rights. These claims may be costly to defend, and we may ultimately be unsuccessful. An adverse determination in any such litigation could subject us to significant liability to third parties (potentially including treble damages), require us to seek licenses from third parties (which may not be available on reasonable terms, or at all), make substantial one-time or ongoing royalty payments, redesign our products or subject us to temporary or permanent injunctions prohibiting the manufacture and sale of our products, the use of our technologies or the conduct of our business. Protracted litigation could also result in our customers or potential customers deferring or limiting their purchase or use of our products until resolution of such litigation. In addition, we may have no insurance coverage in connection with such litigation and may have to bear all costs arising from any such litigation to the extent we are unable to recover them from other parties. Any of these outcomes could have a material adverse effect on our business, financial condition and results of operations.

 

19
 

Our business could be adversely affected by seasonal trends, incentive policy changes and construction cycles.

 

We may be subject to industry-specific seasonal fluctuations in the future, particularly in climates that experience colder weather during the winter months. There are various reasons for periodic fluctuations, mostly related to economic incentives and weather patterns. A change in government incentives may result in the pull-in of demand from solar module manufacturers due to increased end-user demand driven by the incentive to purchase a solar system prior to the enactment of the decreased feed-in tariff. As a result, we may see atypical net sales during one reporting period as compared to another. In addition, our Spanish operation tends to have lower net sales during the third quarter of the year due to the European summer vacation, which occurs in August. Our net sales are also typically lower in December, as module manufacturers often defer purchases of our encapsulants to the next calendar year due to reduced consumption during the holiday period and the desire to reduce year-end inventory. Solar module customers will sometimes make purchasing decisions toward the end of the year in order to take advantage of tax credits or for budgetary reasons. In addition, construction activity is typically slower in colder months, especially in light of dangerous or difficult conditions brought about by ice and snow and frozen ground. Finally, due to the rapid emergence of Chinese module manufacturers and the resulting global market share they possess, Chinese New Year can impact the production schedules of our Chinese customers, which could impact demand for our encapsulants during the first quarter of the year. Accordingly, our business and results of operations could be affected by similar fluctuations in the future.

 

Fluctuations in exchange rates could have an adverse effect on our results of operations, even if our underlying business results improve or remain steady.

 

Our reporting currency is the U.S. dollar, and we are exposed to foreign exchange rate risk because a significant portion of our net sales and costs are currently denominated in foreign currencies, primarily Euros and Chinese renminbi, which we convert to U.S. dollars for financial reporting purposes. We currently do not engage in any hedging activities with respect to currency fluctuations. Changes in exchange rates on the translation of the earnings in foreign currencies into U.S. dollars are directly reflected in our financial results. To the extent the value of the U.S. dollar increases against these foreign currencies, it will negatively impact our net sales, even if our results of operations have improved or remained steady. While the currency of our net sales and costs is generally matched, to the extent our costs and net sales are not denominated in the same currency for a particular location, we could experience further exposure to foreign currency fluctuations. We cannot predict the impact of future exchange rate fluctuations on our results of operations and may incur net foreign currency losses in the future.

 

We are a holding company with no business operations of our own and depend on our subsidiaries for cash.

 

We are a holding company with no significant business operations of our own. Our operations are conducted through our subsidiaries. Dividends from, and cash generated by, our subsidiaries are our principal sources of cash to repay any future indebtedness, fund operations and pay any stockholder dividends. Accordingly, our ability to repay any indebtedness, fund operations and pay any dividends to our stockholders is dependent on the earnings and the distributions of funds from our subsidiaries.

 

Compliance with environmental and health and safety regulations can be expensive, and noncompliance with these regulations may result in adverse publicity, potentially significant liabilities, monetary damages and fines.

 

We are required to comply with federal, state, local and foreign laws and regulations regarding protection of the environment and health and safety. If more stringent laws and regulations are adopted in the future, the costs of compliance with these new laws and regulations could be substantial. If we do not comply with such present or future laws and regulations or related permits, we may be required to pay substantial fines, suspend production or cease operations. We use, generate and discharge hazardous substances, chemicals and wastes in our product development and manufacturing activities. In addition, some of our facilities are located on properties with a history of use involving hazardous substances, chemicals and wastes and may be contaminated. We have performed environmental investigations and remediation activities at our 10 Water Street, Enfield, Connecticut and our former (sold in 2014) 18 Craftsman Road, East Windsor, Connecticut locations. During our investigations, each site was found to contain the presence of various contaminants. Any failure by us to control the use of, to remediate the presence of, or to restrict adequately the discharge of, such substances, chemicals or wastes could subject us to potentially significant liabilities, clean-up costs, monetary damages, fines or suspensions in our business operations. See Item 1,-Business,-Environmental Regulation. We cannot assure that we will not discover further environmental contamination or that we would not be required to incur significant expenditures for environmental remediation in the future.

 

We may undertake acquisitions, investments, joint ventures or other strategic alliances, which may have a material adverse effect on our ability to manage our business, and such undertakings may be unsuccessful.

 

Acquisitions, joint ventures and strategic alliances may expose us to new operational, regulatory, market and geographic risks as well as risks associated with additional capital requirements.

 

20
 

These risks include, among other things:

 

our inability to integrate new operations, personnel, products, services and technologies;
     
unforeseen or hidden liabilities, including exposure to lawsuits associated with newly acquired companies;
     
the diversion of resources from our existing business;
     
disagreement with joint venture or strategic alliance partners;
     
contravention of regulations governing cross-border investment;
     
failure to comply with laws and regulations, as well as industry or technical standards of the overseas markets into which we expand;
     
our inability to generate sufficient net sales to offset the costs and expenses of acquisitions, strategic investments, joint ventures or other strategic alliances;
     
potential loss of, or harm to, employee or customer relationships;
     
diversion of our management’s time; and
     
disagreements as to whether opportunities belong to us or the joint venture.

 

Any of these events could disrupt our ability to manage our business, which in turn could have a material adverse effect on our financial condition and results of operations. Such risks could also result in our failure to derive the intended benefits of the acquisitions, strategic investments, joint ventures or strategic alliances, and we may be unable to recover our investment in such initiatives.

 

Unanticipated changes in our tax provisions, the adoption of a new U.S. tax legislation, or exposure to additional income tax liabilities could affect our financial results.

 

We are subject to income taxes in the United States and the foreign jurisdictions in which we operate. Our tax liabilities are affected by the amounts we charge for intercompany transactions. We are subject to potential tax examinations in these various jurisdictions. Tax authorities may disagree with our intercompany charges, cross-jurisdictional transfer pricing or other tax positions and assess additional taxes. We regularly assess the likely outcomes of these examinations in order to determine the appropriateness of our tax provision in accordance with ASC 740, Income Taxes. However, there can be no assurance that we will accurately predict the outcomes of these potential examinations, and the amounts ultimately paid upon resolution of examinations could be materially different from the amounts previously included in our income tax expense and therefore, could have a material impact on our tax provision, net earnings, and cash flows. In addition, our future effective tax rate could be adversely affected by changes to our operating structure, changes in the mix of earnings, changes in the valuation of deferred tax assets and liabilities, changes in tax laws, and the discovery of new information in the course of our tax return preparation process.

 

We have received financial incentives from government bodies in certain foreign jurisdictions that are based on the maintenance of various requirements. If such requirements are not maintained, we may lose the financial incentives, which could negatively impact our results of operations and financial condition.

 

We have received financial incentives from government entities in certain foreign jurisdictions based on the maintenance of various requirements. For example, our Spanish subsidiary has received grants for production equipment that require us to maintain a specific level of employment and use of assets.

 

If we do not satisfy these requirements in the future, we may not qualify for future incentives or may be required to refund a portion of previously granted incentives, which could negatively impact our results of operations and financial condition.

 

21
 

The acquisition of control of us by Zhenfa, a Chinese company, may expose us to greater regulatory scrutiny.

 

At various times during recent years, the governments of the United States and China have had disagreements over political and economic issues. Controversies may arise in the future between these two countries. Any political or trade controversies between the United States and China could adversely affect our ability to successfully conduct our business in China, the market price of our common stock and our ability to access the capital markets in the United States. Also, as a result of recent controversies involving Chinese controlled companies, it is possible that such companies have come under increased scrutiny in the United States and other countries. If we become subject to enhanced regulatory review and oversight, responding to such review and oversight may be expensive and time consuming and may have a material adverse effect on our operations, even if we otherwise have complied with all legal and regulatory requirements.

 

A lawsuit has been filed against us, which, if not resolved in a manner favorable to us, could adversely affect our financial condition and results of operation.

 

In October 2016, a complaint was filed by Solaria Energia y Medio Ambiente S.A. (“Solaria”) against us and our Spanish subsidiary, Specialized Technology Resources España S.A. (“STR Spain”), in the Court of the First Instance No. 8 in Oviedo, Spain, relating to a product quality claim in connection with a non-encapsulant product that STR Spain purchased from a vendor in 2005 and 2006 and resold to Solaria. Solaria is seeking approximately €3.3 million, plus interest, in damages.

 

While we believe we have meritorious defenses against the claim, if such claim is not resolved in a manner favorable to us it may result in significant financial liability, which in turn could have a material adverse effect on our financial condition and results of operations.

 

Certain of our directors and officers may be located outside of the United States.

 

Certain of our directors and officers are not United States citizens or may reside outside of the United States. It may not be possible for our stockholders to effect service of process upon such directors and officers within the United States, to bring action against such directors or officers or to enforce against such directors or officers court judgments based on the civil liabilities provisions of the federal securities laws of the United States. Further, it is unclear if extradition treaties now in effect between the United States and China (and, for that matter, any other country that one of our directors or officers may be a citizen of or reside in) would permit effective enforcement of criminal penalties against our directors outside of the United States under the United States Federal securities laws or otherwise.

 

Risks Related to Owning Our Common Stock

 

We currently have fewer than 300 stockholders of record and, therefore, are eligible to terminate the registration of our common stock under the Exchange Act.

 

As a public company with fewer than 300 stockholders of record, we currently register our shares of common stock under the Exchange Act, on a voluntary basis. Section 12(g)(4) of the Exchange Act allows for the registration of any class of securities to be terminated 90 days after a company files a certification with the SEC that the number of holders of record of such class of security is fewer than 300 persons. Upon the effectiveness of the termination of registration under Section 12, we would not be required to comply with certain disclosure requirements under the Exchange Act, including, but not limited to, proxy statement filings and filings by insiders to disclose the acquisition and disposition of our securities. In addition, upon the filing of the certification with the SEC, our obligation to file annual, quarterly and current reports under Section 12(g) of the Exchange Act would be immediately suspended. If we cease filing periodic and current reports for any reason, investors would have limited access to information about our business, which may reduce the value of our common stock and also affect your ability to sell our common stock.

 

Our common stock was suspended from the New York Stock Exchange (the "NYSE") on September 29, 2015 (and subsequently delisted) and we began trading on the OTC Marketplace on September 30, 2015. Delisting from the NYSE could limit the liquidity of our common stock, and hinder our ability to raise additional capital as well as having other negative results.

 

Our common stock was suspended from the New York Stock Exchange (the "NYSE") on September 29, 2015 (and subsequently delisted) due to our failure to satisfy the NYSE's continued listing criteria. Our common stock currently trades on the OTCQX Marketplace under the symbol “STRI," which is a less prestigious and less active marketplace. Accordingly, liquidity in the trading of our common stock could be limited, which could limit the ability of our stockholders to sell our common stock in the secondary market.

 

22
 

On December 1, 2016, we were notified by the OTCQX that the Company did not meet the OTCQX Requirements for Continued Qualification found in Section 3.2 of the OTCQX Rules for U.S. Companies due to the Company failing to maintain a market capitalization of at least $5.0 million for at least one of every 30 consecutive calendar days. The OTCQX has granted us a 60 day extension beginning on January 3, 2017 with a re-evaluation on or after February 28, 2017. Following that re-evaluation, if our market capitalization has not returned to at least $5.0 million, our stock will move to trading on the OTCQB market. As of the date hereof, our stock continues to trade on the OTCQX.

 

Additionally, trading on an over-the-counter quotation system could adversely affect our ability to raise additional financing through public or private sales of equity securities and could also have other negative results, including the loss of institutional investor interest and fewer business development opportunities.

 

Our common stock is classified as a “penny stock” and trading of our shares may be restricted by the SEC’s penny stock regulations.

 

Rules 15g-1 through 15g-9 promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), impose sales practice and disclosure requirements on certain brokers-dealers who engage in transactions involving a “penny stock.” The SEC has adopted regulations which generally define “penny stock” to be any equity security that has a market price of less than $5.00 per share or an exercise price of less than $5.00 per share, other than securities registered on certain national securities exchanges, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or system. Our common stock is covered by the penny stock rules, which impose additional sales practice requirements on broker-dealers who sell to persons other than established customers and “accredited investors.” The penny stock rules require a broker-dealer, prior to a transaction in a penny stock not otherwise exempt from the rules, to deliver a standardized risk disclosure document in a form prepared by the SEC which provides information about penny stocks and the nature and level of risks in the penny stock market. The broker-dealer also must provide the customer with current bid and offer quotations for the penny stock, the compensation of the broker-dealer and its salesperson in the transaction, and monthly account statements showing the market value of each penny stock held in the customer’s account. In addition, the penny stock rules require that, prior to a transaction in a penny stock that is not otherwise exempt, the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser’s written agreement to the transaction. These disclosure requirements may have the effect of reducing the level of trading activity in the secondary market for stock that is subject to these penny stock rules. Consequently, these penny stock rules may affect the ability of broker-dealers to trade our securities. We believe that the penny stock rules may discourage investor interest in and limit the marketability of our common shares.

 

We expect that our stock price may continue to fluctuate significantly, which could cause the value of your investment to decline, and you may not be able to sell your shares at or above your purchase price.

 

Over the past few years the market prices of many companies in the solar industry have been extremely volatile. This market volatility, as well as general economic, market or political conditions, could reduce the market price of our common stock regardless of our operating performance. The trading price of our common stock is likely to continue to be volatile and subject to wide price fluctuations in response to various factors, including:

 

actual or anticipated fluctuations in our financial and operating results, including our cash balance;
     
market conditions in the broader stock market;
     
potential short selling interest in our common stock;
     
the amount of public float that trades regularly;
     
introduction of new products by us or our competitors;
     
issuance of new or changed securities analysts’ reports or recommendations;
     
investor perceptions of us and the solar energy industry;
     
sales, or anticipated sales, of large blocks of our stock;
     
23
 
     
potential action of corporate raiders or other potential acquirers of us if our stock price is undervalued;
     
additions or departures of key personnel;
     
regulatory or political developments;
     
litigation and governmental investigations; and
     
changing economic conditions.

 

These and other factors may cause the market price and demand for our common stock to fluctuate substantially, which may limit or prevent investors from readily selling their shares of common stock and may otherwise negatively affect the liquidity of our common stock. In addition, in the past, when the market price of a stock has been volatile, holders of that stock have sometimes instituted securities class action litigation against the company that issued the stock or have become activist stockholders. If any of our stockholders brings a lawsuit against us, or becomes active with demands, we could incur substantial costs defending the lawsuit and responding to various requests. These events clearly could also divert the time and attention of our management from our business, which could significantly harm our profitability and reputation.

 

As a public company, we are subject to financial and other reporting and corporate governance requirements that may be difficult for us to satisfy.

 

We are required to file with the SEC annual and quarterly information and other reports that are specified in Section 13 of the Exchange Act. We are required to ensure that we have the ability to prepare financial statements that are fully compliant with all SEC reporting requirements on a timely basis. We are also subject to other reporting and corporate governance requirements and certain provisions of the Sarbanes-Oxley Act of 2002 and the regulations promulgated thereunder, which impose significant compliance obligations upon us. If we fail to maintain the requirements with respect to our internal accounting and audit functions, our ability to report our operating results on a timely and accurate basis could be negatively affected.

 

We have implemented the standards required by Section 404 of the Sarbanes-Oxley Act of 2002 (“Section 404”), and failure to maintain effective internal control over financial reporting in accordance with Section 404 could have a material adverse effect on us.

 

We have documented and tested our internal control procedures to satisfy the requirements of Section 404, which requires an annual management assessment of the effectiveness of our internal control over financial reporting. If we are unable to maintain adequate internal control over financial reporting, we may be unable to report our financial information on a timely basis and may suffer adverse regulatory consequences or violations of applicable stock exchange listing rules. There could also be a negative reaction in the financial markets due to a loss of investor confidence in us and the reliability of our financial statements.

 

If a substantial number of shares are sold in a short period of time, the market price of our common stock could decline.

 

If our stockholders sell substantial amounts of our common stock in the public market, the market price of our common stock could decrease significantly. The perception in the public market that such stockholders might sell shares of common stock could also depress the market price of our common stock. As of February 28, 2017, we had 19,307,482 shares of our common stock outstanding, some of which are owned by our directors, executive officers and affiliates. Subject to vesting requirements, these shares are eligible for sale in the public market. A decline in the price of shares of our common stock might impede our ability to raise capital through the issuance of additional shares of our common stock or other equity securities.

 

If securities or industry analysts do not publish research or reports about our business, if they adversely change their recommendations regarding our stock or if our results of operations do not meet their expectations, our stock price and trading volume could decline.

 

The trading market for our common stock may be influenced by the research and reports that industry or securities analysts publish about us or our business. If one or more of these analysts fail to publish reports on us regularly, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume to decline. Moreover, if one or more analysts downgrade our stock, or if our results of operations do not meet their expectations, our stock price could decline.

 

24
 

Some provisions of Delaware law and our certificate of incorporation and bylaws may deter third parties from acquiring us and diminish the value of our common stock.

 

Our certificate of incorporation and bylaws provide for, among other things:

 

restrictions on the ability of our stockholders to call a special meeting and the business that can be conducted at such meeting;
     
restrictions on the ability of our stockholders to remove a director or fill a vacancy on the Board of Directors;
     
our ability to issue preferred stock with terms that the Board of Directors may determine, without stockholder approval;
     
the absence of cumulative voting in the election of directors;
     
a prohibition of action by written consent of stockholders unless such action is recommended by all directors then in office; and
     
advance notice requirements for stockholder proposals and nominations.

 

These provisions in our certificate of incorporation and bylaws may discourage, delay or prevent a transaction involving a change of control of us that is in the best interest of our minority stockholders. Even in the absence of a takeover attempt, the existence of these provisions may adversely affect the prevailing market price of our common stock if they are viewed as discouraging future takeover attempts.

 

Zhenfa beneficially owns a controlling interest in our common stock and controls our Board of Directors. As a result, it is able to exert significant influence over us, and Zhenfa's interests may conflict with the interests of our other stockholders.

 

As a result of the Transaction with Zhenfa U.S., Zhenfa controls 48% of the voting power of our common stock as of December 31, 2016 and is able to, subject to certain conditions set forth in the Purchase Agreement, control or exert substantial influence over us, including the election of our directors and most matters requiring board or stockholder approval, including business strategies, mergers, business combinations, acquisitions or dispositions of significant assets, issuances of common stock, incurrence of debt or other financing and the payment of dividends. The controlling stockholder may have the effect of making it difficult for a third party to seek, or may discourage or delay a third party from seeking, to acquire a majority of our outstanding common stock, which could adversely affect the market price of our stock. Zhenfa maintains separate business operations from us. As a result, Zhenfa's interests may not always be consistent with the interests of our other stockholders. To the extent that conflicts of interest may arise among us, Zhenfa and its affiliates, those conflicts may be resolved in a manner adverse to our other stockholders.

 

ITEM 1B. Unresolved Staff Comments

 

Not applicable.

 

ITEM 2. Properties

 

Our principal executive offices are located at 10 Water Street, Enfield, Connecticut, 06082. This facility also headquarters our research and development function and has manufacturing capacity. Our other facilities are principally manufacturing facilities.

 

The following table summarizes information regarding our significant owned and leased facilities as of December 31, 2016:

 

Location   Square Feet   Owned/Leased   Manufacturing Status
Johor, Malaysia     142,270       Owned       Idle  
Asturias, Spain     105,000       Owned       Active  
Enfield, Connecticut     69,500       Owned       Idle  
Shajiabang, China     57,500       Leased       Active  

 

25
 

From time to time, we evaluate our production requirements and may close or consolidate existing facilities or open new facilities.

 

In August 2015, we ceased operations at our owned facility in Johor. In November 2016, a formal purchase and sale agreement was executed. Refer to Item 7, -Management’s Discussion and Analysis of Financial Condition and Results of Operations for further discussion.

 

ITEM 3. Legal Proceedings

 

From time to time, we are and have been a party to litigation that arises in the ordinary course of our business.

 

In October 2016, a complaint was filed by Solaria Energia y Medio Ambiente S.A. (“Solaria”) against the Company and its Spanish subsidiary, Specialized Technology Resources España S.A. (“STR Spain”), in the Court of the First Instance No. 8 in Oviedo, Spain, relating to a product quality claim in connection with a non-encapsulant product that STR Spain purchased from a vendor in 2005 and 2006 and resold to Solaria. The Company stopped selling this product in 2006. Solaria is seeking approximately €3.3 million, plus interest, in damages.

 

As of the date of this filing, the Company has filed its documentation answering the claim, as well as its technical report related to the claim, and is in compliance with the requirements of the court relative to the claim. A trial is scheduled for April 6, 2017, in Oviedo, Spain. The Company believes it has meritorious defenses and plans to vigorously defend the matter.

 

ITEM 4. Mine Safety Disclosures

 

Not applicable.

 

PART II

 

ITEM 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 

At February 28, 2017, there were approximately 26 holders of record of our common stock.

 

The table below sets forth the high and low sales prices per share of our common stock reported on the OTCQX and the NYSE, as applicable, for the periods indicated.

 

    Common Stock
Price Range
    High   Low
Fiscal 2016                
1 st  Quarter   $ 0.50     $ 0.25  
2 nd  Quarter     0.38       0.17  
3 rd  Quarter     0.35       0.15  
4 th  Quarter     0.28       0.15  

 

 

    Common Stock
Price Range
    High   Low
Fiscal 2015                
1 st  Quarter   $ 1.70     $ 0.50  
2 nd  Quarter     1.46       1.09  
3 rd  Quarter     1.18       0.37  
4 th  Quarter (1)     0.53       0.36  
                 

 

(1) Our common stock began trading on the OTC Pink Marketplace beginning on September 30, 2015 under the ticker symbol “STRI.” On October 5, 2015, our common stock began trading on the OTCQX Marketplace under the symbol “STRI.”

 

 

26
 

Dividend Program

 

In connection with the closing of the Transaction, we paid a special dividend (the “Special Dividend”) to all of our stockholders of record (other than Zhenfa U.S.) in an amount equal to $2.55 per share on January 2, 2015.

 

Other than the Special Dividend, we have not declared or paid cash dividends on our common stock during the two most recent fiscal years. Any future determination to pay dividends will be at the discretion of our Board of Directors and will take into account:

 

our financial condition and results of operations;
     
general economic and business conditions;
     
our capital requirements;
     
the ability of our operating subsidiaries to pay dividends and make distributions to us; and
     
such other factors as our Board of Directors may deem relevant.

 

On January 30, 2015, we effected a one-for-three reverse split of our common stock.

 

ITEM 6. Selected Financial Data

 

We are not required to provide this Item 6 because we are a smaller reporting company.

 

 

27
 

ITEM 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion and analysis of the financial condition and results of our operations should be read together with our Consolidated Financial Statements and the related Notes to the Consolidated Financial Statements included in Item 8 of this Annual Report on Form 10 - K. This discussion contains forward - looking statements, based on current expectations and related to future events and our future financial performance, that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those set forth under Item 1A, - Risk Factors in this Annual Report on Form 10 - K.

 

Explanatory Note: All share amounts and per share amounts below have been adjusted to reflect the one-for-three reverse stock split effected as of January 30, 2015.

 

Forward-Looking Statements

 

This Annual Report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to inherent risks and uncertainties. These forward-looking statements present our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business and are based on assumptions that we have made in light of our industry experience and perceptions of historical trends, current conditions, expected future developments and other factors management believes are appropriate under the circumstances. However, these forward-looking statements are not guarantees of future performance or financial or operating results. Forward-looking statements include, but are not limited to, the statements regarding the following: (1) incurring substantial losses for the foreseeable future and our inability to achieve or sustain profitability in the future; (2) the potential impact of pursuing strategic alternatives, including dissolution and liquidation of our Company, winding up our operations in China, restructuring our business to align with our customers’ geography; (3) our reliance on a single product line and any contemplated pursuits of new market sectors; (4) our securing net sales to new customers, growing net sales to existing key customers and increasing our market share; (5) customer concentration in our business and our relationships with and dependence on key customers; (6) the outsourcing arrangements and reliance on third parties for the manufacture of a portion of our encapsulants; (7) technological changes in the solar energy industry or our failure to develop and introduce or integrate new technologies could render our encapsulants uncompetitive or obsolete; (8) competition; (9) our failure to manufacture product in China negatively affecting our ability to sell to Chinese solar module manufacturers; (10) excess capacity in the solar supply chain; (11) demand for solar energy in general and solar modules in particular; (12) our operations and assets in China being subject to significant political and economic uncertainties; (13) limited legal recourse under the laws of China if disputes arise; (14) our ability to adequately protect our intellectual property, particularly during the outsource manufacturing of our products; (15) our lack of credit facility and our inability to obtain credit; (16) a significant reduction or elimination of government subsidies and economic incentives or a change in government policies that promote the use of solar energy; (17) volatility in commodity costs; (18) our customers’ financial profile causing additional credit risk on our accounts receivable; (19) our dependence on a limited number of third-party suppliers for raw materials for our encapsulants and other significant materials used in our process; (20) potential product performance matters and product liability; (21) our substantial international operations and shift of business focus to emerging markets; (22) the impact of changes in foreign currency exchange rates on financial results, and the geographic distribution of revenues; (23) losses of financial incentives from government bodies in certain foreign jurisdictions; (24) compliance with the qualifications of the OTCQX; (25) the ability to realize synergies from the transaction with Zhenfa Energy Group Co., Ltd. (“Zhenfa”); and (26) the other risks and uncertainties described under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and in subsequent periodic reports on Form 10-K, 10-Q and 8-K. You are urged to carefully review and consider the disclosure found in our filings, which are available on http://www.sec.gov or http://www.strsolar.com. Should one or more of these risks or uncertainties materialize, or should any of these assumptions prove to be incorrect, actual results may vary materially from those projected in these forward-looking statements. We undertake no obligation to publicly update any forward-looking statement contained in this Annual Report, whether as a result of new information, future developments or otherwise, except as may be required by law.

 

Overview

 

We were founded in 1944 as a plastic and industrial materials research and development company and evolved into two core businesses: solar encapsulant manufacturing and quality assurance services. We launched our former Quality Assurance business (“QA”) in 1973 and we commenced sales of our solar encapsulant products in the late 1970s.

 

We are a provider of encapsulant to the solar module industry. Encapsulant is a critical component used in solar modules. Our PhotoCap ® products consist of ethylene-vinyl acetate (“EVA”), which is modified with additives and put through our proprietary extrusion manufacturing process to increase product stability and make the encapsulant suitable for use in extreme, long-term outdoor applications. Our encapsulants can be used in both crystalline silicon and thin-film solar modules. To date, over 20 GW of solar modules utilizing our encapsulants have been installed in the field with no reported module power performance issues being caused by our encapsulants.

 

28
 

Prior to its divestiture in September 2011, QA provided product development, inspection, testing and audit services that enabled retailers and manufacturers to determine whether products met applicable safety, regulatory, quality, performance and social standards.

 

On September 1, 2011, we completed the sale of QA to Underwriters Laboratories, Inc. (“UL”). This strategic divestiture was executed to allow us to focus exclusively on the solar encapsulant opportunity and to seek further product offerings related to the solar industry, as well as other growth markets related to our polymer manufacturing capabilities, and to retire our long-term debt.

 

QA’s historical operating results are recorded in discontinued operations in the Consolidated Statements of Comprehensive Loss and Cash Flows for all periods presented where applicable.

 

Current Business Environment, Components of Net Sales and Expenses and Anticipated Trends

 

Strategic Focus

 

We continue to operate at a substantial net loss. We incurred net losses from continuing operations of approximately $15.9 million and $13.4 million for the years ended December 31, 2016 and 2015, respectively.

 

Our business unit in China (“STR China”) incurred a loss of approximately $5.8 million during 2016, including a bad debt expense of $1.5 million. In light of continued poor financial results of STR China, we have decided to conduct an orderly wind down of our China manufacturing operations to eliminate operating losses related to this business unit. Given that our China factory has been manufacturing encapsulants for sale outside of China, we are currently working to accommodate production in the primary export market, namely India.

 

We continue to explore options for reorganizing of our encapsulant business to better align with customer geography, to reduce the cash burn related to unprofitable locations and to convert assets to cash for potential redeployment into more profitable endeavors, and possible business opportunities in potentially more profitable parts of the solar supply-chain, as well as other strategic alternatives. We cannot assure that we will be able to successfully pursue any such potential transactions. If we are successful in pursuing any such transactions, we may be required to expend significantly dilute our current stockholders and may negatively affect our operating results and financial condition. We cannot assure that any such strategic transactions, or any financing in connection therewith, would be available on favorable terms, if at all, or that we will realize any anticipated benefits from any such transactions that we complete. In the event that we are not successful in restructuring our encapsulant business or pursuing opportunities in the downstream solar market or other strategic transactions, we also intend to consider alternatives, including without limitation, the acquisition of another business, the divestiture of all or certain of our assets, joint ventures and other transactions outside the ordinary course of business.

 

If we are not successful in executing on our strategic plans to reorganize our encapsulant business and achieve profitability, we may decide to wind down or cease any or all of our operations.

 

In addition, any further wind-down or dissolution of us may be a lengthy and complex process, yield unexpected results and delay any potential distributions to our stockholders. Such process may also require the further expenditure of our resources, such as legal, accounting and other professional fees and expenses and other related charges, which would decrease the amount of assets available for distributions to our stockholders.

 

Recent Developments

 

Manufacturing Facility Fire

 

During October 2016, our manufacturing plant located in Shajiabang, Jiangsu, China suffered a fire that damaged a portion of its production facility. No employee injuries have been reported. As of the date of this report, the facility has been restored to operational condition and one of our two production lines is operating. The second production line was ruled a total loss by our insurer and has been removed from the facility and disposed of. We have insurance coverage and are currently working with our agents and the carrier to finalize the claim related to this event. During 2016, a $0.9 million loss on disposal of fixed assets was recorded.

 

29
 

Zhenfa Module-for-Encapsulant Swap Transaction

 

During the second quarter of 2015, the Company entered into a module-for-encapsulant swap transaction with Zhenfa and Zhejiang ReneSola Jiangsu Co., Ltd. (“ReneSola”) to settle outstanding accounts receivable due from ReneSola. As part of this three-party transaction, the Company agreed to accept solar modules as settlement of approximately $7.5 million of outstanding receivables from ReneSola, and Zhenfa agreed to purchase these modules from the Company for $7.5 million. During the third quarter of 2016, the Company increased the amount due by approximately $1.2 million to reflect an inadvertent overpayment of modules made to Zhenfa by ReneSola. In October 2016, the Company received bank acceptance notes and cash from Zhenfa for approximately $3.2 million in full payment of the balance due under these arrangements.

 

2014 Transaction with Zhenfa

 

In 2014, we entered into certain definitive agreements with Zhenfa and its indirect wholly-owned subsidiary, Zhen Fa New Energy (U.S.) Co., Ltd., a Nevada corporation (“Zhenfa U.S.”).

 

Purchase Agreement and Special Dividend

 

On August 11, 2014, we entered into a Stock Purchase Agreement (the “Purchase Agreement”) with Zhenfa U.S., pursuant to which we agreed to issue and sell to Zhenfa U.S., and Zhenfa U.S. agreed to purchase from us, an aggregate of approximately 9.2 million shares (the “Purchased Shares”) of our common stock for an aggregate purchase price (“Purchased Price”) of approximately $21.7 million, or $2.35 per share (the “Transaction”). The Purchased Shares represented approximately 51% of our outstanding shares of common stock upon the closing of the Transaction (the “Closing”) , which occurred on December 15, 2014.

 

In connection with the Closing, we declared a special dividend (the “Special Dividend”) on December 11, 2014 to be paid to all of our stockholders of record (other than Zhenfa U.S.) in an amount equal to $2.55 per common share on January 2, 2015. The cash used to pay the Special Dividend was paid to our transfer agent as of December 31, 2014.

 

Sales Service Agreement

 

In connection with the execution of the Purchase Agreement, Specialized Technology Resources, Inc., our wholly owned subsidiary, entered into a sales service agreement (the "Sales Service Agreement") with Zhenfa, whereby Zhenfa agreed, among other things, to assist us in a number of endeavors, including, without limitation, marketing and selling our products in China, acquiring local raw materials, hiring and training personnel in China, and complying with Chinese law. The Sales Service Agreement also provided us an option to lease a Zhenfa-owned manufacturing facility rent free for a period of five years, which expired on December 15, 2016. The Sales Service Agreement became effective on the date of Closing, for an initial term of two years, and automatically renews for one year periods unless terminated earlier. The Sales Service Agreement may also be terminated by either party at such time as Zhenfa and its affiliates own less than 10% of our outstanding Common Stock.

 

Net Sales

 

Our net sales are derived from the sale of encapsulants to solar module manufacturers. Net sales to our customers are typically made through non-exclusive, short-term purchase order arrangements that specify prices and delivery parameters but do not obligate the customer to purchase any minimum amounts. Our customers are solar module manufacturers located mainly in North America, Europe and Asia.

 

We expect that our results of operations for the foreseeable future will depend primarily on the sale of encapsulants to a relatively small number of customers. We believe the concentration will increase as we expect a consolidation of module manufacturers driven in part by overcapacity. Our top five customers accounted for approximately 51% and 49% of our net sales in 2016 and 2015, respectively. Global Wedge, Inc. and Heckert Solar accounted for at least 10% of our net sales, and in the aggregate accounted for approximately 33% of our net sales for the year ended December 31, 2016. ReneSola and Global Wedge, Inc. accounted for at least 10% of our net sales, and in the aggregate accounted for approximately 28% of our net sales for the year ended December 31, 2015.

 

30
 

Our net sales are significantly driven by end-user demand for solar modules. As more solar modules are sold, there is greater demand from module manufacturers for encapsulants. The solar power industry is impacted by a variety of factors, including government subsidies and incentives, availability of financing, worldwide economic conditions, environmental concerns, energy costs, the availability of polysilicon and other factors. A key demand driver for solar module growth in the future will be the ability of solar module manufacturers and downstream solar system installers to reduce their cost structure, primarily in the balance of system cost components such as inverters, installation costs, wiring, racking and logistics. Increased competition, particularly from China, and continued vertical integration of many manufacturers in the solar supply chain have resulted in a sharp increase in capacity over the last several years. Overcapacity and increased competition caused many module manufacturers to significantly reduce the selling price of their modules as the extra capacity drove a severe inventory build and or poor absorption resulting from idle capacity. As a result of falling prices, many companies in the solar supply chain lacked profitability. From an industry standpoint, the reduction in module selling prices has improved rates of return on solar investments for the end-user. We believe this is a long-term industry trend and will help to bring solar energy costs closer to grid-parity and in turn will increase demand for solar encapsulants. In 2016, the industry achieved record production and installations, but also experienced steep reductions in average selling price (“ASP”), as much as approximately 30% in the unit cost of solar panels, which has in turn resulted in pricing pressure for solar module components such as encapsulants. The growth in 2016 prompted many module manufacturers to add new capacity, approximately 20 GW in China, ahead of a mid-year policy pullback that has resulted in a return to overcapacity, prompting a strong environment of ASP decline and pricing pressure throughout the solar supply chain.

 

Demand for encapsulants also depends in large part on government incentives aimed to promote greater use of solar energy. The types of government incentives vary from country to country as well as on a more local level, and can change rapidly. As the industry continues to reduce the cost of solar power, we expect the level of government subsidies to continue to decrease.

 

Even though we expect reduced solar module demand in the European Union and continued reduction in government subsidies in the next few years, we anticipate an increase in global demand for solar energy, particularly in China and the United States. This increase will be primarily driven by solar energy becoming more cost effective as a result of continued cost reductions in module selling prices and balance of system costs and continued emergence of end-user financing. In addition, many foreign governments such as India, Taiwan and Japan, as well as certain state regulatory entities, have enacted renewable portfolio standards that require utilities to increase their production of energy from renewable sources.

 

Pricing of our encapsulants is impacted by the competition faced by our customers, and the quality and performance of our encapsulant formulations, including their impact on improving our customers’ manufacturing yields, their historical in- field performance, our ability to meet our customers’ delivery requirements, overall supply and demand levels in the industry and our customer service and technical support. Historically, we typically priced our encapsulants at a premium to our competition based on product attributes that, among other benefits, provide a high value proposition to our customers in a period of tight capacity. During the past few years, however, the excess capacity that existed at most module manufacturers has reduced the value proposition of the throughput and other production efficiencies that our encapsulants provide and has caused encapsulant cost to become a more important factor in the procurement process for many customers. In addition, low-cost competition from China has intensified competition. Based on these factors, we experienced an ASP decline during 2016 of approximately 8% from the prior year.

 

For several years, we have been working to increase our market share in China through investments in people, research and development and facilities.

 

We have also entered into a strategic transaction with Zhenfa and certain of its affiliates (the “Zhenfa Group”) to help us increase our net sales in China.

 

Notwithstanding these efforts, we have continued to face losses related to our operations in China.

 

Our factory in China has recently derived a majority of its sales not from China but rather from India. Our experience in India thus far is that the payment terms there are acceptable and that timeliness of payment is generally good. We have therefore been working for several months to qualify a tolling partner in India and plan to launch commercial-scale production of our products within India during the second quarter of 2017.

 

The future growth and success in our encapsulant business depends on the ability of our customers to grow and our ability to meet any demand arising from such growth and to grow by adding new customers. If our customers do not increase production of solar modules, there will be no corresponding overall increase in their encapsulant orders. It is possible that our customers may reduce their purchases from us. If our customers do not grow or they find alternative sources for encapsulants to meet their demands, it could limit our ability to grow our business and increase our net sales.

 

31
 

Cost of Sales

 

Cost of sales consists of our costs of raw materials, direct labor, manufacturing overhead, salaries, other personnel-related expenses, write-offs of excess or obsolete inventory, quality control, freight, insurance, disposition of defective product and depreciation of fixed assets. Approximately 78% of our cost of sales is variable in nature; 16% is step-variable and relates to direct labor cost and is fixed in the short-term, while the remaining 6% is fixed. Resin constitutes the majority of our raw material costs at approximately 49% of our cost of sales. The price and availability of resin and other raw materials are subject to market conditions affecting supply and demand and are subject to volatility. We do not believe that resin can be effectively hedged in the commodity markets.

 

Prior to 2014, we manufactured all of the products that we sold. In January 2014, our Hong Kong subsidiary entered into a manufacturing agreement, pursuant to which, certain of our solar encapsulant products were and continue to be manufactured by others according to our specifications. We have supplied and expect to continue to supply our manufacturing partners with all of the proprietary information and assistance necessary to manufacture the covered products to our specifications, and we actively monitor their process and the quality of the product they manufacture under contract with us.

 

Gross Loss

 

Gross loss is affected by numerous factors, including our average selling prices, fluctuations in foreign exchange rates, seasonality, our manufacturing costs and the effective utilization of our facilities. Another factor impacting gross loss is the time required for new production facilities and the expansion of existing facilities to reach full production capacity. During 2015, following a recent decision by our largest customer in Malaysia to exit its OEM module production in that country, we decided to cease production at our Malaysian facility. We recorded less than $0.1 million and $0.8 million of associated non-recurring restructuring costs in cost of sales in 2016 and 2015, respectively. In total, we incurred $0.1 million and $0.9 million of restructuring charges recorded in cost of sales associated with our recent cost reduction efforts in 2016 and 2015, respectively. During 2016 and 2015, we recorded a gross loss of $2.0 million and $1.8 million, respectively, primarily due to decreased volume and a decline in ASP as well as lower absorption of fixed costs.

 

Selling, General and Administrative Expenses (“SG&A”)

 

Our selling expenses consist primarily of salaries, travel and other personnel-related expenses for employees engaged in sales, marketing and support of our products and services, trade shows and promotions. General and administrative expenses consist mainly of insurance, outside professional fees and expenses for our finance, administrative, information technology, legal and human resource functions.

 

During 2016 and 2015, we recorded less than $0.1 million and $0.5 million of non-recurring restructuring costs related to the closure of the Malaysia facility, respectively, as discussed above. We incurred $0.1 million and $0.7 million of restructuring charges in SG&A during 2016 and 2015, respectively.

 

Research and Development Expense

 

We have a long history of innovation dating back to our establishment in 1944 as a plastics and polymer research and development firm. As our operations expanded from solely providing research and development services into the manufacturing of solar encapsulants, we created a separate research and development function accounting that tracks employees and costs that are fully dedicated to research and development activities. Our research and development expense consists primarily of salaries and fringe benefit costs and the cost of materials and outside services used in our pre-commercialization process and product development efforts. We also record depreciation expense for equipment that is used specifically for research and development activities.

 

We incurred $1.2 million and $1.3 million of research and development expense in 2016 and 2015, respectively. We expect annual research and development expense to decrease for the near-term based upon on-going cost reduction measures.

 

Provision for Bad Debt Expense

 

We reserve for estimated losses that may result from the inability of our customers to make required payments. We review the collectability of our receivables on an ongoing basis and reserve for uncollectible accounts after reasonable collection efforts have been made and collection is deemed doubtful.

 

32
 

Our bad debt expense in prior years was the result of many solar module manufacturers declaring bankruptcy due to continued solar industry consolidation and our customers’ inability to compete, and more recently due to the poor financial condition and/or payment practices of certain customers (mainly in China). We expect our bad debt expense to decrease going forward as the solar industry transitions to a sustainable, self-supporting industry. In 2016 and 2015 we recorded a bad debt expense of $2.4 million and a bad debt recovery of $0.3 million, respectively.

 

Interest (Expense) Income, Net

 

Interest (expense) income, net was comprised of interest income earned on our cash and cash equivalents.

 

We expect our interest income to increase in 2017 due to having higher cash balances primarily resulting from the proceeds from the expected sale of our Malaysia facility. In 2016 and 2015 we recorded less than $0.1 million of interest income and less than $0.1 million of interest expense, respectively.

 

Other (Expense) Income, Net

 

In July 2015, we announced a restructuring plan that included the closure of our Malaysia facility, effective August 2, 2015. During the first six months of 2016, we received and accepted an offer of RM25.0 million ($6.3 million as of June 30, 2016) for the land-use right and building. We entered into a definitive agreement (“Purchase and Sale Agreement”) on November 18, 2016. As a result of the pending sale (subject to the approval of the Johor Port Authority), an analysis of the asset group was performed and an impairment of assets held for sale of $1.7 million was recorded during 2016 and a loss on reclassification of $0.7 million was recorded during 2015.

 

Foreign Currency Transaction (Loss) Gain

 

Foreign currency transaction (loss)/gain is primarily the result of changes in the Euro, Hong Kong dollar, Chinese renminbi and Malaysian ringgit exchange rates. The majority of our foreign exchange exposure is due to U.S. denominated accounts receivable at our Spain facility, the settlement of intercompany transactions, U.S. cash balances held in foreign locations and non-resin costs incurred by our Malaysia subsidiary whose functional currency is the U.S. dollar, the currency that it formerly used to invoice customers and procure resin.

 

Income Taxes

 

Income tax expense (benefit) is comprised of federal, state, local and foreign taxes based on income in multiple jurisdictions and changes in uncertain tax positions. Starting in 2015, we were no longer able to carryback operating losses for U.S. federal tax purposes and we no longer record an income tax benefit in our consolidated statement of comprehensive loss. We expect to record a full valuation allowance against any taxable loss until, and if, we generate taxable income in the U.S.

 

Critical Accounting Policies

 

Our discussion and analysis of our consolidated financial position and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles (”GAAP”). The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, net sales and expenses, and related disclosures of contingent assets and liabilities. We continually evaluate our estimates, including those related to bad debts, valuation of inventory, long-lived assets, product performance matters, income taxes, stock-based compensation and deferred tax assets and liabilities. We base our estimates on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions.

 

The accounting policies we believe to be most critical to understanding our financial results and condition and that require complex and subjective management judgments are discussed below.

 

Revenue Recognition and Accounts Receivable

 

We recognize revenue when evidence of an arrangement exists, delivery of the product has occurred and title and risk of loss have passed to the customer, the sales price is fixed or determinable, and collectability of the resulting receivable is reasonably assured.

 

33
 

Our business recognizes revenue from the manufacture and sale of its encapsulants, which is the only contractual deliverable, either at the time of shipping or at the time the product is received at the customer’s port or dock, depending upon terms of the sale.

 

We do not offer general rights of return on our product. On isolated occasions, we have offered limited short-term performance warranties relating to our encapsulants not causing module power loss. This type of arrangement may increase or decrease in 2017. Our encapsulants are validated by long-term performance testing during product development prior to launch and during customer certification prior to mass production.

 

Allowance for Doubtful Accounts

 

We maintain an allowance for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. We review the collectability of our receivables on an ongoing basis and write off accounts receivable after reasonable collection efforts have been made and the debt is deemed uncollectible.

 

Inventory Valuation

 

Our primary raw materials consist of resin, chemicals/additives, packaging material and paper.

 

Our finished goods inventories are typically made-to-order and have a shelf life of six to nine months from the date of manufacture. On rare occasions, we may build finished goods inventory safety stock in order to respond to short lead times in China. Cost is determined on a first-in, first-out basis and includes both the costs of acquisition and the costs of manufacturing. These costs include direct material, direct labor and fixed and variable indirect manufacturing costs, including depreciation.

 

We write inventory down to net realizable value when it is probable that our inventory carrying cost is not fully recoverable through sale or other disposition. Our write-down considers overall market conditions, customer inventory levels, legal or contractual provisions and age of the finished goods inventories.

 

In 2016 and 2015, we reserved $0.4 million and $0.7 million, respectively, of inventory, a majority of which is related to excess raw material, expired finished goods inventory and unusable recycled materials.

 

Long-Lived Assets

 

Our long-lived assets consist of property, plant and equipment.

 

Property, Plant and Equipment

 

Property, plant and equipment are recorded at cost and include expenditures for items that increase the useful lives of existing equipment. Maintenance and repairs are expensed as incurred. Property, plant and equipment accounts are relieved at cost, less related accumulated depreciation, when properties are disposed of or otherwise retired. Gains and losses from disposal of property, plant and equipment are included in net earnings.

 

In July 2015, we announced a restructuring plan that included the closure of our Malaysia facility, effective August 2, 2015. During the first six months of 2016, we received and accepted an offer of RM25.0 million ($6.3 million) for the land-use right and building. We entered into a definitive Purchase and Sale Agreement on November 18, 2016. As a result of the pending sale (subject to the approval of the Johor Port Authority), an analysis of the asset group was performed and an impairment of assets held for sale of $1.7 million was recorded during 2016 and a loss on reclassification of $0.7 million was recorded 2015.

 

Impairment Testing

 

In accordance with ASC 360-Property, Plant and Equipment, we assessed the impairment of our long-lived assets whenever changes in events or circumstances indicated that the carrying value of such assets may not be recoverable. During each reporting period, we assessed if the following factors were present, which would cause an impairment review: overall negative solar industry conditions; a significant or prolonged decrease in net sales generated under our trademarks; loss of a significant customer or a reduction in demand for customers’ products; a significant adverse change in the extent to or manner in which we used our trademarks or proprietary technology; such assets becoming obsolete due to new technology or manufacturing processes entering the markets or an adverse change in legal factors; and the market capitalization of our common stock.

 

34
 

In accordance with ASC 360-Property, Plant and Equipment, we assessed the impairment of our long-lived assets whenever changes in events or circumstances indicated that the carrying value of such assets may not be recoverable. During each reporting period, we assessed if the following factors were present, which would cause an impairment review: overall negative solar industry conditions; a significant or prolonged decrease in net sales generated under our trademarks; loss of a significant customer or a reduction in demand for customers’ products; a significant adverse change in the extent to or manner in which we used our trademarks or proprietary technology; such assets becoming obsolete due to new technology or manufacturing processes entering the markets or an adverse change in legal factors; and the market capitalization of our common stock.

 

At December 31, 2016, we recorded valuation allowances against our deferred tax assets. The valuation allowances were recorded since we had three consecutive years of taxable losses and determined that our history of actual net losses was negative evidence that should be given more weight than future projections. We determined the recording of valuation allowances to be an indicator to test our long-lived assets, which consist solely of property, plant and equipment, for impairment. We assessed the specific recoverability of our property, plant and equipment using updated real estate appraisals and other data for our other fixed assets, mainly production equipment. Based upon this analysis, we believes our property, plant and equipment carrying value was recoverable and depreciable lives were appropriate as of December 31, 2016. If we experience a significant reduction in future sales volume, further ASP reductions, lower profitability, a cessation of operations at any of our facilities, or negative changes in U.S. or Spain real estate markets, our property, plant and equipment may be subject to future impairment or accelerated depreciation.

 

Due to our decision to close our Malaysia facility, we performed an analysis to assess the specific recoverability of our property, plant and equipment using updated real estate appraisals and other data for our other fixed assets, mainly production equipment. Based upon this analysis, an impairment of assets held for sale of $1.7 million was recorded during 2016 and a loss on reclassification of $0.7 million was recorded during 2015.

 

Factoring Arrangement

 

We have entered into a factoring agreement to sell, with recourse, certain European, U.S. and other foreign company-based receivables to Eurofactor Hispania S.A.U. We receive funds from the factor for certain outstanding receivables for which we record a liability. Once the customer pays the factor directly for those receivables we clear the accounts receivable and the liability. As of December 31, 2016 we had recorded $0.4 million as due to factoring on the consolidated balance sheets.

 

Product Performance Accrual

 

We provide a short-term warranty that we have manufactured our products to our specifications. On a limited number of occasions, we incur costs to service our products in connection with specific product performance matters that do not meet our specifications. Anticipated future costs are recorded as part of cost of sales and accrued liabilities for specific product performance matters when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated.

 

On isolated occasions, we have offered limited short-term performance warranties relating to our encapsulants not causing module power loss. This type of arrangement may increase in 2017. Our encapsulants are validated by long-term performance testing during product development prior to launch and during customer certification prior to mass production. We have operated our solar business since the 1970s and over 20 GW of solar modules incorporating our encapsulants have been installed in the field with no verified module power performance issues caused by our encapsulants. Based on this fact pattern, we have not accrued any warranty liability associated for this potential liability, as its occurrence is deemed to be remote.

 

Income Taxes

 

We operate in multiple taxing jurisdictions and are subject to the jurisdiction of a number of U.S. and non-U.S. tax authorities and to tax agreements and treaties among those authorities. Operations in these jurisdictions are taxed on various bases, including income before taxes as calculated in accordance with jurisdictional regulations.

 

35
 

We account for income taxes using the asset and liability method in accordance with ASC 740-Income Taxes. Under this method, we recognize deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and for operating loss and tax credit carryforwards. We estimate our deferred tax assets and liabilities using the enacted tax laws expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, and will recognize the effect of a change in tax laws on deferred tax assets and liabilities in the results of our operations during the period that includes the enactment date.

 

In assessing the need for a valuation allowance, we consider all positive and negative evidence including: estimates of future taxable income, considering the feasibility of ongoing tax planning strategies, the reliability of tax loss carryforwards and the future reversal of existing temporary differences. Valuation allowances related to deferred tax assets can be impacted by changes to tax laws, changes to statutory tax rates and future taxable income levels. In the event we were to determine that we would not be able to realize all or a portion of our tax assets in the future, the unrealizable amount would be charged to earnings in the period in which that determination is made. By contrast, if we were to determine that we would be able to realize deferred tax assets in the future in excess of the net carrying amounts, we would decrease the recorded valuation allowance through a favorable adjustment to earnings in the period in which that determination is made. As of December 31, 2016, we have recorded $5.4 million of valuation allowances relating to our China and Hong Kong subsidiaries, which have generated operating losses since their inception. If we are able to generate future profits at such subsidiaries, we will reverse the valuation allowance. As of December 31, 2016, we have recorded a full valuation allowance against a deferred tax asset of $3.1 million for a loss carryforward benefit at our Spain subsidiary. We recorded a valuation allowance for this carryforward as we believe it is more likely than not that the benefit of the loss carryforward will not be fully realized due to lack of taxable income that will be generated by our Spain subsidiary. In the United States, we had carryback losses (generated in the United States) in 2014. After 2014, any taxable losses have to be carried forward, therefore we have recorded a full valuation allowance of $1.8 million against net operating loss carryforwards and deferred tax assets in the U.S. as of December 31, 2016. We expect to record a full valuation allowance for future taxable losses generated in the United States until we generate taxable income.

 

ASC 740 also addresses the accounting for uncertainty in income taxes recognized in a company’s financial statements and how companies should recognize, measure, present and disclose uncertain tax positions that have been or are expected to be taken. Tax benefits related to uncertain tax positions taken or expected to be taken on a tax return are recorded when such benefits meet a more likely than not threshold. Otherwise, these tax benefits are recorded when a tax position has been effectively settled, which means that the appropriate taxing authority has completed its examination whether or not the statute of limitations remains open or has expired. Interest and penalties related to uncertain tax positions are recognized as part of our provision for income taxes and are accrued beginning in the period that such interest and penalties would be applicable under relevant tax law until such time that the related tax benefits are recognized.

 

We are subject to the examinations of our income tax returns by various domestic and international taxing authorities. The final outcome of any examinations or legal proceedings as well as the outcome of competent authority proceedings, changes and interpretation in regulatory tax laws, or expiration of statutes of limitation could impact our financial statements. Accordingly, we had accruals recorded for which it was reasonably possible that the amount of the unrecognized tax benefit could increase or decrease. Based on the uncertainties associated with the status of examinations, including the protocols of finalizing audits by the relevant tax authorities, which could include formal legal proceedings, changes to our estimates may impact the future results of our operations.

 

We currently have a tax holiday in Malaysia through 2019, however, we are in the process of disposing our Malaysia fixed assets. As of December 31, 2016, we have not asserted that we will permanently reinvest our foreign subsidiary’s earnings. As a result, U.S. federal taxes will have to be provided on any future taxable income generated by our foreign subsidiaries, if any.

 

Stock-Based Compensation

 

ASC 718-Compensation-Stock Compensation, addresses accounting for share-based awards, including stock options, with compensation expense measured using fair value and recorded over the requisite service or performance period of the award.

 

Starting in 2013, we determined the fair value of the stock options issued using the Black-Scholes option pricing model. Prior to 2013, we used an independent outside appraisal firm. Our assumptions about stock-price volatility were based on the historical implied volatilities of our common stock and those of other publicly traded options to buy stock with contractual terms closest to the expected life of options granted to our employees. The expected term represents the estimated time until employee exercise is estimated to occur taking into account vesting schedules and using the Hull-White model. The risk-free interest rate for periods within the contractual life of the award is based on the U.S. Treasury 10-year zero-coupon strip yield in effect at the time of grant. The expected dividend yield was based on the assumption that no dividends are expected to be distributed in the near future.

 

36
 

 

    Year Ended
December 31, 2015
Expected volatility     68.3 %
Risk-free interest rates     1.9 %
Expected term (in years)     6.9  
Dividend yield      
Weighted-average estimated fair value of options granted during the period   $ 0.99  

 

Deferred Compensation

 

We had a deferred compensation arrangement with certain members of management, including Robert S. Yorgensen, that stated upon the earlier of December 31, 2015, our sale (which included a change of control transaction) or termination of employment for any reason, the members were entitled to bonus payments based upon a formula set forth in their respective employment agreements. The payments were tied to distribution amounts they would have received with respect to their former ownership in our predecessor company if the assets were sold at fair market value compared to the value of our stock price. The amount of the potential bonus payment was capped at $1.2 million. In accordance with ASC 718-30, the obligation was re-measured quarterly at fair value. We determined fair value using observable current market information as of the reporting date. The most significant input to determine the fair value was determined to be our common stock price which is a Level 2 input. Based upon the difference of the floor in the agreements and the effective valuation of the Transaction of $4.80 per share for Mr. Yorgensen, $0.2 million of accrued compensation was paid out during the first quarter of 2015. As of December 31, 2016, no deferred compensation arrangements exist.

 

Consolidated Results of Operations

 

The following tables set forth our consolidated results of continuing operations in dollars and as a percentage of net sales, for the fiscal years ended December 31, 2016 and 2015:

 

    Year Ended December 31, 2016   Year Ended December 31, 2015
Statement of Continuing Operations Data:                
Net sales   $ 20,112     $ 29,783  
Cost of sales     22,127       31,607  
Gross loss     (2,015 )     (1,824 )
Selling, general and administrative expenses     7,058       10,186  
Research and development expense     1,216       1,265  
Provision (recovery) for bad debt expense     2,354       (255 )
Operating loss     (12,643 )     (13,020 )
Interest income (expense), net     37       (38 )
Other expense     (1,848 )     (723 )
Loss on disposal of fixed assets     (890 )      
Foreign currency transaction loss     (526 )     (34 )
Loss from continuing operations before income tax benefit     (15,870 )     (13,815 )
Income tax benefit from continuing operations           (400 )
Net loss from continuing operations   $ (15,870 )   $ (13,415 )

 

 

37
 

 

 

    Year Ended
December 31, 2016
  Year Ended
December 31, 2015
Statement of Continuing Operations Data:                
Net sales     100.0 %     100.0 %
Cost of sales     110.0 %     106.1 %
Gross loss     (10.0 )%     (6.1 )%
Selling, general and administrative expenses     35.1 %     34.2 %
Research and development expense     6.0 %     4.2 %
Provision (recovery) for bad debt expense     11.7 %     (0.9 )%
Operating loss     (62.9 )%     (43.7 )%
Interest income (expense), net     0.2 %     (0.1 )%
Other expense     (9.2 )%     (2.4 )%
Loss on disposal of fixed assets     (4.4 )%      
Foreign currency transaction loss     (2.6 )%     (0.1 )%
Loss from continuing operations before income tax benefit     (78.9 )%     (46.4 )%
Income tax benefit from continuing operations           (1.3 )%
Net loss from continuing operations     (78.9 )%     (45.0 )%

 

 

Year Ended December 31, 2016 Compared to Year Ended December 31, 2015

 

The following tables set forth our consolidated results of continuing operations in dollars and as a percentage of net sales for the fiscal years ended December 31, 2016 and 2015:

 

Net Sales

 

    Years Ended December 31,
    2016   2015   Change
    Amount   % of
Net Sales
  Amount   % of
Net Sales
  Amount   %
Net sales   $ 20,112       100.0 %   $ 29,783       100.0 %   $ (9,671 )     (32.5 )%

 

The decrease in net sales for the year ended December 31, 2016 compared to the corresponding period in 2015 was driven by an approximate 8% decrease in our ASP and an approximate 26% decrease in sales volume.

 

The price decline was primarily the result of higher concentration of China sales and overall encapsulant market conditions.

 

The volume decline was driven by a reduction of net sales with our largest customer, who modified its OEM manufacturing partner footprint in the latter part of 2014 and announced the significant reduction of its OEM module business by the end of 2015 and an increase in its in-house module production in China. Excluding this customer, volume decreased by approximately 16% with our remaining customers, primarily driven by a 20% volume decrease in Spain, partially offset by a 3% volume increase in China, mainly in the first half of 2016, as well as growth in India.

 

Cost of Sales

 

    Years Ended December 31,
    2016   2015   Change
    Amount   % of
Net Sales
  Amount   % of
Net Sales
  Amount   %
Cost of sales   $ 22,127       110.0 %   $ 31,607       106.1 %   $ (9,480 )     (30.0 )%

 

The decrease in our cost of sales for the year ended December 31, 2016 compared to the corresponding period in 2015 was primarily driven by a 26% decrease in sales volume combined with an approximately 9% decrease in raw material cost per unit. The lower raw material cost per unit was primarily driven by an 11% increase in paperless sales mix, as well as improved efficiencies at our China factory for the year ended December 31, 2016 versus the corresponding 2015 period. Direct labor decreased by $0.8 million, associated with the sales volume decrease. Overhead costs decreased by $2.0 million primarily due to continued cost-reduction actions.

 

38
 

Gross Loss

 

    Years Ended December 31,
    2016   2015   Change
    Amount   % of
Net Sales
  Amount   % of
Net Sales
  Amount   %
Gross loss   $ (2,015 )     (10.0 )%   $ (1,824 )     (6.1 )%   $ (191 )     (10.5 )%

 

Gross loss as a percentage of net sales increased for the year ended December 31, 2016 compared to the corresponding period in 2015 mainly as a result of a decline in ASP and volume and lower absorption of fixed costs that more than offset our decrease in raw material costs as described above.

 

Selling, General and Administrative Expenses (“SG&A”)

 

    Years Ended December 31,
    2016   2015   Change
    Amount   % of
Net Sales
  Amount   % of
Net Sales
  Amount   %
SG&A   $ 7,058       35.1 %   $ 10,186       34.2 %   $ (3,128 )     (30.7 )%

 

SG&A decreased $3.1 million for the year ended December 31, 2016 compared to 2015. This decrease was primarily driven by a $0.9 million decrease in labor and benefits, a $0.6 million decrease in restructuring expense, a $0.5 million decrease in professional fees, a $0.4 million decrease in travel expenses, a $0.2 million decrease of non-cash stock based compensation expense, as well as a $0.1 million decreases in annual incentive compensation, dues and fees expense and insurance expense.

 

Research and Development Expense (“R&D”)

 

    Years Ended December 31,
    2016   2015   Change
    Amount   % of
Net Sales
  Amount   % of
Net Sales
  Amount   %
R&D   $ 1,216       6.0 %   $ 1,265       4.2 %   $ (49 )     (3.9 )%

 

Research and development expense decreased by less than $0.1 million for the year ended December 31, 2016 compared to the prior year as our research and development staffing and activity has remained relatively consistent during these periods. Our research and development cost as a percentage of sales, however, increased year over year.

 

Provision (Recovery) for Bad Debt Expense

 

    Years Ended December 31,
    2016   2015   Change
    Amount   % of
Net Sales
  Amount   % of
Net Sales
  Amount   %
Bad debt expense   $ 2,354       11.7 %   $ (255 )     (0.9 )%   $ 2,609       1,023.1 %

 

The provision for bad debt expense for the year ended December 31, 2016 primarily related to certain Chinese customers’ balances, partially offset by receiving payment related to aged accounts receivable balances that were previously reserved. The recovery for bad debt expense recorded during the year ended December 31, 2015 primarily related to receiving cash for previously aged accounts receivable that were reserved for under our policy.

 

Other (Expense) Income

 

    Years Ended December 31,
    2016   2015   Change
    Amount   % of
Net Sales
  Amount   % of
Net Sales
  Amount   %
Other (expense) income   $ (1,848 )     (9.2 )%   $ (723 )     (2.4 )%   $ (1,125 )     (155.6 )%

 

 

39
 

In July 2015, we announced a restructuring plan that included the closure of our Malaysia facility, effective August 2, 2015. During the first six months of 2016, we received and accepted an offer of RM25.0 million ($6.3 million) for the land-use right and building. We entered into a definitive Purchase and Sale Agreement on November 18, 2016. As a result of the pending sale (subject to the approval of the Johor Port Authority), an analysis of the asset group was performed and an impairment of assets held for sale of $1.7 million was recorded during the second quarter of 2016 and a loss on reclassification of $0.7 million was recorded during the third quarter of 2015.

 

Gain (Loss) on Disposal of Fixed Assets

 

    Years Ended December 31,
    2016   2015   Change
    Amount   % of
Net Sales
  Amount   % of
Net Sales
  Amount   %
Gain (loss) on disposal of fixed assets   $ (890 )     (4.4 )%   $       %   $ (890 )     (100.0 )%

 

During October 2016, a fire damaged a portion of our production facility located in Shajiabang, Jiangsu, China. The damage was mainly to one production line, as well as to certain ancillary equipment and related systems. As a result, we recorded a loss on disposal of fixed assets of $0.9 million and any insurance recovery is expected to be reflected in 2017.

 

Foreign Currency Transaction (Loss) Gain

 

    Years Ended December 31,
    2016   2015   Change
    Amount   % of
Net Sales
  Amount   % of
Net Sales
  Amount   %
Foreign currency transaction (loss) gain   $ (526 )     (2.6 )%   $ (34 )     (0.1 )%   $ (492 )     (1,447.1 )%

 

The foreign currency transaction impact was a loss of approximately $0.5 million for the year ended December 31, 2016 compared to a loss of less than $0.1 million in the corresponding 2015 period. This change was primarily the result of volatility in the Euro spot exchange rate versus the U.S. dollar.

 

Our primary foreign currency exposures are intercompany loans, U.S. dollar cash balances in foreign locations and some U.S. dollar denominated accounts receivable at our Spanish facility.

 

Income Tax (Benefit) Expense from Continuing Operations

 

    Years Ended December 31,
    2016   2015   Change
    Amount   % of
Net Sales
  Amount   % of
Net Sales
  Amount   %
Income tax (benefit) expense from
continuing operations
  $       %   $ (400 )     (1.3 )%   $ 400       100.0 %

 

Our effective income tax rate from continuing operations for the year ended December 31, 2016 was 0.0% compared to the U.S. federal statutory tax rate of 35.0%. Our effective income tax rate from continuing operations was 2.9% for the year ended December 31, 2015.

 

In 2016, our operations generated a loss from continuing operations that was taxed at the U.S. federal statutory rate of 35.0%, prior to the impact of any deductions or non-deductible expenses. The expected 2016 income tax benefit was decreased as the result of a full valuation allowance recorded against the U.S. loss from continuing operations. The December 31, 2016 effective tax rate from continuing operations was further decreased for Malaysia pre-tax losses for which there is no tax benefit due to the tax holiday as well as other foreign losses for which no tax benefit has been recorded.

 

In 2015, our operations generated a loss from continuing operations that was taxed at the U.S. federal statutory rate of 35.0%, prior to the impact of any deductions or non-deductible expenses. The expected 2015 income tax benefit was primarily decreased as the result of a full valuation allowance recorded against the U.S. loss from continuing operations. The income tax benefit was primarily increased as the result of reversing the income tax payable of $0.4 million relating to uncertain tax positions due to a lapse in the statute of limitations. The December 31, 2015 effective tax rate from continuing operations was further decreased for Malaysia pre-tax losses for which there is no tax benefit due to the tax holiday as well as other foreign losses for which no tax benefit has been recorded.

 

40
 

Net Loss from Continuing Operations

 

    Years Ended December 31,
    2016   2015   Change
    Amount   % of
Net Sales
  Amount   % of
Net Sales
  Amount   %
Net loss from continuing operations   $ (15,870 )     (78.9 )%   $ (13,415 )     (45.0 )%   $ (2,455 )     (18.3 )%

 

Net loss from continuing operations for the year ended December 31, 2016 increased compared to the corresponding 2015 period driven by a $0.2 million increase in gross loss, a $2.6 million increase in bad debt expense, $1.7 million of impairment of assets held for sale, $0.9 million of loss on disposal of fixed assets, $0.5 million of negative foreign exchange impact and $0.4 million of reduced income tax benefit. These negative impacts were partially offset by a $3.1 million decrease in selling, general and administration expenses and the non-recurrence of $0.7 million of loss on reclassification of held for sale assets.

 

Cost Reduction Actions in 2016 and 2015

 

In July 2015, following a decision by our largest customer to exit its OEM module production in Malaysia, we decided to close our Malaysia facility, effective August 2, 2015 . During 2015, we recognized $0.3 million of severance and benefits as well as a $0.5 million inventory write down in cost of sales and $0.5 million of severance and benefits in selling, general and administrative expenses related to the Malaysia facility closure.

 

In June 2016, we eliminated certain positions at our Spain facility effective July 5, 2016. We recorded $0.1 million of severance and benefits in cost of sales and $0.1 million of severance and benefits in selling, general and administrative expenses during 2016.

 

The restructuring accrual activity during the year ended December 31, 2016 related to the costs associated with the closure of the Malaysia facility and other minor cost-reductions made globally.

 

A rollforward of the restructuring accrual activity is as follows:

 

    December 31,
2015
Balance at December 31, 2015   $ 0.3  
Additions     0.3  
Reductions     (0.3 )
Balance at December 31, 2016   $ 0.3  

 

The restructuring accrual as of December 31, 2016 consists of $0.3 million for severance and benefits. We will continue to adjust our anticipated labor resources and production capabilities to match forecasted demand for our encapsulants.

 

Net Earnings (Loss) from Discontinued Operations

 

    Years Ended December 31,
    2016   2015   Change
    Amount   % of
Net Sales
  Amount   % of
Net Sales
  Amount   %
Net earnings (loss) from
discontinued operations
  $       %   $ 3,952       13.3 %   $ (3,952 )     (100.0 )%

 

Net earnings from discontinued operations for the year ended December 31, 2015 relates to the reversal of $4.0 million of uncertain tax positions of the Company’s former QA business due to the expiration of the statute of limitations.

 

41
 

Net Loss

 

    Years Ended December 31,
    2016   2015   Change
    Amount   % of
Net Sales
  Amount   % of
Net Sales
  Amount   %
Net loss   $ (15,870 )     (78.9 )%   $ (9,463 )     (31.8 )%   $ (6,407 )     (67.7 )%

 

Net loss from continuing operations for the year ended December 31, 2016 increased compared to the corresponding 2015 period driven by $0.2 million of increased gross loss, $2.6 million of increased bad debt expense, $1.7 million of impairment of assets held for sale, $0.9 million of loss on disposal of fixed assets, $0.5 million of negative foreign exchange impact, $0.4 million of reduced income tax benefit and $4.0 million of discontinued operations income tax benefit that did not recur in 2016. These negative impacts were partially offset by $3.1 million of lower selling, general and administration expenses and the non-recurrence of $0.7 million of loss on reclassification of held for sale assets.

 

Adjusted EBITDA

 

We define Adjusted EBITDA as net profit or loss from continuing operations before interest income and expense, income tax expense (benefit), depreciation expense, restructuring, stock-based compensation expense, asset impairment and certain non-recurring income and expenses from the results of continuing operations.

 

We present Adjusted EBITDA because it is one of the main metrics used by our management and our Board of Directors to plan and measure our segment’s operating performance. Our management believes that Adjusted EBITDA is useful to investors because Adjusted EBITDA is frequently used by securities analysts, investors and other interested parties in their evaluation of the operating performance of companies in industries similar to ours. We also believe Adjusted EBITDA is useful to our management and investors as a measure of comparative operating performance from period to period. By reporting Adjusted EBITDA, we provide a basis for comparison of our business operations between current, past and future periods. In addition, measures similar to Adjusted EBITDA are among the metrics utilized to measure performance based bonuses paid to certain of our managers and were used to determine compliance with financial covenants under our prior Credit Agreement.

 

Adjusted EBITDA, however, does not represent and should not be considered as an alternative to net income or cash flow from operations, as determined in accordance with generally accepted accounting principles, and our calculations thereof may not be comparable to similarly entitled measures reported by other companies. Although we use Adjusted EBITDA as a measure to assess the operating performance of our business, Adjusted EBITDA has significant limitations as an analytical tool because it excludes certain material costs. For example, it does not include interest expense, which was a necessary element of our costs. Because we use capital assets, depreciation expense is a necessary element of our costs and ability to generate net sales. In addition, the omission of the substantial, impairment associated with our property, plant and equipment and restructuring charges, further limits the usefulness of this measure. Adjusted EBITDA also does not include the payment of taxes, which is also a necessary element of our operations. Because Adjusted EBITDA does not account for these expenses, its utility as a measure of our operating performance has material limitations. Because of these limitations management does not view Adjusted EBITDA in isolation and also uses other measures, such as net loss, net sales, gross margin and operating loss, to measure operating performance.

 

We report our business in one reported segment. We measure segment performance based on net sales and Adjusted EBITDA. See Note 19-Reportable Segment and Geographical Information located in the Notes to the Consolidated Financial Statements for a definition of Adjusted EBITDA, a reconciliation to net loss from continuing operations and further information. Net sales for our segment from continuing operations is described in further detail above. The discussion that follows is a summary analysis of the primary changes in Adjusted EBITDA for the year ended December 31, 2016 compared to the year ended December 31, 2015.

 

    Years Ended December 31,
    2016   2015   Change
    Amount   Amount   Amount   %
Adjusted EBITDA   $ (10,643 )   $ (8,842 )   $ (1,801 )     (20.4 )%
Adjusted EBITDA as % of segment net sales     (52.9 )%     (29.7 )%                

 

Adjusted EBITDA as a percentage of net sales declined for the year ended December 31, 2016 compared to 2015 driven by a decline in ASP, lower sales volume, increased bad debt expense and a negative foreign exchange impact. These negative impacts were partially offset by reduced selling, general and administrative expenses.

 

42
 

Quarterly Consolidated Results of Operations

 

The following tables set forth our consolidated results of continuing operations and Adjusted EBITDA on a quarterly basis for the year ended December 31, 2016 and the year ended December 31, 2015:

 

    Year Ended December 31, 2016
    First
Quarter
  Second
Quarter
  Third
Quarter
  Fourth
Quarter
    (Unaudited)
    (dollars in thousands)
Statement of Operations Data:                
Net sales   $ 6,423     $ 6,691     $ 4,030     $ 2,968  
Cost of sales     6,824       6,631       4,929       3,743  
Gross (loss) earnings     (401 )     60       (899 )     (775 )
Selling, general and administrative expenses     1,909       1,782       1,798       1,569  
Research and development     327       314       308       267  
(Recovery) provision for bad debt expense     425       934       651       344  
Operating loss     (3,062 )     (2,970 )     (3,656 )     (2,955 )
Interest (expense) income net     (11 )     52       (2 )     (2 )
Other (expense) income           (1,699 )     9       (158 )
Gain (loss) on disposal of fixed assets           2             (892 )
Foreign currency transaction loss     (88 )     (199 )     (64 )     (175 )
Loss from continuing operations before income tax (benefit) expense     (3,161 )     (4,814 )     (3,713 )     (4,182 )
Income tax (benefit) expense from continuing operations     (214 )     199       (35 )     50  
Net loss from continuing operations   $ (2,947 )   $ (5,013 )   $ (3,678 )   $ (4,232 )
Adjusted EBITDA:                                
Adjusted EBITDA   $ (2,515 )   $ (2,371 )   $ (3,099 )   $ (2,658 )
Depreciation expense     (474 )     (476 )     (468 )     (296 )
Interest (expense) income net     (11 )     52       (2 )     (2 )
Income tax benefit (expense)     214       (199 )     35       (50 )
Other expense                       (124 )
Impairment of assets held for sale           (1,708 )           (31 )
Restructuring     (2 )     (192 )     (25 )     (37 )
Stock-based compensation     (159 )     (121 )     (119 )     (142 )
Gain (loss) on disposal of fixed assets           2             (892 )
Net loss from continuing operations   $ (2,947 )   $ (5,013 )   $ (3,678 )   $ (4,232 )

 

 

43
 

 

 

    Year Ended December 31, 2015
    First
Quarter
  Second
Quarter
  Third
Quarter
  Fourth
Quarter
    (Unaudited)
    (dollars in thousands)
Statement of Operations Data:                
Net sales   $ 6,863     $ 8,515     $ 6,594     $ 7,811  
Cost of sales     7,009       8,581       8,088       7,929  
Gross loss     (146 )     (66 )     (1,494 )     (118 )
Selling, general and administrative expenses     2,582       2,808       3,155       1,641  
Research and development     352       360       334       219  
(Recovery) provision for bad debt expense     (43 )     (189 )     225       (248 )
Operating loss     (3,037 )     (3,045 )     (5,208 )     (1,730 )
Interest income (expense) net     4       (52 )     13       (3 )
Other expense                 (722 )     (1 )
Foreign currency transaction gain (loss)     480       (163 )     (256 )     (95 )
Loss from continuing operations before income tax expense (benefit)     (2,553 )     (3,260 )     (6,173 )     (1,829 )
Income tax expense (benefit) from continuing operations     53       53       (422 )     (84 )
Net loss from continuing operations   $ (2,606 )   $ (3,313 )   $ (5,751 )   $ (1,745 )
Adjusted EBITDA:                                
Adjusted EBITDA   $ (1,769 )   $ (2,480 )   $ (3,341 )   $ (1,252 )
Depreciation expense     (490 )     (512 )     (421 )     (466 )
Interest income (expense) net     4       (52 )     13       (3 )
Income tax (expense) benefit     (53 )     (53 )     422       84  
Other expense                       (1 )
Loss on reclassification                 (722 )        
Restructuring     (145 )     6       (1,524 )     75  
Stock-based compensation     (153 )     (222 )     (178 )     (182 )
Net loss from continuing operations   $ (2,606 )   $ (3,313 )   $ (5,751 )   $ (1,745 )

 

Financial Condition, Liquidity and Capital Resources

 

We have funded our operations primarily through our existing cash balance. As of December 31, 2016, our principal source of liquidity was $12.4 million of cash and $3.4 million of Chinese bank acceptance notes. Our principal needs for liquidity have been, and for the foreseeable future we expect will continue to be, for working capital and capital investments. Payment terms are currently longer in China than in many other locations, which results in delayed cash receipts from certain of our customers. Additionally, evolving China currency control regulations may limit our access to the $2.1 million of cash and $3.4 million of bank acceptance notes located in China for use outside the country. Although we believe that our available cash will be sufficient to meet our liquidity needs, including capital investments (mainly equipment upgrades and information technology needs), through at least the next 15 months, if we are unable to collect our accounts receivable, or fail to receive payment in a timely fashion, or obtain bank acceptance notes from our customers, or fail to receive payment on the sale of our Malaysia property, our financial condition and results of operations will be negatively affected. In order to mitigate this risk, we are attempting to obtain bank acceptance notes with respect to the accounts receivable from certain of our Chinese customers.

 

We incurred bad debt reserves of $2.6 million during 2016 and filed lawsuits against three customers of STRC for non-payment. Four of our other customers are significantly behind terms and certain of them may require legal action to effect collection. In certain cases, STR may prevail in Chinese court but then still not be paid timely. Our staff spends an inordinate amount of time and energy pursuing payment from delinquent accounts in China. We have rejected orders from multiple customers, to whom we were successful in securing technical qualification, due to their failure to meet certain credit metrics or in some cases, a poor history of payment to us.

 

In October 2015, our wholly owned Spanish subsidiary, Specialized Technology Resources España S.A., entered into a factoring agreement to sell, with recourse, certain European, U.S. and other foreign company-based receivables to Eurofactor Hispania S.A.U. Under the current terms of the factoring agreement, the maximum amount of outstanding advances at any one time is €1.5 million ($1.6 million as of December 31, 2016), which is subject to adjustment based on the level of eligible receivables, restrictions on concentrations of receivables and the historical performance of the receivables sold.  The annual discount rate is 2% plus EURIBOR for Euro-denominated receivables and 2% plus LIBOR for all other currencies. The term of the agreement is for one year, which will be automatically extended unless terminated by either party with 90 days prior written notice. As of December 31, 2016, €1.1 million ($1.2 million as of December 31, 2016) was available under the factoring agreement based upon receivables outstanding.

 

In connection with our continued efforts to return our encapsulant business to profitability, on July 24, 2015 our Board approved a restructuring of our encapsulant business, which included the shut-down of our Malaysia manufacturing facility, effective August 2, 2015. We are in the process of selling the Malaysia facility and its production and ancillary equipment. In connection with the shut-down and sale of the Malaysia facility, we incurred approximately $1.3 million of associated non-recurring costs during the second half of 2015. During 2016, we accepted an offer of RM25.0 million ($6.3 million) for the land-use right and building, subject to completion of definitive documentation. As a result, an analysis of the asset group was performed and an impairment of assets held for sale of $1.7 million was recorded. Effective November 18, 2016, we executed the formal Purchase and Sale Agreement. We cannot assure that we will be able to close the sale of our Malaysian real estate on a timely basis or on favorable terms or that the costs of closure of that facility will not be higher than anticipated.

 

44
 

We remain open to exploring possible business opportunities in potentially more profitable parts of the solar supply chain, alternate geographic markets, as well as other strategic alternatives. We cannot assure that we will be able to successfully pursue any such potential opportunities. If we are successful in pursuing any such opportunities, we may be required to expend significant funds, incur debt or other obligations or issue additional securities, any of which could significantly dilute our current stockholders and may negatively affect our operating results and financial condition. We cannot assure that any such strategic opportunities or related transactions, or any financing in connection therewith, would be available on favorable terms, if at all, or that we will realize any anticipated benefits from any such transactions that we complete. In the event that we are not successful in restructuring our encapsulant business or pursuing opportunities in the downstream solar market or other strategic transactions, we also intend to consider alternatives, including, without limitation, the acquisition of another business, the divestiture of all or certain of our assets, joint ventures and other transactions outside the ordinary course of business.

 

If we are not able to fund our working capital needs, we will have to slow our projected growth, which may further impede or delay our attempt to return to profitability. We expect to fund our cash requirements with our existing cash and bank acceptance notes, leveraging our European factoring facility and other potential working capital financing arrangements.

 

Our cash and cash equivalents balance is located in the following geographies:

 

    Year Ended
December 31, 2016
United States   $ 7,981  
Spain     1,803  
Malaysia     328  
China     2,075  
Hong Kong     192  
Consolidated   $ 12,379  

 

Due to, among other things, the difficulty repatriating cash to the U.S., we may have limited access to the $2.1 million of cash and $3.4 million of bank acceptance notes located in China for use outside the country.

 

We do not permanently re-invest our Malaysia subsidiary’s earnings. Based upon the Malaysia subsidiary’s liabilities to us, we expect the undistributed earnings of our Malaysia subsidiary will be repatriated to the U.S. in a tax-free manner. We do not permanently re-invest our Spain earnings, so this cash balance is available for dividend repatriation. We have accrued for this tax liability. We have not elected to permanently re-invest our Hong Kong and China earnings and plan to utilize our cash located in Hong Kong and China to fund a portion of our working capital requirements and capital investment in China. Our goal is to achieve and maintain self-sufficiency in each of our manufacturing locations to meet their cash requirements. We cannot assure that we will continue to fund the manufacturing operations in any location, if such operations would require investment of additional cash from other jurisdictions.

 

Cash Flows

 

Cash Flow from Operating Activities from Continuing Operations

 

Net cash provided by operating activities from continuing operations was $4.5 million for the year ended December 31, 2016 compared to net cash used in operating activities of $6.5 million for the year ended December 31, 2015. Net loss plus and minus non-cash adjustments (“cash loss”) improved by approximately $1.7 million for the year ended December 31, 2016 compared to the same period in 2015. This improvement was driven by the receipt of an $8.3 million income tax refund, $1.9 million received from Zhenfa as well as consumption of excess Malaysia inventory and the continued impact of cost-reduction efforts. These positive impacts were partially offset by the $5.4 million received from Zhenfa during 2015.

 

Net cash used in operating activities from continuing operations was $6.5 million for the year ended December 31, 2015 compared to net cash used in operating activities of $14.4 million for the year ended December 31, 2014. Cash loss decreased by approximately $3.3 million for the year ended December 31, 2015 compared to the same period in 2014. This improvement was driven by cost-reduction efforts. In addition, we received $5.4 million as a deposit from Zhenfa under our EVA for module swap settlement entered into between Zhenfa and ReneSola for payment of prior outstanding ReneSola accounts receivable balances. These positive impacts were partially offset by the 2014 period benefiting from the receipt of $11.9 million in income tax refunds that did not recur in 2015.

 

45
 

Cash Flow from Operating Activities from Discontinued Operations

 

Net cash used in operating activities from discontinued operations was $0.9 million for the year ended December 31, 2015 due to a cash payment related to a state income tax audit.

 

Cash Flow from Investing Activities from Continuing Operations

 

Net cash used in investing activities was $0.2 million and $1.8 million for the year ended December 31, 2016 and 2015, respectively. The 2016 capital investments related to the building improvements at our Enfield, Connecticut location and the continued build out of our leased facility in China.

 

Net cash used in investing activities was $1.8 million for the year ended December 31, 2015. The 2015 capital investments related to the building improvements at our Enfield, Connecticut location and the continued build out of our leased facility in China.

 

We anticipate 2017 consolidated capital investments to be less than $0.5 million, and we expect to fund these from our existing cash balance. However, we may delay a portion of these capital investments if we are not timely in collecting our accounts receivable or do not arrange other working capital financing options.

 

Cash Flow from Financing Activities from Continuing Operations

 

Net cash used in financing activities was less than $0.1 million for the year ended December 31, 2016 primarily due to funds received by our Spanish subsidiary related to the factoring agreement.

 

Net cash provided by financing activities was $0.6 million for the year ended December 31, 2015 primarily due to funds received by our Spanish subsidiary related to the factoring agreement.

 

Off-Balance Sheet Arrangements

 

We have no significant off-balance sheet financing arrangements.

 

Effects of Inflation

 

Inflation generally affects us by increasing costs of raw materials, labor and equipment. During the year ended 2016, we were not materially affected by inflation.

 

Recently Issued Accounting Standards

 

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers” (Topic 606). This ASU is intended to clarify the principles for recognizing revenue by removing inconsistencies and weaknesses in revenue requirements; providing a more robust framework for addressing revenue issues; improving comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets; and providing more useful information to users of financial statements through improved revenue disclosure requirements. The provisions of this ASU are effective for interim and annual periods beginning after December 15, 2016. On August 12, 2015, the FASB issued ASU 2015-14, "Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date," which delays the effective date of ASU 2014-09 by one year. The new standard is effective for reporting periods beginning after December 15, 2017. Early application is permitted for reporting periods beginning after December 15, 2016. The standard shall be applied retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. In March, April and May 2016, the FASB clarified the implementation guidance on principal versus agent, identifying performance obligations, licensing, and collectability. We are currently evaluating the new guidance to determine the impact it may have on its consolidated financial statements.

 

In February 2015, the FASB issued ASU No. 2015-02, “Consolidation (Topic 810) Amendments to the Consolidation Analysis.” The amendments contained in this update affect reporting entities that are required to evaluate whether they should consolidate certain legal entities. All legal entities are subject to reevaluation under the revised consolidation model. The amendments in this update affect limited partnerships and similar legal entities, evaluating fees paid to a decision maker or a service provider as a variable interest, the effect of fee arrangements on the primary beneficiary determination, the effect of related parties on the primary beneficiary determination and certain investment funds. This ASU is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2015. In October 2016, the FASB issued Update 2016-17, to amend the consolidation guidance on how a reporting entity that is the single decision maker of a variable interest entity should treat indirect interests in the entity held through related parties that are under common control with the reporting entity when determining whether it is the primary beneficiary of that variable interest entity. The amendments in this update are effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2016. We are currently evaluating the new guidance to determine the impact it may have to its consolidated financial statements.

 

46
 

In January 2016, the FASB issued ASU 2016-01, “Financial Instruments - Overall: Recognition and Measurement of Financial Assets and Financial Liabilities.” The main objective of this update is to enhance the reporting model for financial instruments to provide users of financial statements with more decision-useful information. The new guidance addresses certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. This ASU is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. We do not expect this ASU to have a significant impact on its financial statements or disclosures.

 

In March 2016, FASB issued ASU 2016-09, "Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting." The objective of this update is to simplify several aspects of the accounting for employee share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. This ASU is effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. Early adoption is permitted. We do not expect this ASU to have a significant impact on its financial statements or disclosures

 

In August 2016, the FASB issued ASU 2016-15, "Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments." This ASU is intended to reduce diversity in practice in presentation and classification of certain cash receipts and cash payments by providing guidance on eight specific cash flow issues. The provisions of this ASU are effective for years beginning after December 15, 2017, with early adoption permitted. We do not expect this ASU to have a significant impact on its financial statements or disclosures.

 

In October 2016, the FASB issued ASU 2016-16, "Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory." This ASU is intended to improve the accounting for the income tax consequences of intra-entity transfers of assets other than inventory. The provisions of this ASU are effective for years beginning after December 15, 2017, with early adoption permitted. We do not expect this ASU to have a significant impact on its financial statements or disclosures.

 

ITEM 7A. Quantitative and Qualitative Disclosures About Market Risk

 

We are not required to provide this Item 7A because we are a smaller reporting company.

 

 

47
 

ITEM 8. Financial Statements and Supplementary Data

 

Report of Independent Registered Public Accounting Firm

 

To the Board of Directors and Stockholders of STR Holdings, Inc.:

 

We have audited the accompanying consolidated balance sheets of STR Holdings, Inc. (the “Company”) as of December 31, 2016 and 2015 and the related consolidated statements of comprehensive loss, changes in stockholders’ equity, and cash flows for the years then ended. In connection with our audits of the consolidated financial statements, we have also audited the financial statement schedule listed in Item 15 (a)(2) for the years ended December 31, 2016 and 2015. STR Holdings, Inc.’s management is responsible for these consolidated financial statements. Our responsibility is to express an opinion on these consolidated financial statements and financial statement schedule based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting for the year ended December 31, 2016. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of STR Holdings, Inc. as December 31, 2016 and 2015 and the results of their operations and their cash flows for the years then ended in conformity with accounting principles generally accepted in the United States of America. In addition, in our opinion, the financial statement schedule listed in the index appearing Item 15 (a)(2) for the years ended December 31, 2016 and 2015 presents fairly, in all material respects, the information set forth therein when read in conjunction with the related consolidated financial statements.

 

 

/s/ UHY LLP
   
New York, NY
March 9, 2017  
   

 

48
 

STR Holdings, Inc. and Subsidiaries

 

CONSOLIDATED BALANCE SHEETS

 

All amounts in thousands except share and per share amounts

 

    December 31,
2016
  December 31,
2015
ASSETS                
CURRENT ASSETS                
Cash and cash equivalents   $ 12,379     $ 7,703  
Bank acceptance notes     3,360       92  
Due from Zhenfa           2,058  
Accounts receivable, trade, less allowances for doubtful accounts of $2,640 and $499 in 2016 and 2015, respectively     2,989       9,112  
Inventories, net     1,847       4,806  
Income tax receivable           8,252  
Prepaid expenses     972       1,221  
Other current assets     1,095       2,044  
Total current assets     22,642       35,288  
Property, plant and equipment, net     7,974       10,581  
Assets held for sale (Note 9)     6,090       7,899  
Other long-term assets     140       148  
Total assets   $ 36,846     $ 53,916  
LIABILITIES AND STOCKHOLDERS’ EQUITY                
CURRENT LIABILITIES                
Accounts payable   $ 1,500     $ 2,192  
Accrued liabilities     2,617       3,080  
Income taxes payable     993       989  
Due to factor     381       483  
Total current liabilities     5,491       6,744  
Total liabilities     5,491       6,744  
COMMITMENTS AND CONTINGENCIES (Note 12)                
Stockholders’ equity                
Preferred stock, $0.01 par value, 20,000,000 shares authorized; no shares issued and outstanding            
Common stock, $0.01 par value, 200,000,000 shares authorized; 19,239,587 and 19,238,347 issued and outstanding, respectively as of December 31, 2016 and 18,261,807 and 18,260,567 issued and outstanding, respectively as of December 31, 2015     187       182  
Treasury stock, 1,240 shares at cost     (57 )     (57 )
Additional paid-in capital     231,627       230,999  
Accumulated deficit     (193,971 )     (178,101 )
Accumulated other comprehensive loss, net of taxes     (6,431 )     (5,851 )
Total stockholders’ equity     31,355       47,172  
Total liabilities and stockholders’ equity   $ 36,846     $ 53,916  

 

 

See accompanying notes to these consolidated financial statements.

 

49
 

STR Holdings, Inc. and Subsidiaries

 

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

 

All amounts in thousands except share and per share amounts

 

    Year Ended
December 31,
2016
  Year Ended
December 31,
2015
Net sales   $ 20,112     $ 29,783  
Cost of sales     22,127       31,607  
Gross loss     (2,015 )     (1,824 )
Selling, general and administrative expenses     7,058       10,186  
Research and development expense     1,216       1,265  
Provision (recovery) for bad debt expense     2,354       (255 )
Operating loss     (12,643 )     (13,020 )
Interest income (expense), net     37       (38 )
Other expense, net     (1,848 )     (723 )
Loss on disposal of fixed assets     (890 )      
Foreign currency transaction loss     (526 )     (34 )
Loss from continuing operations before income tax benefit     (15,870 )     (13,815 )
Income tax benefit from continuing operations           (400 )
Net loss from continuing operations     (15,870 )     (13,415 )
Discontinued operations (Note 4):                
Income tax benefit from discontinued operations           (3,952 )
Net earnings from discontinued operations           3,952  
Net loss   $ (15,870 )   $ (9,463 )
Other comprehensive loss:                
Foreign currency translation (net of tax effect of $(102) and $0, respectively)     (580 )     (1,792 )
Other comprehensive loss     (580 )     (1,792 )
Comprehensive loss   $ (16,450 )   $ (11,255 )
Net (loss) earnings per share (Note 5):                
Basic from continuing operations   $ (0.86 )   $ (0.74 )
Basic from discontinued operations           0.22  
Basic   $ (0.86 )   $ (0.52 )
Diluted from continuing operations   $ (0.86 )   $ (0.74 )
Diluted from discontinued operations           0.22  
Diluted   $ (0.86 )   $ (0.52 )
Weighted-average shares outstanding (Note 5):                
Basic     18,391,283       18,098,207  
Diluted     18,391,283       18,098,207  

 

 

See accompanying notes to these consolidated financial statements.

 

50
 

STR Holdings, Inc. and Subsidiaries

 

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

 

All amounts in thousands except share and per share amounts

 

    Common Stock   Treasury Stock   Additional
Paid-In-
  Accumulated
Other
Comprehensive
  Accumulated   Total
Stockholders’
    Issued   Amount   Acquired   Amount   Capital   Loss   Deficit   Equity
Balance at January 1, 2015     18,065,672     $ 181       1,240     $ (57 )   $ 230,276     $ (4,059 )   $ (168,618 )   $ 57,723  
Stock-based compensation     146,335       1                   631                   632  
Employee stock purchase plan     3,034                         3                   3  
Common stock issuance to Zhenfa, net                             (4 )                 (4 )
Special dividend                                         (20 )     (20 )
Shared services arrangement with Zhenfa                             93                   93  
Fractional shares retired resulting from split     (279 )                                          
Net loss                                         (9,463 )     (9,463 )
Foreign currency translation                                   (1,792 )           (1,792 )
Balance at December 31, 2015     18,214,762     $ 182       1,240     $ (57 )   $ 230,999     $ (5,851 )   $ (178,101 )   $ 47,172  
Stock-based compensation     455,165       5                   572                   577  
Shared services arrangement with Zhenfa                             56                   56  
Net loss                                         (15,870 )     (15,870 )
Foreign currency translation, net of tax                                   (580 )           (580 )
Balance at December 31, 2016     18,669,927     $ 187       1,240     $ (57 )   $ 231,627     $ (6,431 )   $ (193,971 )   $ 31,355  

 

 

See accompanying notes to these consolidated financial statements.

 

51
 

STR Holdings, Inc. and Subsidiaries

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

All amounts in thousands

 

    Year Ended
December 31,
2016
  Year Ended
December 31,
2015
OPERATING ACTIVITIES                
Net loss   $ (15,870 )   $ (9,463 )
Net earnings from discontinued operations           3,952  
Net loss from continuing operations     (15,870 )     (13,415 )
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:                
Depreciation     1,714       1,889  
Stock-based compensation expense     541       735  
Loss on disposal of property, plant and equipment     890        
Provision (recovery) for bad debt expense     2,354       (255 )
Loss on reclassification on held for sale assets           722  
Impairment of assets held for sale     1,739        
Deferred income tax expense (benefit)            
Changes in operating assets and liabilities:                
Accounts receivable     3,380       (4,817 )
Due from Zhenfa     1,924       5,429  
Cash received from income tax refunds     8,252        
Inventories, net     2,837       3,162  
Other current assets     (3,737 )     (923 )
Accounts payable     (597 )     (62 )
Accrued liabilities     791       294  
Income taxes payable     6       (400 )
Other, net     252       1,130  
Net cash provided by (used in) continuing operations     4,476       (6,511 )
Net cash used in discontinued operations           (905 )
Total net cash provided by (used in) operating activities     4,476       (7,416 )

 

 

See accompanying notes to these consolidated financial statements.

 

52
 

STR Holdings, Inc. and Subsidiaries

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

All amounts in thousands

 

    Year Ended
December 31,
2016
  Year Ended
December 31,
2015
INVESTING ACTIVITIES                
Capital investments     (329 )     (2,408 )
Proceeds from sale of fixed assets     82       601  
Net cash used in continuing operations     (247 )     (1,807 )
Net cash provided by discontinued operations            
Net cash used in investing activities     (247 )     (1,807 )
FINANCING ACTIVITIES                
Special dividend           (20 )
Common stock issuance fees           (4 )
Shared services arrangement with Zhenfa     56       93  
Factoring arrangement     (90 )     493  
Common stock issued under employee stock purchase plan           3  
Net cash (used in) provided by continuing operations     (34 )     565  
Net cash used in discontinued operations            
Net cash (used in) provided by financing activities     (34 )     565  
Effect of exchange rate changes on cash     481       (191 )
Net increase (decrease) in cash and cash equivalents     4,676       (8,849 )
Cash and cash equivalents, beginning of period     7,703       16,552  
Cash and cash equivalents, end of period   $ 12,379     $ 7,703  
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION                
Cash (received) paid during the period for:                
Income taxes   $ (8,252 )   $ 905  
Interest expense paid to factoring arrangement   $ 38     $ 8  

 

 

See accompanying notes to these consolidated financial statements.

 

53

STR Holdings, Inc. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 1—BASIS OF PRESENTATION AND NATURE OF OPERATIONS

 

Basis of Presentation

 

These consolidated financial statements reflect the financial statements of STR Holdings, Inc. (“Holdings” or the “Company”) and its subsidiaries on a consolidated basis. Due to the divestiture of the Quality Assurance (“QA”) business as discussed below, the QA business’ historical operating results are recorded in discontinued operations in the Consolidated Statements of Comprehensive Loss and Consolidated Statements of Cash Flows for all applicable periods presented. See Note 4 below.

 

On January 30, 2015, the Company filed a Certificate of Amendment to its Restated Certificate of Incorporation in order to effect a one-for-three reverse split of its common stock and its common stock began trading on the New York Stock Exchange (“NYSE”) on a split-adjusted basis on February 2, 2015. No fractional shares were issued in connection with the reverse stock split. As a result of the reverse stock split, the number of issued and outstanding shares of the Company’s common stock was reduced to approximately 18,074,291 and 18,073,051, respectively, at December 31, 2014. The change in the number of shares resulting from the reverse stock split has been applied retroactively to all shares and per share amounts presented in the consolidated financial statements and accompanying notes.

 

On September 29, 2015, the Company was notified by the NYSE that the Company was not in compliance with the continued listing standards set forth in Section 802.01B of the NYSE Listed Company Manual due to the Company’s failure to maintain an average global market capitalization over a consecutive 30 trading-day period of at least $15,000. The Company’s common stock began trading on the OTC Pink Marketplace beginning on September 30, 2015 under the ticker symbol “STRI.” On October 5, 2015, the Company’s common stock began trading on the OTCQX Marketplace under the symbol “STRI.”

 

On December 1, 2016, the Company was notified by the OTCQX that the Company did not meet the OTCQX Requirements for Continued Qualification found in Section 3.2 of the OTCQX Rules for U.S. Companies due to the Company failing to maintain a market capitalization of at least $5,000 for at least one of every 30 consecutive calendar days. The OTCQX has granted us a 60 day extension beginning on January 3, 2017 with a re-evaluation on or after February 28, 2017. Following that re-evaluation, if the Company’s market capitalization has not returned to at least $5,000, the Company’s stock will move to trading on the OTCQB market. As of the date hereof, the Company’s stock continues to trade on the OTCQX.

 

The accompanying consolidated financial statements and the related information contained within the notes to the consolidated financial statements have been prepared in accordance with Generally Accepted Accounting Principles (“GAAP”) in the United States of America and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for financial information and annual reports on the Form 10-K.

 

Nature of Operations

 

The Company was incorporated in 1944 as a plastics and industrial materials research and development company and evolved into two core businesses: solar encapsulant manufacturing and quality assurance services. The Company currently designs, develops and manufactures encapsulants that protect the embedded semiconductor circuits of solar panels and sells these products to solar module manufacturers worldwide.

 

The Company launched its former QA business in 1973 and commenced sales of solar encapsulant products in the late 1970s. The Company’s strategic divestiture of the QA business is described below and in Note 4.

 

NOTE 2—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

A summary of the Company’s significant accounting policies is as follows:

 

Basis of Accounting. The consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America.

 

Principles of Consolidation. The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany transactions and account balances have been eliminated.

 

54

STR Holdings, Inc. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 2—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Use of Estimates. The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires the Company to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and the accompanying notes. The Company’s significant estimates include its revenue recognition, allowance for doubtful accounts receivable, inventory valuation, valuation of long-lived assets, product performance accrual, income taxes payable, deferred income taxes, its assessment of uncertain tax positions and its valuation of stock-based compensation costs. Actual results could differ materially from these estimates.

 

Fair Value Estimates. Accounting Standards Codification (“ASC”) 820-10 Fair Value Measurements defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820-10 classifies the inputs used to measure fair value into the following hierarchy:

 

  Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities
  Level 2: Unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability
  Level 3: Unobservable inputs for the asset or liability

 

The carrying values for cash, accounts receivable, income tax receivable, accounts payable, accrued liabilities, income taxes payable and other current assets and liabilities approximate their fair values due to their short maturities. The carrying value of the Company’s money market funds is based on the balance of its money market funds as of December 31, 2016, which is a Level 1 input.

 

Foreign Currency Translation and Transactions. The Company’s international operations use the local currency as their functional currency, except for its Malaysian subsidiary whose functional currency is the U.S. dollar. Assets and liabilities of international operations are translated at period-end rates of exchange; revenues and expenses are translated at average rates of exchange. The resulting translation gains or losses are reflected in accumulated other comprehensive loss. Gains or losses resulting from foreign currency transactions are included in net loss.

 

Cash and Cash Equivalents. All highly-liquid investments with a maturity of three months or less at the date of purchase are considered to be cash equivalents. The Company deposits its cash balances with a limited number of banks. Cash balances in these accounts generally exceed government insured limits.

 

Recognition of Revenue and Accounts Receivable. The Company recognizes revenue net of any sales returns and allowances when evidence of an arrangement exists, delivery of the product or service has occurred and title and risk of loss have passed to the customer, the sales price is fixed or determinable, and collectability of the resulting receivable is reasonably assured.

 

The Company recognizes revenue from the manufacture and sale of its encapsulants, which is the only contractual deliverable, either at the time of shipping or at the time the product is received at the customer’s port or dock, depending upon terms of the sale. The Company does not offer a general right of return on its products.

 

On isolated occasions, the Company has offered limited short-term performance warranties relating to its

encapsulants not causing module power loss . The Company’s encapsulants are validated by long-term performance testing during product development prior to launch and during customer certification prior to mass production. The Company has operated its solar business since the 1970s and over 20 GW of solar modules incorporating its encapsulants have been installed in the field with no reported module power performance issues caused by its encapsulants and no related warranty claims to-date. Based on this fact pattern, the Company has not accrued any warranty liability associated for this potential liability as its occurrence is deemed to be remote. If the Company were to ever receive a warranty claim for such matter, it would assess the need for a warranty accrual at that time.

 

Allowance for Doubtful Accounts. The Company maintains an allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. The Company reviews the collectability of its receivables on an ongoing basis and writes off accounts receivable after reasonable collection efforts have been made and collection is deemed uncollectible.

 

55

STR Holdings, Inc. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 2—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Inventories. The Company’s inventories are stated at the lower of cost or market. The Company’s primary raw materials consist of resin, paper, packaging material and chemicals/additives. The Company’s finished goods inventories are typically made-to-order and possess a shelf life of six to nine months from the date of manufacture. Cost is determined on a first-in, first-out basis and includes both the costs of acquisition and the costs of manufacturing. These costs include direct material, direct labor and fixed and variable indirect manufacturing costs, including depreciation expense.

 

The Company will write down inventory to its net realizable value when it is probable that the inventory carrying cost is not fully recoverable through sale or other disposition. The Company’s write-down considers overall market conditions, customer inventory levels, legal or contractual provisions and age of the inventories.

 

In 2016, the Company reserved $435 of inventory, a majority of which was related to excess raw material and expired finished goods inventory. In 2015, the Company reserved $696 of inventory, a majority of which was related to excess raw material and expired finished goods inventory.

 

Long-Lived Assets. The Company’s long-lived assets consist of property, plant and equipment. Property, plant and equipment are recorded at cost and include expenditures for items that increase the useful lives of existing equipment. Maintenance and repairs are expensed as incurred. Property, plant and equipment accounts are relieved at cost, less related accumulated depreciation, when properties are disposed of or otherwise retired. Gains and losses from disposal of property, plant and equipment are included in net loss.

 

In accordance with ASC 360-Property, Plant, and Equipment, the Company reviews the carrying value of its long-lived assets, including property, plant and equipment, for impairment when events or changes in circumstances indicate the carrying value of an asset may not be recoverable. If a long-lived asset is found to be impaired, the amount recognized for impairment is equal to the difference between the carrying value and the asset’s fair value. Fair value is estimated based upon discounted future cash flows, appraisals or other reasonable estimates of fair market value.

 

Asset Retirement Obligations. The Company accounts for asset retirement obligations in accordance with ASC 410-Asset Retirement and Environmental Obligations, which requires a company to recognize a liability for the fair value of obligations to retire tangible long-lived assets when there is a contractual obligation to incur such costs. The Company has recorded its asset retirement obligations relating to the cost of removing improvements from lease facilities at the end of the lease terms. The Company’s conditional asset retirement obligations are not material.

 

Leases. The Company leases certain facilities and equipment used in its operations. The Company accounts for its leases under the provisions of ASC 840-Leases, which requires that leases be evaluated and classified as operating or capital leases for financial reporting purposes. Operating lease expense is recorded on a straight-line basis over the lease term.

 

Income Taxes. The Company accounts for income taxes using the asset and liability method in accordance with ASC 740-Income Taxes. Under this method, the Company recognizes deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and for operating loss and tax credit carryforwards. The Company estimates its deferred tax assets and liabilities using the enacted tax laws expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, and will recognize the effect of a change in tax laws on deferred tax assets and liabilities in the results of its operations during the period that includes the enactment date. The Company records a valuation allowance to reduce its deferred tax assets if it determines that it is more likely than not that some or all of the deferred tax assets will not be realized.

 

The Company operates in multiple taxing jurisdictions and is subject to the jurisdiction of a number of U.S. and non-U.S. tax authorities and to tax agreements and treaties among those authorities. Operations in these jurisdictions are taxed on various bases in accordance with jurisdictional regulations.

 

Tax benefits related to uncertain tax positions taken or expected to be taken on a tax return are recorded when such benefits meet a more likely than not threshold. Otherwise, these tax benefits are recorded when a tax position has been effectively settled, which means that the appropriate taxing authority has completed their examination even though the statute of limitations remains open or the statute of limitation expires. Interest and penalties related to uncertain tax positions are recognized as part of the Company’s provision for income taxes and are accrued beginning in the period that such interest and penalties would be applicable under relevant tax law until such time that the related tax benefits are recognized. See Note 16.

 

56

STR Holdings, Inc. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 2—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Factoring Arrangement. The Company has entered into a factoring agreement to sell, with recourse, certain European, U.S. and other foreign company-based receivables to Eurofactor Hispania S.A.U. The Company receives funds from the factor for certain outstanding receivables for which the Company records a liability. Once the customer pays the factor directly for those receivables the Company clears the accounts receivable and the liability. As of December 31, 2016 the Company has recorded $381 as due to factoring on the consolidated balance sheets. See Note 15.

 

Product Performance Accrual. The Company provides a short-term warranty that it has manufactured its products to the Company’s specifications. On limited occasions, the Company incurs costs to service its products in connection with specific product performance matters that do not meet the Company’s specifications. Anticipated future costs are recorded as part of cost of sales and accrued liabilities for specific product performance matters when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated.

 

On isolated occasions, the Company has offered limited short-term performance warranties relating to its

encapsulants not causing module power loss . The Company’s encapsulants are validated by long-term performance testing during product development prior to launch and during customer certification prior to mass production. The Company has operated its solar business since the 1970s and over 20 GW of solar modules incorporating its encapsulants have been installed in the field with no reported module power performance issues caused by its encapsulants and no related warranty claims to date. Based on this fact pattern, the Company has not accrued any warranty liability associated for this potential liability as its occurrence is deemed to be remote. If the Company were to ever receive a warranty claim for such matter, it would assess the need for a warranty accrual at that time.

 

Cost of Sales. The Company includes the cost of inventory sold and related costs for the distribution of its product in cost of sales. These costs include raw materials and other components, direct labor, product performance matters, manufacturing overhead, salaries and other personnel-related expenses, write-off of inventory, quality control, freight, insurance and depreciation. Shipping and handling costs are classified as a component of cost of sales. Customer payments for shipping and handling costs are recorded as a component of net sales.

 

Selling, General and Administrative Expenses. Selling, general and administrative expenses consist primarily of salaries, travel, commissions and other personnel-related expenses for employees engaged in sales, marketing and support of the Company’s products and services, trade shows and promotions. General and administrative expenses consist of expenses for the Company’s finance, administrative, information technology, compliance and human resource functions.

 

Research and Development Expense. The Company’s research and development expense consists primarily of salaries and fringe benefit costs and the cost of materials and outside services used in its pre-commercialization process and development efforts. The Company records depreciation expense for equipment that is used specifically for research and development activities.

 

Stock-Based Compensation. In accordance with ASC 718-Compensation-Stock Compensation, the Company recognizes the grant date fair value of stock-based awards granted to employees as compensation expense over the vesting period of the awards. See Note 18.

 

Loss Per Share. The Company computes basic loss per common share in accordance with ASC 260-Earnings Per Share. Under the provisions of ASC 260, basic net loss per common share is computed by dividing the net loss available to common stockholders by the weighted-average common shares outstanding during the period. Diluted net loss per common share adjusts basic net loss per common share for the effects of stock options and restricted stock awards only in periods in which such effect is dilutive. See Note 5.

 

Comprehensive Loss. Comprehensive loss consists of net loss and the effects on the consolidated financial statements of translating the financial statements of the Company’s international subsidiaries. Comprehensive loss is presented in the consolidated statements of comprehensive loss. The Company’s accumulated other comprehensive loss is presented as a component of equity in its consolidated balance sheets and consists of the cumulative amount of the Company’s foreign currency translation adjustments, net of tax.

 

57

STR Holdings, Inc. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 2—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Recent Accounting Pronouncements:

 

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers” (Topic 606). This ASU is intended to clarify the principles for recognizing revenue by removing inconsistencies and weaknesses in revenue requirements; providing a more robust

framework for addressing revenue issues; improving comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets; and providing more useful information to users of financial statements through improved revenue disclosure requirements. The provisions of this ASU are effective for interim and annual periods beginning after December 15, 2016. On August 12, 2015, the FASB issued ASU 2015-14, "Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date," which delays the effective date of ASU 2014-09 by one year. The new standard is effective for reporting periods beginning after December 15, 2017. Early application is permitted for reporting periods beginning after December 15, 2016. The standard shall be applied retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. In March, April and May 2016, the FASB clarified the implementation guidance on principal versus agent, identifying performance obligations, licensing, and collectability. The Company is currently evaluating the new guidance to determine the impact it may have on its consolidated financial statements.

 

In February 2015, the FASB issued ASU No. 2015-02, “Consolidation (Topic 810) Amendments to the Consolidation Analysis.” The amendments contained in this update affect reporting entities that are required to evaluate whether they should consolidate certain legal entities. All legal entities are subject to reevaluation under the revised consolidation model. The amendments in this update affect limited partnerships and similar legal entities, evaluating fees paid to a decision maker or a service provider as a variable interest, the effect of fee arrangements on the primary beneficiary determination, the effect of related parties on the primary beneficiary determination and certain investment funds. This ASU is effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2015. In October 2016, the FASB issued Update 2016-17, to amend the consolidation guidance on how a reporting entity that is the single decision maker of a variable interest entity should treat indirect interests in the entity held through related parties that are under common control with the reporting entity when determining whether it is the primary beneficiary of that variable interest entity. The amendments in this update are effective for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2016. The Company is currently evaluating the new guidance to determine the impact it may have to its consolidated financial statements.

 

In January 2016, the FASB issued ASU 2016-01, “Financial Instruments - Overall: Recognition and Measurement of Financial Assets and Financial Liabilities.” The main objective of this update is to enhance the reporting model for financial instruments to provide users of financial statements with more decision-useful information. The new guidance addresses certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. This ASU is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company does not expect this ASU to have a significant impact on its financial statements or disclosures.

 

In March 2016, FASB issued ASU 2016-09, "Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting." The objective of this update is to simplify several aspects of the accounting for employee share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. This ASU is effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. Early adoption is permitted. The Company does not expect this ASU to have a significant impact on its financial statements or disclosures

 

In August 2016, the FASB issued ASU 2016-15, "Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments." This ASU is intended to reduce diversity in practice in presentation and classification of certain cash receipts and cash payments by providing guidance on eight specific cash flow issues. The provisions of this ASU are effective for years beginning after December 15, 2017, with early adoption permitted. The Company does not expect this ASU to have a significant impact on its financial statements or disclosures.

 

58

STR Holdings, Inc. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 2—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

In October 2016, the FASB issued ASU 2016-16, "Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory." This ASU is intended to improve the accounting for the income tax consequences of intra-entity transfers of assets other than inventory. The provisions of this ASU are effective for years beginning after December 15, 2017, with early adoption permitted. The Company does not expect this ASU to have a significant impact on its financial statements or disclosures.

 

NOTE 3—TRANSACTION WITH ZHEN FA NEW ENERGY (U.S.) CO., LTD. AND ZHENFA ENERGY GROUP CO., LTD.

 

The Company has entered into certain definitive agreements with Zhenfa Energy Group Co., Ltd., a Chinese limited liability company (“Zhenfa”) and its affiliate, Zhen Fa New Energy (U.S.) Co., Ltd., a Nevada corporation (“Zhenfa U.S.”).

 

Purchase Agreement and Special Dividend

 

On August 11, 2014, the Company entered into a Stock Purchase Agreement (the “Purchase Agreement”) with Zhenfa U.S., pursuant to which the Company agreed to issue and sell to Zhenfa U.S., and Zhenfa U.S. agreed to purchase from the Company, an aggregate of 9,210,710 shares (the “Purchased Shares”) of its authorized but unissued common stock, par value $0.01 per share, for an aggregate purchase price of approximately $21,664 (the “Purchase Price”), or $2.35 per share (the “Transaction”). The Purchased Shares represented approximately 51% of the Company’s outstanding shares of common stock upon the closing of the Transaction, which occurred on December 15, 2014 (the “Closing Date”).

 

In connection with the closing of the Transaction, the Company declared a special dividend (the “Special Dividend”) on December 11, 2014 to be paid to all of its stockholders of record (other than Zhenfa U.S.) in an amount equal to $2.55 per common share on January 2, 2015.

 

The Company also entered into a guarantee agreement (the “Guarantee Agreement”) with Zhenfa pursuant to which Zhenfa agreed to guarantee all obligations of Zhenfa U.S. under the Purchase Agreement, including but not limited to, the payment of the Purchase Price and the performance of all covenants and agreements of Zhenfa U.S in the Purchase Agreement.

 

In connection with the closing of the Transaction, the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with Zhenfa U.S. that, among other things, requires the Company to register the Purchased Shares, at the Company’s expense, upon the request of Zhenfa U.S. or certain transferees of Zhenfa U.S.

 

Sales Service Agreement

 

In connection with the execution of the Purchase Agreement, Specialized Technology Resources, Inc., an operating subsidiary of the Company, entered into a Sales Service Agreement with Zhenfa whereby Zhenfa agreed, among other things, to assist the Company in a number of endeavors, including, without limitation, marketing and selling the Company’s products in China, acquiring local raw materials, hiring and training personnel in China, and complying with Chinese law. The Sales Service Agreement also provides the Company a two-year option, which expires on December 15, 2016, to lease a Zhenfa-owned manufacturing facility rent free for a period of five years, extendable by an additional five years at 50% of the then-current market rental rate.  The Company has not exercised this option as of December 31, 2016. The Sales Service Agreement became effective on the Closing Date for an initial term of two years, and automatically extends for one year periods unless terminated earlier by either party. The Sales Service Agreement may also be terminated by either party at such time as Zhenfa and its affiliates own less than 10% of the outstanding common stock of the Company.

 

NOTE 4—DISCONTINUED OPERATIONS

 

On August 16, 2011, the Company entered into an equity purchase agreement to sell its Quality Assurance (“QA”) business to Underwriters Laboratories (“UL”) for $275,000 plus assumed cash. The QA business provided consumer product testing, inspection, auditing and consulting services that enabled retailers and manufacturers to determine whether products and facilities met applicable safety, regulatory, quality, performance, social and ethical standards. In addition, the Company and UL entered into a transition services agreement, pursuant to which the Company agreed to provide certain services to UL following the closing of the sale, including accounting, tax, legal, payroll and employee benefit services. UL agreed to provide certain information technology services to the Company pursuant to such agreement. On September 1, 2011, pursuant to the terms and conditions of the equity purchase agreement, as amended, the Company transferred the applicable assets, liabilities, subsidiaries and employees of the QA business to Nutmeg Holdings, LLC (“Nutmeg”) and STR International, LLC (“International,” and together with Nutmeg and their respective subsidiaries, the “Nutmeg Companies”), and immediately thereafter sold its equity interest in each of the Nutmeg Companies to designated affiliates of UL for total net cash proceeds of $283,376, which included $8,376 of estimated cash assumed in certain QA locations.

 

59

STR Holdings, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 4—DISCONTINUED OPERATIONS (Continued)

 

In accordance with ASC 250–20 –Presentation of Financial Statements–Discontinued Operations and ASC 740–20–Income Taxes–Intraperiod Tax Allocation, the accompanying Condensed Consolidated Statements of Comprehensive Loss and Condensed Consolidated Cash Flows present the results of the QA business as discontinued operations. Prior to the sale, the QA business was a segment of the Company. The Company has no continuing involvement in the operations of the QA business and does not have any direct cash flows from the QA business subsequent to the sale. Accordingly, the Company has presented the QA business as discontinued operations in these condensed consolidated financial statements.

 

During 2015, the Company settled an income tax audit for the tax years 2009, 2010 and 2011 related to state filings of the Company’s QA business sold in 2011. As a result, the Company recorded an income tax expense to discontinued operations of $21 in 2015. Additionally, the Company recorded an income tax benefit to discontinued operations of $3,967 relating to the reversal of uncertain tax positions due to the expiration of the statute of limitations and a benefit of $6 related to a statute lapse on a proposed amended return that was never filed.

 

The following table sets forth the operating results of the QA business presented as a discontinued operation for the year ended December 31, 2015:

 

    Year Ended
December 31,
2015
Net sales   $  
Loss from operations before income tax expense      
Gain on sale before income tax expense      
Net earnings before income tax expense   $  
Income tax (benefit) expense   $ (3,952 )

 

 

60

STR Holdings, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 5—EARNINGS PER SHARE

 

The calculation of basic and diluted net loss per share for the periods presented is as follows:

 

    Year Ended
December 31,
2016
  Year Ended
Dece mber 31,
2015
Basic and diluted net (loss) earnings per share                
Numerator:                
Net loss from continuing operations   $ (15,870 )   $ (13,415 )
Net earnings loss from discontinued operations           3,952  
Net loss   $ (15,870 )   $ (9,463 )
Denominator:                
Weighted-average shares outstanding     18,391,283       18,098,207  
Add:                
Dilutive effect of stock options            
Dilutive effect of restricted common stock            
Weighted-average shares outstanding with dilution     18,391,283       18,098,207  
Net (loss) earnings per share:                
Basic from continuing operations   $ (0.86 )   $ (0.74 )
Basic from discontinued operations           0.22  
Basic   $ (0.86 )   $ (0.52 )
Diluted from continuing operations   $ (0.86 )   $ (0.74 )
Diluted from discontinued operations           0.22  
Diluted   $ (0.86 )   $ (0.52 )

 

Due to the loss from continuing operations during the years ended December 31, 2016 and 2015, the computation of dilutive weighted-average common shares outstanding does not include any stock options or any shares of unvested restricted common stock as these potential awards do not share in any loss generated by the Company and are anti-dilutive.

 

Because the effect would be anti-dilutive, there were 30 shares of common stock issuable upon the exercise of options issued under the STR Holdings, Inc. 2010 Employee Stock Purchase Plan (“ESPP”) that were not included in the computation of diluted weighted-average shares outstanding for the year ended December 31, 2015. The Company terminated the ESPP as of October 1, 2015.

 

Because the effect would be anti-dilutive, there were 1,121,332 and 1,501,331 stock options outstanding that were not included in the computation of diluted weighted-average shares outstanding for the years ended December 31, 2016 and 2015, respectively.

 

NOTE 6—BANK ACCEPTANCE NOTES

 

Customers in China may settle their accounts with bank acceptance notes. Bank acceptance notes are draft instruments that are guaranteed to be paid at maturity by the issuing bank. Upon receipt of the bank acceptance note, the Company can elect to hold the instrument until maturity and receive full face value, discount it with the bank for a fee, or transfer it at full face value to suppliers who will accept the note as settlement of the Company’s accounts payable balance with them.

 

61

STR Holdings, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 6—BANK ACCEPTANCE NOTES (Continued)

 

Bank acceptance notes consists of the following:

 

    December 31,
2016
  December 31,
2015
Balance as of beginning of period   $ 92     $  
Received from customers     7,030       5,874  
Converted to cash           (1,566 )
Paid to suppliers     (3,756 )     (4,216 )
Foreign exchange impact     (6 )      
Balance as of end of period   $ 3,360     $ 92  

 

All of the bank acceptance notes as of December 31, 2016 mature prior to June 30, 2017. Due to the short time to maturity, the Company believes the bank acceptance notes’ carrying value approximates fair value. As of December 31, 2016, the annual effective discount rate for all of the bank acceptance notes was 4.8%.

 

NOTE 7—INVENTORIES, NET

 

Inventories consist of the following:

 

    December 31,
2016
  December 31,
2015
Finished goods   $ 470     $ 872  
Raw materials     1,812       4,630  
Reserve     (435 )     (696 )
Inventories, net   $ 1,847     $ 4,806  

 

NOTE 8—LONG-LIVED ASSETS

 

Property, Plant and Equipment

 

Property, plant and equipment consist of the following:

 

    Estimated
Useful
Lives
  December 31,
2016
  December 31,
2015
Land           $ 2,039     $ 2,113  
Buildings and improvements     15 - 40       5,007       6,636  
Machinery and equipment     5 - 8       9,079       9,998  
Furniture, fixtures and computers     3 - 5       2,693       2,869  
Less: accumulated depreciation             (12,649 )     (12,852 )
Subtotal             6,169       8,764  
Construction-in-progress             1,805       1,817  
Property, plant and equipment, net           $ 7,974     $ 10,581  

 

Depreciation expense was $1,714 and $1,889 for the years ended December 31, 2016 and 2015, respectively.

 

Due to its decision to close its Malaysia facility, the Company performed an analysis to assess the specific recoverability of its property, plant and equipment using updated real estate appraisals and other data for its other fixed assets, mainly production equipment. Based upon this analysis, the Company recorded an impairment loss of $1,739 in the Company’s condensed consolidated statement of comprehensive loss in other income (expense), net during 2016 as well as a $722 loss of reclassification during 2015.

 

62

STR Holdings, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 8—LONG-LIVED ASSETS (Continued)

 

Impairment Testing

 

In accordance with ASC 360-Property, Plant and Equipment, the Company assesses the impairment of its long-lived assets whenever changes in events or circumstances indicate that the carrying value of such assets may not be recoverable. During each reporting period, the Company assessed if the following factors were present, which would cause an impairment review: overall negative solar industry conditions; a significant or prolonged decrease in net sales generated under its trademarks; loss of a significant customer or a reduction in demand for customers’ products; a significant adverse change in the extent to or manner in which the Company used its trademarks or proprietary technology; such assets becoming obsolete due to new technology or manufacturing processes entering the markets or an adverse change in legal factors; and the market capitalization of the Company’s common stock.

 

At December 31, 2016 and December 31, 2015, the Company recorded valuation allowances against its deferred tax assets. The valuation allowances were recorded since the Company had three consecutive years of taxable losses and determined that its history of actual net losses was negative evidence that should be given more weight than future projections. The Company determined the recording of valuation allowances to be an indicator to test its long-lived assets, which consist solely of property, plant and equipment, for impairment. The Company assessed the specific recoverability of its property, plant and equipment using updated real estate appraisals and other data for its other fixed assets, mainly production equipment. Based upon this analysis, the Company believes its property, plant and equipment carrying value was recoverable and depreciable lives were appropriate as of December 31, 2016. If the Company experiences a significant reduction in future sales volume, further average selling price (“ASP”) reductions, lower profitability, a cessation of operations at any of its facilities, or negative changes in U.S. or Spain real estate markets, the Company’s property, plant and equipment may be subject to future impairment or accelerated depreciation.

 

NOTE 9—ASSETS HELD FOR SALE

 

In July 2015, the Company announced a restructuring plan that included the closure of its Malaysia facility effective August 2, 2015. Subsequent to the announcement, the Company engaged advisors and was actively trying to sell its land-use right, building and other fixed assets located at the facility. In the first six months of 2016, the Company received and ultimately accepted an offer for RM25,000 ($6,265) for the land-use right and building, subject to completion of definitive documentation. In November 2016, the formal purchase and sale agreement was executed.

 

In accordance with ASC 360-Property, Plant and Equipment, the Company assessed the asset group attributed to the sale for impairment. Based upon the Company’s assessment of the status of the Malaysian property, plant and equipment, all of the requirements (including the held for sale requirements) set forth in ASC 360-10-45-9 were met and the assets were classified on the condensed consolidated balance sheet as of December 31, 2016 and December 31, 2015 as assets held for sale. An impairment loss of $1,739 was recorded in the Company’s condensed consolidated statement of comprehensive loss in other income (expense), net during the second quarter of 2016 as well as a $722 loss of reclassification during the third quarter of 2015.

 

NOTE 10—LEASES

 

The Company leases facility space under non-cancelable operating leases. The leases require the Company to pay property taxes, common area maintenance and certain other costs in addition to base rent. The Company also leases office equipment under operating leases.

 

Future minimum payments under all non-cancelable operating leases were as follows as of December 31, 2016:

 

2017   $ 148  
2018     62  
Thereafter      
    $ 210  

 

Rental expense on facility space and equipment operating leases was $198 and $195 for the years ended December 31, 2016 and 2015, respectively.

 

63

STR Holdings, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 11—ACCRUED LIABILITIES

 

Accruals consist of the following:

 

    December 31,
2016
  December 31,
2015
Product performance (see Note 12)   $ 21     $  
Salary and wages     310       411  
Accrued bonus     270       131  
Professional fees     535       510  
Restructuring severance and benefits (see Note 13)     269       268  
Environmental (see Note 12)     57       57  
Accrued franchise tax     66       125  
Client deposits     922       972  
Other     167       606  
Total   $ 2,617     $ 3,080  

 

NOTE 12—COMMITMENTS AND CONTINGENCIES

 

The Company is a party to claims and litigation in the normal course of its operations. Management believes that the ultimate outcome of these matters will not have a material adverse effect on the Company’s financial position, results of operations, or cash flows.

 

Product Performance Matters

 

The Company provides a short-term warranty that it has manufactured its products to the Company’s specifications. On limited occasions, the Company incurs costs to service its products in connection with specific product performance matters that do not meet the Company’s specifications. Anticipated future costs are recorded as part of cost of sales and accrued liabilities for specific product performance matters when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated.

 

On isolated occasions, the Company has also offered limited short-term performance warranties relating to its encapsulants not causing module power loss. The Company’s encapsulants are validated by long-term performance testing during product development prior to launch and during customer certification prior to mass production. The Company has operated its solar business since the 1970s and over 20 GW of solar modules incorporating its encapsulants have been installed in the field with no reported module power performance issues caused by the Company’s encapsulants and no related warranty claims to date. Based on this fact pattern, the Company has not accrued any warranty liability associated for this potential liability as its occurrence is deemed to be remote. If the Company was to ever receive a warranty claim for such matter, the Company would assess the need for a warranty accrual at that time.

 

The Company has accrued for specific product performance matters incurred in 2016 and 2015 that are based on management’s best estimate of ultimate expenditures that it may incur for such items. The following table summarizes the Company’s product performance liability that is recorded in accrued liabilities in the consolidated balance sheets:

 

    December 31,
2016
  December 31,
2015
Balance as of beginning of period   $     $ 189  
Additions     22       156  
Reductions     (1 )     (340 )
Foreign exchange impact           (5 )
Balance as of end of period   $ 21     $  

 

Environmental

 

During 2010, the Company performed a Phase II environmental site assessment at its 10 Water Street, Enfield, Connecticut location. During its investigation, the site was found to contain a presence of volatile organic compounds. The Company has been in contact with the Department of Environmental Protection and has engaged a licensed contractor to remediate this circumstance. Based on ASC 450-Contingencies, the Company has accrued the estimated cost to remediate. The Company’s environmental liability that is recorded in accrued liabilities in the consolidated balance sheets was $57 as of December 31, 2016 and December 31, 2015.

 

64

STR Holdings, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 12—COMMITMENTS AND CONTINGENCIES (Continued)

 

Solaria

 

In October 2016, a complaint was filed by Solaria Energia y Medio Ambiente S.A. (“Solaria”) against the Company and its Spanish subsidiary, Specialized Technology Resources España S.A. (“STR Spain”), in the Court of the First Instance No. 8 in Oviedo, Spain, relating to a product quality claim in connection with a non-encapsulant product that STR Spain purchased from a vendor in 2005 and 2006 and resold to Solaria. The Company stopped selling this product in 2006. Solaria is seeking approximately €3.3 million, plus interest, in damages.

 

As of the date of this filing, the Company has filed its documentation answering the claim, as well as its technical report related to the claim, and is in compliance with the requirements of the court relative to the claim. A trial is scheduled for April 6, 2017, in Oviedo, Spain. The Company believes it has meritorious defenses and plans to vigorously defend the matter. The Company does not believe a loss is probable or can be reasonably estimated. As such, no accrual relating to this complaint was recorded as of December 31, 2016 and December 31, 2015.

 

NOTE 13—COST REDUCTION ACTIONS

 

In July 2015, the Company reassessed the continued operations of its Malaysia facility and decided to close this facility, effective August 2, 2015, following a decision by the Company's largest customer to exit its OEM module production in Malaysia. The Company reviewed the current inventory on hand and began to transfer inventory to its other

manufacturing locations. An analysis was performed and inventory was written down to net realizable value. During the second half of 2015 the Company recognized $352 of severance and benefits as well as a $467 inventory write down in cost of sales and $467 of severance and benefits in selling, general and administrative expenses related to the Malaysia facility closure. The Company recorded an additional $25 of disposal costs in cost of sales and $2 of disposal costs in selling, general and administrative expenses.

 

In June 2016, the Company eliminated certain positions at its Spain facility, effective July 5, 2016. The Company recorded $121 of severance and benefits in cost of sales and $108 of severance and benefits in selling, general and administrative expenses during 2016.

 

The restructuring accrual consists of $269 for severance and benefits as of December 31, 2016. A rollforward of the severance and other exit cost accrual activity is as follows:

 

Balance at January 1, 2015   $ 32  
Additions     1,600  
Reductions     (1,364 )
Balance at December 31, 2015     268  
Additions     256  
Reductions     (255 )
Balance at December 31, 2016   $ 269  

 

NOTE 14—FAIR VALUE MEASUREMENTS

 

The Company measures certain financial assets and liabilities at fair value on a recurring basis in the financial statements. The hierarchy ranks the quality and reliability of inputs, or assumptions, used in the determination of fair value and requires financial assets and liabilities carried at fair value to be classified and disclosed in one of the following three categories:

 

65

STR Holdings, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 14—FAIR VALUE MEASUREMENTS (Continued)

 

Level 1-quoted prices in active markets for identical assets and liabilities;
     
Level 2-unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability; and
     
Level 3-unobservable inputs that are not corroborated by market data.

 

The following table provides the fair value measurements of applicable financial assets and liabilities as of December 31, 2016:

 

    Financial assets and liabilities
at fair value as of
December 31, 2016
    Level 1   Level 2   Level 3
Money market funds (1)   $ 7,429     $     $  
Bank acceptance notes (2)     3,360              
Non-recurring fair value measurements (3)                 6,090  
Total   $ 10,789     $     $ 6,090  

 

The following table provides the fair value measurements of applicable financial assets and liabilities as of December 31, 2015:

 

    Financial assets and liabilities
at fair value as of
December 31, 2015
    Level 1   Level 2   Level 3
Money market funds (1)   $ 3,002     $     $  
Bank acceptance notes (2)     92              
Non-recurring fair value measurements (3)                 7,899  
Total   $ 3,094     $     $ 7,899  

______________________

(1) Included in cash and cash equivalents on the Company’s Consolidated Balance Sheets. The carrying amount of money market funds is a reasonable estimate of fair value.
(2) Refer to Note 6 for further information.
(3) Included in assets held for sale on the Company’s Consolidated Balance Sheets. Refer to Note 9 for further information.

 

NOTE 15—FACTORING ARRANGEMENT

 

In October 2015, the Company’s wholly owned Spanish subsidiary, Specialized Technology Resources España S.A., entered into a factoring agreement to sell, with recourse, certain European, U.S. and other foreign company-based receivables to Eurofactor Hispania S.A.U. Under the current terms of the factoring agreement, the maximum amount of outstanding advances at any one time is € 1,500 million ($1,572 million as of December 31, 2016), which is subject to adjustment based on the level of eligible receivables, restrictions on concentrations of receivables and the historical performance of the receivables sold. The annual discount rate is 2% plus EURIBOR for Euro denominated receivables and 2% plus LIBOR for all other currencies. The term of the agreement is for one year, which will be automatically extended unless terminated by either party with 90 days prior written notice. As of December 31, 2016 and 2015 the Company has recorded $381 and $483, respectively, as due to factoring on the consolidated balance sheets.

 

66

STR Holdings, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 16—INCOME TAXES

 

Loss from continuing operations before income tax expense (benefit) is as follows:

 

    Year Ended
December 31, 2016
  Year Ended
December 31, 2015
Domestic   $ (3,070 )   $ (4,761 )
Foreign     (12,800 )     (9,054 )
Total   $ (15,870 )   $ (13,815 )

 

The expense (benefit) for income taxes from continuing operations consists of the following components:

 

    Year Ended
December 31, 2016
  Year Ended
December 31, 2015
Current income tax (benefit) expense from continuing operations                
U.S. federal   $     $ (414 )
Foreign           14  
State and local            
Total current income tax (benefit) expense from continuing operations           (400 )
Deferred income tax expense (benefit) from continuing operations                
U.S. federal            
Foreign            
State and local            
Total deferred income tax expense (benefit) from continuing operations            
Total income tax expense (benefit) from continuing operations   $     $ (400 )

 

There were no tax benefits for the years ended December 31, 2016 and 2015, respectively, associated with the exercise of stock options that were recorded to additional paid-in capital. Tax benefits associated with the “windfall” for stock options exercised are determined on a “with and without” basis.

 

During 2015 and 2016, the Company issued new non-qualified stock options. The Company has no “windfall” in additional paid-in-capital as of December 31, 2016. The Company recorded a deferred tax expense before valuation allowance of $43 and $21 relating to non-qualified stock option cancellations for the years ended December 31, 2016 and 2015, respectively.

 

A deferred tax expense of $0 relating to the cumulative translation adjustment of the Company’s foreign subsidiaries financial statements was recorded in other comprehensive (loss) income for the years ended December 31, 2016 and 2015.

 

The Company was not subject to income taxes for the years ended December 31, 2016 and 2015. 

 

67

STR Holdings, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 16—INCOME TAXES (Continued)

 

Following is a reconciliation of the Company’s effective income tax rate from continuing operations to the United States federal statutory tax rate:

 

    Year Ended
December 31, 2016
  Year Ended
December 31, 2015
Expected tax at U.S. statutory income tax rate     35.0 %     35.0 %
U.S. state and local income taxes net of federal income tax effect     0.0 %     0.0 %
Foreign rate differential     (6.3 )%     (11.7 )%
Foreign unremitted earnings     (22.5 )%     (14.7 )%
Unrecognized tax benefits     0.0 %     2.9 %
Stock option cancellations     (0.3 )%     (0.1 )%
Change in valuation allowance     1.6 %     (8.1 )%
Other     (7.5 )%     (0.4 )%
Effective tax rate     0.0 %     2.9 %

 

The effect of temporary differences is included in deferred tax accounts as follows:

 

    Year Ended
December 31, 2016
  Year Ended
December 31, 2015
Deferred tax assets:        
Long-term deferred tax assets:                
Accrued compensation   $ 79     $ 9  
Inventory     2       24  
Bad debt reserves     45       46  
Product performance accrual     20       20  
Non-qualified stock option compensation     252       159  
Operating loss carryforwards     10,298       8,282  
Fixed assets     223       190  
Other     149       150  
Total long-term deferred tax assets before valuation allowance   $ 11,068     $ 8,880  
Valuation allowance     (11,068 )     (8,880 )
Long term-deferred tax assets            
Total deferred tax assets   $     $  
Deferred tax liabilities:                
Foreign unremitted earnings   $     $  
Total deferred tax liabilities   $     $  
Total net deferred tax assets   $     $  

 

A valuation allowance is recorded on certain deferred tax assets if it has been determined it is more likely than not that all or a portion of these assets will not be realized. The Company has recorded a valuation allowance of $11,068 and $8,880 for deferred tax assets existing as of December 31, 2016 and December 31, 2015, respectively. The valuation allowance as of December 31, 2016 is attributable to deferred taxes in the United States and net operating loss carryforwards in the United States, Spain, China and Hong Kong. The valuation allowance as of December 31, 2015 is attributable to deferred taxes in the United States and net operating loss carryforwards in the United States, Spain, China and Hong Kong.

 

During November 2015, the FASB issued ASU 2015-17, “Balance Sheet Classification of Deferred Taxes”, which simplifies the presentation of deferred income taxes. This ASU requires that deferred tax assets and liabilities be classified as non-current in a statement of financial position. The Company early adopted ASU 2015-17 effective December 31, 2015 on a prospective basis. Adoption of this ASU resulted in a reclassification of the Company’s net current deferred tax asset to the net non-current deferred tax asset in its consolidated balance sheet as of December 31, 2015. No prior periods were retrospectively adjusted.

 

68

STR Holdings, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 16—INCOME TAXES (Continued)

 

The Company recognizes interest accrued related to its liability for unrecognized tax benefits and penalties in income tax expense. The Company recorded interest and penalties related to unrecognized tax benefits as a component of income tax expense from continuing operations in the amount of approximately $0 and $(39) for the years ended December 31, 2016 and 2015, respectively. The Company had approximately $0 and $0 for payment of interest and penalties accrued as of December 31, 2016 and December 31, 2015, respectively.

 

A reconciliation of the beginning and ending amount of the Company’s liability for unrecognized tax benefits, excluding interest and penalties, is as follows (includes continuing and discontinued operations):

 

Balance at January 1, 2015   $ 3,199  
Additions for tax positions of prior years      
Reductions for tax positions of prior years     (3,199 )
Balance at December 31, 2015   $  
Additions for tax positions of prior years      
Reductions for tax positions of prior years      
Balance at December 31, 2016   $  

 

The amount of unrecognized tax benefit that would potentially impact the Company’s effective tax rate from continuing operations and discontinued operations was $0 (excluding interest and penalties) as of December 31, 2016 and 2015. During 2015, the Company had reductions for tax positions of prior years of $3,199 for a lapse in the statute of limitations. The Company recorded an income tax benefit in continuing operations of $0 (excluding interest and penalties) and an income tax benefit in discontinued operations of $0 (excluding interest and penalties). The Company has open tax years from 2005-2016 with various foreign tax jurisdictions. The Company expects $0 (excluding interest and penalties) of unrecognized tax benefits to reverse within the next twelve months.

 

The Company conducts its business globally and as a result, the Company and one or more of its subsidiaries file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. The Company is subject to examination by taxing authorities in each of these jurisdictions.

 

The Company has an open tax year of 2015 for U.S. federal tax purposes. The Company has open tax years from 2013-2015 with various state tax jurisdictions. In connection with the examination of the Company’s tax returns, contingencies can arise that generally result from differing interpretations of applicable tax laws and regulations as they relate to the amount, timing or inclusion of revenues or expenses in taxable income, or the sustainability of tax credits to reduce incomes taxes payable. The Company believes it has sufficient accruals for its contingent tax liabilities. Annual tax provisions include amounts considered sufficient to pay assessments that may result from examination of prior year tax returns, although actual results may differ.

 

During 2014, and 2015, the Company went through several examinations that resulted in no material adjustments, including: an examination in the United States by the Internal Revenue Service for tax years 2011, 2012, 2013, and 2014; an examination by the State of Florida for the tax years 2010, 2011 and 2012; and an inspection for the 2012 return filed for Spain. During 2016, the Company received an income tax refund of $8,252 from the Internal Revenue Service resulting from a 2014 federal net operating loss carryback.

 

During 2015, the Company settled an audit conducted by the State of Massachusetts for tax years 2009, 2010, and 2011, relating to the Company’s QA business, which was sold in 2011. The Company recorded an income tax expense to discontinued operations of $21 for the year ended December 31, 2015. Refer to Note 4-Discontinued Operations for further explanation.

 

No U.S. taxes need to be provided for the undistributed earnings of a foreign subsidiary if the Company can assert that such earnings are planned to be reinvested indefinitely outside of the United States. The Company periodically assesses its business operations and the cash flow needs of its foreign and domestic subsidiaries to determine if the earnings of any of its foreign subsidiaries will be indefinitely reinvested outside the United States. The Company is not permanently reinvesting earnings generated in any foreign jurisdiction.

 

69

STR Holdings, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 16—INCOME TAXES (Continued)

 

The Company’s subsidiary in Malaysia is operating under a tax holiday arrangement that extends through 2019. The impact of the tax holiday on its effective rate is a reduction in the benefit of 6.5% and 11.7% percentage points for 2016 and 2015, respectively.

 

NOTE 17—STOCKHOLDERS’ EQUITY

 

Preferred Stock

 

The Company’s Board of Directors has authorized 20,000,000 shares of preferred stock, $0.01 par value, issuable in series. At December 31, 2016 and 2015, there were no shares issued or outstanding.

 

Common Stock

 

Reverse Stock Split

 

As more fully described in Note 1, the Company effected a one-for-three reverse split of its common stock on January 30, 2015.

 

The Company’s Board of Directors has authorized 200,000,000 shares of common stock, $0.01 par value. At December 31, 2016, there were 19,239,587 shares of issued and 19,238,347 shares of outstanding common stock. Each share of common stock is entitled to one vote per share. Included in the 19,238,347 shares outstanding are 18,669,927 shares of common stock and 568,420 shares of restricted unvested common stock.

 

At December 31, 2015, there were 18,261,807 shares of issued and 18,260,567 shares of outstanding common stock. Each share of common stock is entitled to one vote per share. Included in the 18,260,567 shares outstanding are 18,214,762 shares of common stock and 45,805 shares of restricted unvested common stock.

 

Treasury Stock

 

At December 31, 2016 and 2015, there were 1,240 shares held in treasury that were purchased at a cost of $57.

 

NOTE 18—STOCK-BASED COMPENSATION

 

On November 6, 2009, the Company’s Board of Directors approved the Company’s 2009 Equity Incentive Plan (the “2009 Plan”) which became effective on the same day. Effective May 14, 2013, the 2009 Plan was amended to increase the number of shares subject to the Plan. As a result, a total of 4,133,133 shares of common stock are reserved for issuance under the 2009 Plan. The 2009 Plan is administered by the Board of Directors or any committee designated by the Board of Directors, which has the authority to designate participants and determine the number and type of awards to be granted, the time at which awards are exercisable, the method of payment and any other terms or conditions of the awards. The 2009 Plan provides for the grant of stock options, including incentive stock options and nonqualified stock options, collectively, “options,” stock appreciation rights, shares of restricted stock, or “restricted stock,” rights to dividend equivalents and other stock-based awards, collectively, the “awards.” The Board of Directors or the committee will, with regard to each award, determine the terms and conditions of the award, including the number of shares subject to the award, the vesting terms of the award, and the purchase price for the award. Awards may be made in assumption of or in substitution for outstanding awards previously granted by the Company or its affiliates, or a company acquired by the Company or with which it combines. Options outstanding generally vest over a three or four-year period and expire ten years from date of grant.

 

70

STR Holdings, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 18—STOCK-BASED COMPENSATION (Continued)

 

The following table summarizes the Company’s stock-based compensation awards under the 2009 Plan during 2016 and 2015:

 

Date   Award Type   Exercise Price   Shares   Recipient
4 th  Quarter 2016   Restricted Stock   $ 0.19       568,420     Board of Directors
4 th Quarter 2016   Restricted Stock   $ 0.22       119,835     Board of Directors
3 rd Quarter 2016   Restricted Stock   $ 0.29       80,272     Board of Directors
2 nd  Quarter 2016   Restricted Stock   $ 0.23       35,472     Board of Directors
2 nd Quarter 2016   Restricted Stock   $ 0.30       100,096     Board of Directors
1 st  Quarter 2016   Restricted Stock   $ 0.37       85,136     Board of Directors
2 nd  Quarter 2015   Restricted Stock   $ 1.16       155,172     Board of Directors
2 nd  Quarter 2015   Restricted Stock   $ 1.43       22,028     Board of Directors
1 st  Quarter 2015   Options   $ 1.52       1,964,665     Various Employees
1 st  Quarter 2015   Restricted Stock   $ 4.11       7,561     Board of Directors

 

There were 1,231,005 shares available for grant under the 2009 Plan as of December 31, 2016.

 

The following table summarizes the stock option activity under the Company’s 2009 Plan for the two years ended December 31, 2016:

 

    Options Outstanding
    Number of
Shares
  Weighted-
Average
Exercise
Price
  Weighted-
Average
Remaining
Contractual
Term
(in years)
  Weighted-
Average
Grant-Date
Fair
Value
  Aggregate
Intrinsic
Value(1)
Balance at January 1, 2015         $           $     $  
Options granted     1,964,665     $ 1.52           $ 0.99     $ (2,692 )
Exercised         $           $     $  
Cancelled/forfeited     (463,334 )   $ 1.52           $ 0.99     $ 635  
Balance at December 31, 2015     1,501,331     $ 1.52           $ 0.99     $ (2,057 )
Options granted         $           $     $  
Exercised         $           $     $  
Cancelled/forfeited     (379,999 )   $ 1.52           $ 0.99     $ 521  
Balance at December 31, 2016     1,121,332     $ 1.52       8.10     $ 0.99     $ (1,536 )
Vested and exercisable as of December 31, 2016     373,775     $ 1.52       8.10     $ 0.99     $ (512 )
Vested and exercisable as of December 31, 2016 and expected to vest thereafter     1,098,980     $ 1.52       8.10     $ 0.99     $ (1,506 )

______________________

(1) The aggregate intrinsic value for December 31, 2016 and December 31, 2015 is calculated as the difference between the exercise price of the underlying awards and the closing stock price of $0.15 of the Company’s common stock on December 31, 2016.

 

As of December 31, 2016, there was $401 of unrecognized compensation cost related to outstanding stock option

awards. This amount is expected to be recognized over a weighted-average remaining vesting period of less than one year. To the extent the actual forfeiture rate is different from what the Company has anticipated, stock-based compensation related to these awards will be different from its expectations. The Company did not receive any proceeds related to the exercise of stock options for the years ended December 31, 2016 and 2015.

 

71

STR Holdings, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 18—STOCK-BASED COMPENSATION (Continued)

 

The following table summarizes the restricted shares activity for the two years ended December 31, 2016:

 

    Unvested
Restricted Shares
    Number of
Shares
  Weighted-Average
Grant-Date
Fair Value
Unvested at January 1, 2015     7,379     $  
Granted     184,761     $ 1.30  
Vested     (146,335 )   $ 1.35  
Cancelled         $  
Unvested at December 31, 2015     45,805     $ 1.14  
Granted     989,231     $  
Vested     (455,165 )   $ 1.14  
Cancelled     (11,451 )   $ 1.14  
Unvested at December 31, 2016     568,420     $  
Expected to vest after December 31, 2016     568,420     $  

 

As of December 31, 2016, there was $90 of unrecognized compensation cost related to unvested restricted shares. This amount is expected to be recognized over a weighted-average remaining vesting period of less than one year. To the extent the actual forfeiture rate is different from what the Company has anticipated, stock-based compensation related to these awards will be different from its expectations.

 

On November 9, 2010, the Company’s Board of Directors adopted the Employee Stock Purchase Plan and reserved 166,667 shares of the Company’s common stock for issuance thereunder. The ESPP was made effective upon its approval by the votes of the Company’s stockholders on May 24, 2011 during the Company’s annual meeting for the purpose of qualifying such shares for special tax treatment under Section 423 of the Internal Revenue Code of 1986, as amended. As of October 1, 2015 the Company terminated the ESPP.

 

Under the ESPP, eligible employees used payroll withholdings to purchase shares of the Company’s common stock at a 10% discount. The Company had established four offering periods in which eligible employees could participate. The first offering period commenced in the fourth quarter of 2011. The Company purchased the number of required shares each period based upon the employees’ contribution plus the 10% discount. The number of shares purchased times the 10% discount was recorded by the Company as stock-based compensation. The Company recorded less than $1 in stock-based compensation expense relating to the ESPP for the year ended December 31, 2015.

 

Stock-based compensation expense was included in the following consolidated statements of comprehensive loss categories for continuing operations:

 

    Years Ended December 31,
    2016   2015
Selling, general and administrative expense   $ 541     $ 735  
Research and development expense   $     $  
Total stock-based compensation expense   $ 541     $ 735  

 

Deferred Compensation

 

The Company had a deferred compensation arrangement with certain members of management, including Robert S. Yorgensen, that stated upon the earlier of December 31, 2015, sale of the Company (which included a change of control transaction), or termination of employment for any reason, the members were entitled to bonus payments based upon a formula set forth in their respective employment agreements. The payments were tied to distribution amounts they would have received with respect to their former ownership in the predecessor Company if the assets were sold at fair market value of the Company’s stock price. The amount of the potential bonus payment was capped at $1,180. In accordance with ASC 718-30, the obligation should have been re-measured quarterly at fair value. The Company determined fair value using observable current market information as of the reporting date. The most significant input to determine the fair value was determined to be the Company’s common stock price which is a Level 2 input. Based upon the difference of the floor in the agreements and the effective valuation of the Transaction of $4.80 per share for Mr. Yorgensen, $204 of accrued compensation was paid out during the first quarter of 2015. As of December 31, 2016, no deferred compensation arrangements exist.

 

72

STR Holdings, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 19—REPORTABLE SEGMENT AND GEOGRAPHICAL INFORMATION

 

ASC 280-10-50-Disclosure about Segments of an Enterprise and Related Information, establishes standards for the manner in which companies report information about operating segments, products, geographic areas and major customers. The method of determining what information to report is based on the way that management organizes the operating segments within the enterprise for making operating decisions and assessing financial performance. Prior to the sale of its QA business, the Company reported two operating segments: QA and Solar. Due to the sale, QA is being reported as a discontinued operation and the Company reassessed its segment reporting. Since the Company has one product, sells to global customers in one industry, procures raw materials from similar vendors and expects similar long-term economic characteristics, the Company has one reporting segment and the information as to its operation is set forth below.

 

Adjusted EBITDA is the main metric used by the management team and the Board of Directors to plan, forecast and review the Company’s segment performance. Adjusted EBITDA represents net loss from continuing operations before interest income and expense, income tax expense, depreciation, stock-based compensation expense, restructuring, and certain non-recurring income and expenses from the results of operations.

 

The following tables set forth information about the Company’s operations by its reportable segment and by geographic area:

 

Operations by Reportable Segment

 

    Year Ended
December 31, 2016
  Year Ended
December 31, 2015
Reconciliation of Adjusted EBITDA to Net Loss from Continuing Operations                
Adjusted EBITDA   $ (10,643 )   $ (8,842 )
Depreciation and amortization     (1,714 )     (1,889 )
Interest (expense) income, net     37       (38 )
Income tax benefit (expense)           400  
Other non-operating expenses     (124 )     (1 )
Restructuring     (256 )     (1,588 )
Stock-based compensation     (541 )     (735 )
Impairment of assets held for sale     (1,739 )      
Loss on reclassification of held for sale assets           (722 )
(Loss) gain on disposal of property, plant and equipment     (890 )      
Net Loss from Continuing Operations   $ (15,870 )   $ (13,415 )

 

 

73

STR Holdings, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 19—REPORTABLE SEGMENT AND GEOGRAPHICAL INFORMATION (Continued)

 

Operations by Geographic Area

 

    Year Ended
December 31, 2016
  Year Ended
December 31, 2015
Net Sales                
United States   $ 58     $ 49  
Spain     9,934       15,675  
China     10,120       10,038  
Malaysia           4,021  
Total Net Sales   $ 20,112     $ 29,783  

 

Long-Lived Assets by Geographic Area

 

    December 31,
2016
  December 31,
2015
Long-Lived Assets                
United States   $ 1,448     $ 1,594  
Spain     5,990       6,765  
China     535       2,220  
Hong Kong     1       2  
Total Long-Lived Assets   $ 7,974     $ 10,581  

 

Foreign sales are based on the country in which the net sales originated. Net sales to two of the Company’s major customers that exceeded 10% of the Company’s net sales for the year ended December 31, 2016 was $6,590. Net sales to two of the Company’s major customers for the year ended December 31, 2015 was $8,448. Accounts receivable from two customers amounted to $597 as of December 31, 2016 and from two customers amounted to $1,570 as of December 31, 2015.

 

NOTE 20—EMPLOYEE BENEFIT PLANS

 

The Company maintained one defined contribution benefit plan for the years ended December 31, 2016 and 2015 covering substantially all U.S. domestic employees. The Company makes matching contributions to the plans using its forfeiture account and can also make discretionary contributions to the plans.

 

The Company also maintained defined contribution benefit plans for certain foreign employees. The expense under these plans was $143 and $179 for the years ended December 31, 2016 and 2015, respectively.

 

NOTE 21—RELATED PARTIES

 

Huhui Supply Agreement

 

The Company’s Chinese subsidiary, Specialized Technology Resources Solar (Suzhou) Co. Ltd. (“STR China”) entered into a supply agreement (the “Huhui Supply Agreement”) dated as of December 31, 2014 with Zhangjiagang Huhui Segpv Co. Ltd ("Huhui"), a solar module manufacturer and an affiliate of Zhenfa. Pursuant to the Huhui Supply Agreement, STR China agreed to supply Huhui with the Company's encapsulant products and Huhui agreed (i) to purchase not less than 535 MW worth of encapsulants (the “Minimum Amount”) during each contract year, (ii) to pay the Company a deposit equal to 10% of the Minimum Amount, and (iii) not to purchase encapsulant products from other encapsulant manufacturers. The initial term of the Huhui Supply Agreement was for one year; however, such initial term was extended for an additional six months due to failure by Huhui to purchase the Minimum Amount at the end of the first year anniversary of the effective date of the Huhui Supply Agreement. The Huhui Supply Agreement further provides that Huhui’s obligations are contingent (unless otherwise provided in the agreement) upon (i) the delivery by STR China of an initial shipment of products in accordance with the specifications and (ii) the qualification of the products by Huhui during a sample production run of not less than 30 days. As of December 31, 2016, Huhui had not commenced the sample production run. The Huhui Supply Agreement shall automatically renew for additional one year terms if either party fails to notify the other party at least 90 days prior to the end of the then current term that it is electing to terminate the agreement. The Company believes that the terms and conditions set forth in the Huhui Agreement at that time were fair and reasonable to the Company. The Company received $1,148 as a deposit from Huhui during the year ended December 31, 2015, which is included in accrued liabilities on the Consolidated Balance Sheets. During the year ended December 31, 2016 the Company did not record any sales to this customer.

 

74

STR Holdings, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

All amounts in thousands except share amounts, per share amounts or unless otherwise noted

 

NOTE 21—RELATED PARTIES (Continued)

 

Module-for-Encapsulant Swap Transaction

 

During the second quarter of 2015, the Company entered into a module-for-encapsulant swap transaction with Zhenfa and Zhejiang ReneSola Jiangsu Co., Ltd. (“ReneSola”) to settle outstanding accounts receivable due from ReneSola. As part of this three-party transaction, the Company agreed to accept solar modules as settlement of approximately $7,487 of outstanding receivables from ReneSola, and Zhenfa agreed to purchase these modules from the Company for $7,487. During the third quarter of 2016, the Company increased the amount due by approximately $1,165 to reflect an inadvertent overpayment of modules made to Zhenfa by ReneSola. In October 2016, the Company received bank acceptance notes and cash from Zhenfa for approximately $3,181 in full payment of the balance due under these arrangements.

 

Debt Settlement Agreement

 

During the second quarter of 2016, the Company entered into a debt settlement agreement with Zhenfa, a company that is a supplier to Zhenfa and a customer of the Company, and that company’s parent company to settle outstanding accounts receivable due from this company. As part of this four-party transaction, Zhenfa agreed to pay the Company approximately RMB 10,000 (approximately $1,500 as of June 30, 2016) as settlement of a similar amount of outstanding receivables due from the Company’s customer, and the customer’s parent company (Zhenfa’s supplier) agreed to cancel a similar amount of outstanding receivables due from Zhenfa. Final execution was concluded in early July, resulting in

application of a previously recorded deposit against the outstanding accounts receivable from this customer. There was a residual receivable due to STR from Zhenfa related to this Debt Settlement Agreement, equal to the difference in the offsetting receivables of approximately RMB 80. The Company received payment for the outstanding balance in October 2016.

 

Employment of Zhenfa Personnel

 

On July 27, 2015, the Company announced the appointment of Mr. Qu Chao to the office of Vice President, Strategic Investment, and Mr. Kong Weijie as Vice President, Business Development and General Manager, China, effective August 1, 2015. At the time, Messrs. Qu and Kong were officers of Zhenfa. Mr. Qu was also a member of the Company’s Board of Directors. The services of Messrs. Qu and Kong were provided by Zhenfa, at no charge to the Company, pursuant to the terms of the Zhenfa Sales Service Agreement, as described in Note 3 above. In October 2015, the Company was advised by representatives of Zhenfa that Mr. Qu resigned as an officer of Zhenfa and that Zhenfa would no longer be supporting Mr. Qu’s services as Vice President, Strategic Investment. The Company has not separately engaged Mr. Qu to continue to provide those services as he is no longer an officer of the Company. As of the date of this report, Mr. Qu is no longer a director of the Company.

 

Mr. Kong attempted to divide his time evenly between his duties with Zhenfa and STR. As a result, the value of Mr. Kong’s services provided was reflected in the Company’s consolidated financial statements. This shared services arrangement was recorded as a non-cash expense in selling, general and administrative expenses and an increase to additional paid-in capital of $56 for year ended December 31, 2016, respectively. Effective June 29, 2016, Mr. Kong was removed by the Company from his position as Vice President, Business Development and General Manager, China and from all other official capacities with the Company and its subsidiaries.

 

NOTE 22—SUBSEQUENT EVENTS

 

In light of continued difficulties in the China market on March 7, 2017, the Company made the decision to wind down its China manufacturing operations substantially by the end of the first quarter of 2017. The decision is consistent with ongoing efforts to reorganize its encapsulant business to better align with customer geography, to reduce losses related to unprofitable locations and to convert assets to cash for potential redeployment into more profitable endeavors. In connection with the restructuring, the Company does not expect any significant asset impairment charges and expects to record during the first quarter of 2017 charges for severance, lease termination and other costs of between $100 and $300.

 

ITEM 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 

None. 

 

75

 

 

ITEM 9A. Controls and Procedures

 

This annual report does not include an audit or attestation report of our registered public accounting firm regarding our internal control over financial reporting because the attestation report requirement has been removed for "smaller reporting companies" under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010."

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports to the Securities Exchange Act of 1934, as amended (“Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chairman, President and Chief Executive Officer and our Vice President, Chief Financial Officer and Chief Accounting Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

 

As of December 31, 2016, we carried out an evaluation, under the supervision and with the participation of our management, including our Chairman, President and Chief Executive Officer and our Vice President, Chief Financial Officer and Chief Accounting Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based upon that evaluation, our Chairman, President and Chief Executive Officer and our Vice President, Chief Financial Officer and Chief Accounting Officer concluded that our disclosure controls and procedures are effective.

 

Report of Management on Internal Control over Financial Reporting

 

We are responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rule 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended, as a process designed by, or under the supervision of our principal executive and principal financial officers and effected by our Board of Directors, management and other personnel to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:

 

pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and disposition of our assets;
     
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorization of our management and directors; and
     
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

We have assessed the effectiveness of our internal control over financial reporting as of December 31, 2016. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control-Integrated Framework (2013).

 

Based on our assessment, management has concluded that, as of December 31, 2016, our internal control over financial reporting is effective.

 

Changes in Internal Control over Financial Reporting

 

There have not been any changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fourth fiscal quarter of the Company’s fiscal year ended December 31, 2016 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

76

 

ITEM 9B. Other Information

 

Effective March 4, 2017, Haiyang (Ocean) Yuan resigned as a member of the Board of Directors of STR Holdings, Inc. Mr. Yuan’s resignation was not a result of any disagreements with the Company on any matter relating to the Company’s operations, policies or practices.

 

PART III

 

All information in this Part may be found in the Company’s proxy statement (the “Proxy Statement”) to be delivered to stockholders not later than 120 days after the end of the fiscal year covered by this Annual Report in connection with the annual meeting of stockholders (the “Annual Meeting”) and such information is incorporated in this report by reference pursuant to General Instruction G (3) of Form 10-K.

 

ITEM 10. Directors, Executive Officers and Corporate Governance

 

The information required by this Item will be included in our Proxy Statement and is incorporated by reference herein.

 

ITEM 11. Executive Compensation

 

The information required by this Item will be included in our Proxy Statement and is incorporated by reference herein.

 

ITEM 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

The information required by this Item will be included in our Proxy Statement and is incorporated by reference herein.

 

ITEM 13. Certain Relationships and Related Transactions, and Director Independence

 

The information required by this Item will be included in our Proxy Statement and is incorporated by reference herein.

 

ITEM 14. Principal Accountant Fees and Services

 

The information required by this Item will be included in our Proxy Statement and is incorporated by reference herein.

 

 

77

 

PART IV

 

ITEM 15. Exhibits and Financial Statement Schedule

 

(a)       List of documents filed as part of this report or incorporated herein by reference:

 

(1)       Financial Statements:

 

The following financial statements of the Registrant as set forth under Part II, Item 8 of this Annual Report on Form 10-K on the pages indicated.

 

 

Page in this
Form 10-K

Reports of Independent Registered Public Accounting Firm 49
Consolidated Balance Sheets as of December 31, 2016 and 2015 50
Consolidated Statements of Comprehensive Loss for the years ended December 31, 2016 and 2015 51
Consolidated Statements of Changes in Stockholders’ Equity for the years ended December 31, 2016 and 2015 52
Consolidated Statements of Cash Flows for the years ended December 31, 2016 and 2015 53
Notes to Consolidated Financial Statements 55

 

(2)       Financial Statement Schedule:

 

Schedule II-Valuation and Qualifying Accounts 80

 

 

78

 

Schedule II-Valuation and Qualifying Accounts

STR Holdings, Inc. and Subsidiaries

 

    Beginning
Balance
  Additions/
Charged to
Expenses
  Currency
Impact
  Reductions   Balance at
End of
Period
Accounts Receivable Allowance for Doubtful Accounts:                                        
Year ended December 31, 2016   $ 499       2,354       (130 )     (83 )   $ 2,640  
Year ended December 31, 2015   $ 833       (255 )     (38 )     (41 )   $ 499  
Tax Valuation Allowance:                                        
Year ended December 31, 2016   $ 8,880       2,188                 $ 11,068  
Year ended December 31, 2015   $ 7,424       1,456                 $ 8,880  
Inventory Reserve:                                        
Year ended December 31, 2016   $ 696       (119 )     (31 )     (111 )   $ 435  
Year ended December 31, 2015   $ 1,025       1,101       (27 )     (1,403 )   $ 696  

 

 

 

79

 

(3)       Exhibits:

 

EXHIBIT INDEX

 

††2.1   Stock Purchase Agreement, dated August 11, 2014, by and between STR Holdings, Inc. and Zhen Fa New Energy (U.S.) Co., Ltd. (filed as Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on August 12, 2014 (file no. 001-34529) and incorporated herein by reference).
3.1   Certificate of Incorporation of STR Holdings, Inc. (filed as Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q filed on November 17, 2009 (file no. 001-34529) and incorporated herein by reference).
3.2   Certificate of Amendment of Certificate of Incorporation. ((filed as Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on January 30, 2015 (file no. 001-34529) and incorporated herein by reference).
3.3   Bylaws of the STR Holdings, Inc. (filed as Exhibit 3.2 to the Company’s Quarterly Report on Form 10-Q filed on November 17, 2009 (file no. 001-34529) and incorporated herein by reference).
4.1   Form of Common Stock Certificate. (filed as Exhibit 4.1 to the Company’s Quarterly Report on Form 10-Q filed on November 17, 2009 (file no. 001-34529) and incorporated herein by reference).
†10.1   Form of Indemnification Agreement between STR Holdings, Inc. and each of its directors and executive officers. (filed as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q filed on November 17, 2009 (file no. 001-34529) and incorporated herein by reference).
†10.2   2009 Equity Incentive Plan. (filed as Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q filed on November 17, 2009 (file no. 001-34529) and incorporated herein by reference).
*†10.3   Employment Agreement, dated as of December 7, 2011, between Specialized Technology Resources, Inc. and Robert S. Yorgensen.
†*10.4   Form of STR Holdings, Inc. Restricted Stock Agreement for executive officers that held incentive units in STR Holdings (New) LLC. (filed as Exhibit 10.18 to the Company’s Quarterly Report on Form 10-Q filed on November 17, 2009 (file no. 001-34529) and incorporated herein by reference).
†10.5   Form of STR Holdings, Inc. Restricted Stock Agreement for other holders of units in STR Holdings (New) LLC. (filed as Exhibit 10.19 to the Company’s Quarterly Report on Form 10-Q filed on November 17, 2009 (file no. 001-34529) and incorporated herein by reference).
†10.6   Form of Restricted Stock Agreement of STR Holdings, Inc. (filed as Exhibit 10.22 to the Company’s Quarterly Report on Form 10-Q filed on November 17, 2009 (file no. 001-34529) and incorporated herein by reference).
†10.7   Specialized Technology Resources, Inc. Management Incentive Plan. (filed as Exhibit 10.23 to the Company’s Quarterly Report on Form 10-Q filed on November 17, 2009 (file no. 001-34529) and incorporated herein by reference).
†10.8   Form of STR Holdings, Inc. Option Award Agreement for executive officers. (filed as Exhibit 10.24 to the Company’s Quarterly Report on Form 10-Q filed on November 17, 2009 (file no. 001-34529) and incorporated herein by reference).
†10.9   Form of Executive Severance Agreement (filed as Exhibit 10.2 to the Company’s Form 8-K filed on October 3, 2012 (file no.001-34529) and incorporated herein by reference).
†10.10   Executive Severance Agreement dated October 1, 2012 between the Company and Robert S. Yorgensen (filed as Exhibit 10.4 to the Company’s Form 10-Q filed on November 8, 2012 (file no. 001-34529) and incorporated herein by reference).
10.11   Sales Service Agreement, dated as of August 11, 2014, by and between Specialized Technology Resources, Inc. and Zhenfa Energy Group Co., Ltd. (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on August 12, 2014 (file no. 001-34529) and incorporated herein by reference).
10.12   Registration Rights Agreement, dated as of December 15, 2014, by and between STR Holdings, Inc. and Zhen Fa New Energy (U.S.) Co., Ltd. (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on December 15, 2014 (file no. 001-34529) and incorporated herein by reference).
10.13   Guarantee Agreement, dated as of August 11, 2014, by and between STR Holdings, Inc. and Zhenfa Energy Group Co., Ltd. (filed as Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on August 12, 2014 (file no. 001-34529) and incorporated herein by reference).
10.14   PhotoCap Supply agreement dated as of December 31, 2014, by and between Specialized Technology Resources Solar (Suzhou) Co., Ltd and Zhangjiagang Huhui Segpv Co., Ltd.
*10.15   Purchase and Sale Agreement dated as of November 18, 2016, by and between Specialized Technology Resources Solar (Malaysia) SDN BHD and Tiong Nam Logistics Solutions SDN BHD.
*21   Subsidiaries of STR Holdings, Inc.
*23.1   Consent of UHY LLP, Independent Registered Public Accounting Firm.
     
 
80

 

     
*31.1   Certification of Chief Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), pursuant to section 302 of the Sarbanes-Oxley Act of 2002.
*31.2   Certification of Chief Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), pursuant to section 302 of the Sarbanes-Oxley Act of 2002.
**32.1   Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002.
**32.2   Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002.
***101.INS   XBRL Instance Document
***101.SCH   XBRL Taxonomy Extension Schema Document
***101.DEF   XBRL Definition Linkbase Document
***101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document
***101.LAB   XBRL Taxonomy Extension Label Linkbase Document
***101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document

______________________

* Filed herewith.
** Furnished herewith.
*** In accordance with Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.
Management contract or compensatory plan or arrangement.
†† Exhibits and schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K.  The Company hereby undertakes to furnish supplemental copies of any of the omitted schedules upon request by the SEC.

 

 

 

81

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  STR HOLDINGS, INC.
(Registrant)
   
   
  By: 

/s/ Robert S. Yorgensen

    Name:  Robert S. Yorgensen
    Title: Chairman, President and Chief Executive Officer

Dated: March 9, 2017

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated.

 

  Name   Title Date
         
By:
Name:

/s/ Robert S. Yorgensen

Robert S. Yorgensen

  Chairman, President and Chief Executive Officer (Principal Executive Officer) March 9, 2017
         
By:
Name: 

/s/ Thomas D. Vitro

Thomas D. Vitro

  Vice President, Chief Financial Officer and Chief Accounting Officer (Principal Financial Officer and Principal Accounting Officer) March 9, 2017
         
By:
Name: 

/s/ John A. Janitz

John A. Janitz

  Director March 9, 2017
         
By:
Name:

 

HuiYing Ju

  Director  
         
By:
Name:

/s/ Andrew M. Leitch

Andrew M. Leitch

  Director March 9, 2017
         
By:
Name:

 

Xin Lin

  Director  
         

 

 

 

82

 

Exhibit 10.3

 

SEVERANCE AGREEMENT

 

This Agreement, is made as of October 1, 2012 (the “  Effective Date  ”), by and between STR HOLDINGS, INC. a Delaware corporation (the “  Company  ”), and  Robert Yorgensen  (the “ Executive  ”).

 

WHEREAS  , the Company considers it essential to the best interests of its stockholders to foster the continued employment of key management personnel; and

 

WHEREAS  , the Board recognizes that the possibility of a Change in Control (as hereinafter defined) exists and that such possibility and the uncertainty and questions which it may raise among management, may result in the departure or distraction of management personnel to the detriment of the Company and its stockholders; and

 

WHEREAS  , the Board has determined that appropriate steps should be taken to reinforce and encourage the continued attention and dedication of members of the Company’s management, including the Executive, to their assigned duties without the potential distractions arising from the possibility of a Change in Control; and

 

WHEREAS  , the Board has determined that additional severance benefits in the absence of a Change in Control should be provided to senior management in order to attract and retain the executive talent required to best serve the Company and its stockholders.

 

NOW, THEREFORE  , in consideration of the premises and the mutual covenants herein contained, the Company and the Executive hereby agree as follows:

 

1. Defined Terms  .  The definitions of capitalized terms used in this Agreement are provided in the last Section of this Agreement.

 

2. Term    This Agreement shall terminate on the fifth (5 th ) anniversary of the Effective Date. The term of this Agreement shall be automatically extended thereafter for successive one (1) year periods unless, at least ninety (90) days prior to the end of the fourth anniversary of the Effective Date or the then current succeeding one-year extended term of this Agreement, the Company or Executive has notified the other that the term hereunder shall expire at the end of the then-current term. Notwithstanding any such notice, the term of this Agreement shall not expire before the date that is eighteen (18) months after a Change in Control that occurs within the term of this Agreement. The initial term of this Agreement, as it may be extended under this Section 2, is herein referred to as the “  Term  .”

 

3. Company’s Covenants Summarized  .  In order to induce the Executive to remain in the employ of the Company and in consideration of the Executive’s continued employment, the Company agrees, under the terms and conditions hereof, to pay the Executive the Severance Payments and the other payments and benefits described in this Agreement.  This Agreement shall not be construed as creating an express or implied contract of employment and, except as otherwise agreed in writing between the Executive and the Company, the Executive shall not have any right to be retained in the employ of the Company.

 

 

 

 

4. Compensation Other Than Severance Payments  .

If the Executive’s employment shall be terminated for any reason during the Term of this Agreement, the Company shall pay the Executive’s full salary to the Executive through the Date of Termination at the rate in effect immediately prior to the Date of Termination or, if there has been a Base Salary Reduction, the rate in effect immediately prior to such Base Salary Reduction, together with all compensation and benefits payable to the Executive through the Date of Termination under the terms of the Company’s compensation and benefit plans, programs or arrangements as in effect immediately prior to the Date of Termination (or, if more favorable to the Executive, as in effect immediately prior to the first occurrence of an event or circumstance constituting Good Reason).

 

5. Severance Payments  .

 

(a) General  .  If the Executive’s employment is terminated during the Term of this Agreement (i) by the Company without Cause, or (ii) by the Executive for Good Reason (collectively, a “ Qualifying Termination  ”), then the Company shall pay the Executive the amounts, and provide the Executive the benefits described in this Section 5 (“  Severance Payments  ”) in addition to any payments and benefits to which the Executive is entitled under Section 4 of this Agreement.

 

(b) Payments — Not During the Change in Control Severance Period  . If a Qualifying Termination occurs other than during a Change in Control Severance Period, then, in lieu of any further salary payments to the Executive for periods subsequent to the Date of Termination (and in lieu of payments due pursuant Section 5(c) below), the Company shall pay to the Executive (i) an amount, in cash, equal to the sum of the product obtained by multiplying the Executive’s base salary as in effect immediately prior to the Date of Termination or, if there has been a Base Salary Reduction, the annual base salary in effect immediately prior to such Base Salary Reduction, by the Applicable Multiplier set forth in column B of  Schedule A  to this Agreement (the “  Periodic Payments  ”), and (ii) a pro-rata portion of the Executive’s Actual Bonus for the performance year during which such Date of Termination occurs (the “  Pro Rata Bonus  ”). This Pro-Rata Bonus shall be determined by multiplying such Actual Bonus by a fraction, the numerator of which is the number of days during such performance year that the Executive is employed by the Company and the denominator of which is 365.  Subject to Section 5(h) below and the Executive’s satisfaction of the conditions set forth in Section 11(a) below, the Periodic Payments shall be paid periodically to the Executive in accordance with the Company’s customary payroll practices and the Pro Rata Bonus shall be paid to the Executive in a lump sum within thirty (30) days following the completion of the Company’s year-end audit for the year during which the Date of Termination occurs, but in no event later than April 1 st  of the fiscal year following the year during which the Date of Termination occurs.

 

2
 


(c) Payments — During the Change in Control Severance Period  . If a Qualifying Termination occurs during a Change in Control Severance Period, then, in lieu of any further salary payments to the Executive for periods subsequent to the Date of Termination (and in lieu of payments due pursuant to Section 5(b) above), the Company shall pay to the Executive  a lump sum severance payment, in cash, equal to the sum of (i) the product obtained by multiplying the Executive’s annual base salary as in effect immediately prior to the Date of Termination or, if there has been a Base Salary Reduction, the annual base salary in effect immediately prior to such Base Salary Reduction, by the Applicable Multiplier set forth in column C of  Schedule A  to this Agreement (the “  Lump Sum Amount  ”), and (ii) the Executive’s Target Bonus for the performance year during which such Date of Termination occurs (the “  Target Bonus Amount  ”). Subject to Section 5(h) and the Executive’s satisfaction of the conditions set forth in Section 11(a) below, the Lump Sum Amount and the Target Bonus Amount shall be paid to the Executive in a lump sum on the date which is sixty (60) days following the Date of Termination.

 

(d) Medical Benefits  . For the Applicable Severance Period, the Company shall on a monthly basis reimburse the Executive for the cost of medical, dental, and accidental death and dismemberment benefits provided under COBRA which benefits shall be  substantially similar to such benefits as provided to the Executive and his dependents immediately prior to the Date of Termination or, if more favorable to the Executive, those provided to the Executive and his dependents immediately prior to the first occurrence of an event or circumstance constituting Good Reason, at no greater cost to the Executive than the cost to the Executive immediately prior to such date or occurrence. The parties intend that during the Applicable Severance Period continued medical and dental coverage shall not constitute a “deferral of compensation” under Treas. Reg. Sect. 1.409A-1(b), and that continued accidental death and dismemberment benefits hereunder shall qualify as a “limited payment” of an “in kind” benefit under Treas. Reg. Sect. 1.409A-1(b)(9)(v)(C) and (D).  Any portion of the continued medical, dental and accidental death and dismemberment coverage under this subsection (d) that is subject to Section 409A is intended to qualify as a “reimbursement or in-kind benefit plan” under Treas. Reg. Sect. 1.409A-3(i)(1)(iv). Benefits otherwise receivable by the Executive pursuant to this subsection (d) shall be reduced to the extent benefits of the same type are received by or made available by a subsequent employer to the Executive during the Applicable Severance Period (and any such benefits received by or made available to the Executive shall be reported to the Company by the Executive); provided, however, that the Company shall reimburse the Executive for the excess, if any, of the cost of such benefits to the Executive over such cost immediately prior to the Date of Termination or, if more favorable to the Executive, the first occurrence of an event or circumstance constituting Good Reason. Any such reimbursement under this subsection (d) that is subject to Section 409A of the Code shall be made promptly in accordance with Company policy, but in any event on or before the last day of the Executive’s taxable year following the taxable year in which the expense or cost was incurred, but notwithstanding the foregoing, any such reimbursements which would otherwise be made prior to the first day of the seventh month following the Date of Termination shall be made on such date if the Executive is a Specified Employee. In no event shall the amount that the Company pays for any such benefit in any one year affect the amount that it will pay in any other year and in no event shall the benefits described in this subsection (d) be subject to liquidation or exchange for another benefit.

 

3
 


(e) Life Insurance  The Company shall (i) prepay all premiums due during the Applicable Severance Period under any insurance policy maintained by the Company insuring the life of the Executive that is in effect and (ii) transfer to the Executive any and all rights and incidents of ownership in such arrangements.

 

(f) Outplacement Services  . The Company shall provide the Executive with a level of outplacement services commensurate with the Executive’s position during the Applicable Severance Period as determined by the Company in its reasonable discretion.  However such services, if otherwise ongoing, shall terminate upon the Executive’s first day of employment with a new employer.  In no event may the reimbursement of any outplacement services expense incurred by the Executive extend beyond the third taxable year of the Executive following the taxable year of the Executive in which the Date of Termination occurred.

 

(g) Legal Fees  . The Company also shall reimburse the Executive for the reasonable legal fees and expenses incurred by the Executive in disputing in good faith any issue hereunder relating to the termination of the Executive’s employment or in seeking in good faith to obtain or enforce any benefit or right provided by this Agreement, provided the Executive is the prevailing party with respect to such dispute.  Such payments shall be made within ten (10) business days after delivery of the Executive’s written request for payment accompanied with such evidence of fees and expenses incurred as the Company reasonably may require.

 

(h) Timing of Payments  .  Severance Payments under Section 5(b) of this Agreement shall be paid as therein set forth; provided, however, that to the extent that the total amount of Periodic Payments to be made under Section 5(b), exceeds the amount of Qualifying Severance Payments, then, for a non-Specified Employee, such excess shall be paid in a lump sum on the date which is sixty (60) days following the Date of Termination or, in the case a Specified Employee, on the first day of the seventh month following the Date of Termination.  In addition, if such total amount of Periodic Payments to be made under Section 5(b) exceeds the amount of Qualifying Severance Payments, each Periodic Payment shall be reduced by an amount determined by dividing such excess by the total number of Periodic Payments and the aggregate of such reductions shall be made as a lump sum on the date which is sixty (60) days following the Date of Termination if the Executive is not a Specified Employee or be made on the first day of the seventh month following the Date of Termination if the Executive is a Specified Employee.  Severance Payments under Section 5(c) of this Agreement shall be paid as therein set forth; provided, however, that to the extent that the total Lump Sum Amount to be paid under Section 5(c) to a Specified Employee exceeds the amount of Qualifying Severance Payments, then such excess shall be paid in a lump sum on the first day of the seventh month following the Date of Termination.  The transfer to the Executive under Section 5(e)(ii) above, and if applicable, any amount by which the payment of base salary under Section 4 of this Agreement exceeds the Executive’s base salary immediately prior to the Date of Termination due to a prior Base Salary Reduction, shall be paid on the date which is sixty (60) days following the Date of Termination if the Executive is not a Specified Employee or be paid on the first day of the seventh month following the Date of Termination if the Executive is a Specified Employee.  Notwithstanding the provisions in Section 5(b) above, in the case of a Specified Employee, the Pro Rata Bonus shall be paid on the first day of the seventh month following the Date of Termination if that is later than the date it would otherwise be paid pursuant to Section 5(b). At the time that payments are made under this Agreement, the Company shall provide the Executive with a written statement setting forth the manner in which such payments were calculated and the basis for such calculations.

 

4
 

 

(i) Coordination with Employment Agreement; Company Policy  .   Severance Payments made under this Section 5 shall be in lieu of (i) any severance benefit payable to the Executive under the Executive’s Employment Agreement, if any, and (ii) any severance benefit payable under any severance plan or policy of the Company or any of its Subsidiaries.

 

6. Termination Procedures and Compensation During Dispute  .

 

(a) Notice of Change in Control; Notice of Termination  .  Within five (5) days after a Change in Control has occurred, the Company shall deliver to the Executive a written statement memorializing the date that the Change in Control occurred.  During the Term of this Agreement, any purported termination of the Executive’s employment (other than by reason of death) shall be communicated by written Notice of Termination from one party hereto to the other party hereto.  For purposes of this Agreement, a “  Notice of Termination  ” shall mean a notice which shall indicate the specific termination provision in this Agreement relied upon and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive’s employment under the provision so indicated.

 

(b) Date of Termination  .  “  Date of Termination  ,” with respect to any purported termination of the Executive’s employment during the Term of this Agreement, shall mean (i) if the Executive’s employment is terminated for Disability, thirty (30) days after Notice of Termination is given (provided that the Executive shall not have returned to the full-time performance of the Executive’s duties during such thirty (30) day period), and (ii) if the Executive’s employment is terminated for any other reason, the date specified in the Notice of Termination (which, in the case of a termination by the Company, shall not be less than thirty (30) days (except in the case of a termination for Cause, subject to subsection (i) above) and, in the case of a termination by the Executive, shall not be less than fifteen (15) days nor more than sixty (60) days, respectively, from the date such Notice of Termination is given). For purposes of determining the date on which to make any payments described under Section 5(d), 5(f) and 5(h), and for purposes of interpreting Section 18(w), a Date of Termination shall only occur upon the Executive’s “separation from service” within the meaning of Section 409A of the Code and as determined after applying the presumptions set forth in Treas. Reg. Section 1.409A-1(h)(1).

 

5
 

 

7. No Mitigation  .  The Company agrees that under this Agreement, if the Executive’s employment with the Company terminates, the Executive is not required to seek other employment or to attempt in any way to reduce any amounts payable to the Executive by the Company pursuant to Section 5 of this Agreement.  Further, the amount of any payment or benefit provided for in this Agreement (other than as specifically provided in Section 5(d) of this Agreement) shall not be reduced by any compensation earned by the Executive as the result of employment by another employer, by retirement benefits, by offset against any amount claimed to be owed by the Executive to the Company, or otherwise.

 

8. Successors; Binding Agreement; Anti-Assignment  .

 

(a) In addition to any obligations imposed by law upon any successor to the Company, the Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company to expressly assume and agree to perform this Agreement in accordance with its terms.  Failure of the Company to obtain such agreement prior to the effectiveness of any such succession shall be a breach of this Agreement and shall entitle the Executive to compensation from the Company in the same amount and on the same terms as the Executive would be entitled to hereunder if the Executive were to terminate the Executive’s employment for Good Reason after a Change in Control, except that, for purposes of implementing the foregoing, the date on which any such succession becomes effective shall be deemed the Date of Termination.

 

(b) This Agreement shall inure to the benefit of and be enforceable by the Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.  If the Executive shall die while any amount would still be payable to the Executive hereunder (other than amounts which, by their terms, terminate upon the death of the Executive) if the Executive had continued to live, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Agreement to the executors, personal representatives or administrators of the Executive’s estate.

 

(c) In no event shall any of the benefits payable to the Executive hereunder be subject to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, attachment, or garnishment by creditors of the Executive or the Executive’s estate.

 

9. Notices  . For the purpose of this Agreement, notices and all other communications provided for in this Agreement shall be in writing and shall be deemed to have been duly given (a) on the date of delivery if delivered by hand, (b) on the date of transmission, if delivered by confirmed facsimile, (c) on the first business day following the date of deposit if delivered by guaranteed overnight delivery service, or (d) on the fourth business day following the date delivered or mailed by United States registered or certified mail, return receipt requested, postage prepaid, addressed as follows:

 

6
 


If to the Executive: at the address (or to the facsimile number) shown on the records of the Company.

 

If to the Company:  STR Holdings, Inc., 1699 King Street, Suite 400, Enfield, Connecticut 06082, Attn:  General Counsel (facsimile no. (860) 758-7301), or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notices of change of address shall be effective only upon receipt.

 

10. Obligations after the Date of Termination  .

 

(a) Confidentiality  .  The Executive agrees that the Executive shall not, directly or indirectly, use, make available, sell, disclose or otherwise communicate to any person, other than in the course of the Executive’s employment and for the benefit of the Company, at any time following the Date of Termination, any nonpublic, proprietary or confidential information, knowledge or data relating to the Company, any of its subsidiaries, affiliated companies or businesses, which shall have been obtained by the Executive during the Executive’s employment by the Company. The foregoing shall not apply to information that (i) was known to the public prior to its disclosure to the Executive; (ii) becomes known to the public subsequent to disclosure to the Executive through no wrongful act of the Executive or any representative of the Executive; or (iii) the Executive is required to disclose by applicable law, regulation or legal process (provided that the Executive provides the Company with prior notice of the contemplated disclosure and reasonably cooperates with the Company at its expense in seeking a protective order or other appropriate protection of such information). Notwithstanding clauses (i) and (ii) of the preceding sentence, the Executive’s obligation to maintain such disclosed information in confidence shall not terminate where only portions of the information are in the public domain.  Unless required otherwise by law or government regulation, the parties will maintain the terms and conditions of this Agreement in confidence.

 

(b) Non-Disparagement  .  Each of the Executive and the Company (for purposes hereof, “the Company” shall mean only (i) the Company by press release or otherwise and (ii) the executive officers and directors thereof and not any other employees) agrees not to make any public statements that disparage or materially criticize the other party, or in the case of the Company, its respective affiliates, officers, directors, products or services.  Notwithstanding the foregoing, statements made in the course of sworn testimony in administrative, judicial or arbitral proceedings (including, without limitation, depositions in connection with such proceedings) or otherwise as required by law shall not be subject to this Section 10(b).

 

(c) Return of Company Property and Records  .  The Executive agrees that upon termination of the Executive’s employment, for any cause whatsoever, the Executive will surrender to the Company in good condition (reasonable wear and tear excepted) all property and equipment belonging to the Company and all records kept by the Executive containing the names, addresses or any other information with regard to customers or customer contacts of the Company, or concerning any proprietary or confidential information of the Company or any operational, financial or other documents given to the Executive during the Executive’s employment with the Company.

 

7
 

 

(d) Cooperation  .  The Executive agrees that, following termination of the Executive’s employment for any reason, the Executive shall upon reasonable advance notice, and to the extent it does not interfere with previously scheduled travel plans and does not unreasonably interfere with other business activities or employment obligations, assist and cooperate with the Company with regard to any matter or project in which the Executive was involved during the Executive’s employment, including any litigation. The Company shall compensate the Executive for any lost wages (or, if the Executive is not then employed, provide reasonable compensation as determined by the Compensation Committee) and expenses associated with such cooperation and assistance.

 

(e) Assignment of Inventions  .  The Executive will promptly communicate and disclose in writing to the Company all inventions and developments including software, whether patentable or not, as well as patents and patent applications (hereinafter collectively called “  Inventions  ”), made, conceived, developed, or purchased by the Executive, or under which the Executive acquires the right to grant licenses or to become licensed, alone or jointly with others, which have arisen or which arise out of the Executive’s employment with the Company, or relate to any matters directly pertaining to the business of the Company or any of its subsidiaries. Included herein as if developed during the employment period is any specialized equipment and software developed for use in the business of the Company. All of the Executive’s right, title and interest in, to, and under all such Inventions, licenses, and right to grant licenses shall be the sole property of the Company. As to all such Inventions, the Executive will, upon request of the Company execute all documents which the Company deems necessary or proper to enable it to establish title to such Inventions or other rights, and to enable it to file and prosecute applications for letters patent of the United States and any foreign country; and do all things (including the giving of evidence in suits and other proceedings) which the Company deems necessary or proper to obtain, maintain, or assert patents for any and all such Inventions or to assert its rights in any Inventions not patented.

 

(f) Equitable Relief and Other Remedies  .  The parties acknowledge and agree that the other party’s remedies at law for a breach or threatened breach of any of the provisions of this Section would be inadequate and, in recognition of this fact, the parties agree that, in the event of such a breach or threatened breach, in addition to any remedies at law, the other party, without posting any bond, shall be entitled to obtain equitable relief in the form of specific performance, temporary restraining order, a temporary or permanent injunction or any other equitable remedy which may then be available.

 

(g) Reformation  .  If it is determined by a court of competent jurisdiction in any state that any restriction in this Section 10 is excessive in duration or scope or is unreasonable or unenforceable under the laws of that state, it is the intention of the parties that such restriction may be modified or amended by the court to render it enforceable to the maximum extent permitted by the law of that state.

 

8
 

 

(h) Survival of Provisions  .  The obligations contained in this Section 10 shall survive the termination or expiration of the Executive’s employment with the Company and shall be fully enforceable thereafter.

 

11. Conditions  .  (a) Any payments or benefits made or provided under this Agreement are subject to the Executive’s:

 

(a) other than as specifically provided in Section 12 of this Agreement, compliance with the provisions of Section 10 hereof;

 

(b) delivery to the Company of an executed Agreement and General Release (the “  General Release  ”), which shall be substantially in the form attached hereto as Exhibit A (with such changes therein or additions thereto as needed under then applicable law to give effect to its intent and purpose) within twenty one (21) days of presentation thereof by the Company to the Executive (which presentation shall be made by the Company no later than two (2) business days following the Date of Termination); and

 

(c) delivery to the Company of a resignation from all offices, directorships and fiduciary positions with the Company, its affiliates and employee benefit plans with the General Release.

 

(d) If the Executive fails to deliver the General Release to the Company, with the documentation described in subsection (c) of this Section 11, within the time specified in subsection (b) of this Section 11, or if he provides such General Release but thereafter revokes it within the seven (7) day period specified in the General Release, all benefits provided for hereunder shall be forfeited and shall not be reinstated for any reason.

 

12. Miscellaneous  .  No provision of this Agreement may be modified, waived or discharged unless such waiver, modification or discharge is agreed to in writing and signed by the Executive and an authorized officer of the Company (other than the Executive).  No waiver by either party hereto at any time of any breach by the other party hereto of, or of any lack of compliance with, any condition or provision of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time.  This Agreement supersedes any other agreements or representations, oral or otherwise, express or implied, with respect to the subject matter hereof which have been made by either party, except for any Employee Non-Disclosure, Non-Compete and Assignment of Invention Agreement or similar agreement not to compete or similar undertaking otherwise in effect as of the Date of Termination, the terms of which shall control in the event of any conflict with the terms of this Agreement.  The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of Connecticut.  Any payments provided for hereunder shall be paid net of any applicable withholding required under federal, state or local law and any additional withholding to which the Executive has agreed.  The obligations of the Company and the Executive under this Agreement which by their nature may require either partial or total performance after its expiration shall survive any such expiration.

 

9
 

 

13. Validity; Counterparts  .  The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, which shall remain in full force and effect.  This Agreement may be executed in several counterparts, each of which shall be deemed to be an original but all of which together will constitute one and the same instrument.

 

14. Expenses  .  Except as otherwise provided in Section 5(g) of this Agreement, the Executive and the Company shall bear their own respective expenses with respect to this Agreement and all matters arising hereunder or pertaining hereto.

 

15. Settlement of Disputes  .  All claims by the Executive for benefits under this Agreement shall be directed to and determined by the Board and shall be in writing.  Any denial by the Board of a claim for benefits under this Agreement shall be delivered to the Executive in writing and shall set forth the specific reasons for the denial and the specific provisions of this Agreement relied upon.  The Board shall afford a reasonable opportunity to the Executive for a review of the decision denying a claim and shall further allow the Executive to appeal to the Board a decision of the Board within sixty (60) days after notification by the Board that the Executive’s claim has been denied.

 

16. Arbitration    Any further dispute or controversy arising under or in connection with this Agreement shall be settled exclusively by arbitration in Hartford, Connecticut, in accordance with the rules of the American Arbitration Association then in effect; provided, however, that the evidentiary standards set forth in this Agreement shall apply.  Judgment may be entered on the arbitrator’s award in any court having jurisdiction.  Notwithstanding any provision of this Agreement to the contrary, the Executive shall be entitled to seek specific performance of the Executive’s right to be paid until the Date of Termination during the pendency of any dispute or controversy arising under or in connection with this Agreement.

 

17. Section 409A Compliance  .  The Agreement is intended to comply with (or in some instances be exempt from) the requirements of Section 409A of the Code (and Regulations issued thereunder), and shall be interpreted and administered in a manner which is consistent with this intention.  Notwithstanding the foregoing, the Company does not guarantee any particular tax result and the Executive is responsible for payment on any taxes owed by him under this Agreement, including without limit, any taxes under Section 409A.

 

18. Definitions  .  For purposes of this Agreement, the following terms shall have the meanings indicated below:

 

(a) “  Actual Bonus  ” shall mean the percentage of the Executive’s annual base salary that is established with respect to the applicable year pursuant to the Company’s management incentive plan (or any successor incentive plan adopted by the Board) that the Executive would have earned assuming he continued his employment through the end of such applicable year and fully satisfied personal performance goals, if any.

 

10
 

 

(b) “  Affiliate  ” shall have the meaning set forth in Rule 12b-2 promulgated under Section 12 of the Exchange Act.

 

(c) “  Applicable Multiplier  ” shall mean that multiplication factor set forth in column B of Schedule A in the event that the Date of Termination occurs other than during a Change in Control Severance Period, or column C of Schedule A in the event the Date of Termination occurs during the Change in Control Severance Period.

 

(d) “  Applicable Severance Period  ” shall mean the period of 12 months multiplied by the relevant Applicable Multiplier immediately following the Date of Termination.

 

(e) “  Base Salary Reduction  ” shall have the meaning set forth in Section 18(s)(i) of this Agreement.

 

(f) “  Beneficial Owner  ” shall have the meaning set forth in Rule 13d-3 and 13d-5 under the Exchange Act.

 

(g) “  Board  ” shall mean the Board of Directors of the Company.

 

(h) “  Cause  ” shall have the meaning set forth in the Executive’s Employment Agreement, if applicable, and otherwise shall mean (i) the Executive’s failure or refusal to follow the reasonable instructions of the Executive’s supervisor (or for the CEO, the Company’s Board of Directors) (other than due to Executive’s Disability), which failure or refusal is not cured within 30 days following written notice; (ii) the Executive’s conviction of a felony or of a misdemeanor if such misdemeanor involves moral turpitude or misrepresentation, including  a plea of guilty or  nolocontendere  ; (iii) the Executive’s unlawful use (including being under the influence) or possession of illegal drugs on the Company’s or any of its Subsidiaries’ premises; (iv) the Executive’s commission of any act of fraud, embezzlement, misappropriation of funds, intentional misrepresentation, breach of fiduciary duty or other act of dishonesty materially detrimental  to the Company or any of its Subsidiaries; or (v) the Executive’s intentional wrongful act or gross negligence that has a materially detrimental effect on the Company or its Subsidiaries.  For purposes of this Agreement, any termination of Executive’s employment due to Executive’s death or Disability shall be deemed a termination by the Company for Cause.

 

(i) “  Change in Control  ” shall mean the first to occur of any one of the following events:

 

(i)                                any Person is or becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing 35% or more of either (1) the total fair market value of the then outstanding shares of common stock of the Company or (2) the then outstanding securities of the Company generally entitled to vote in the election of directors of the Company, excluding any Person who becomes such a Beneficial Owner in connection with a transaction described in clause (1) of paragraph (iii) below; or

 

11
 

 

(ii)                             during any twelve (12) month period, individuals who, as of the beginning of such period, constitute the Board (the “  Incumbent Board  ”) cease to constitute at least a majority of the Board; provided, that any person becoming a director of the Company subsequent to the beginning of such period whose election, or nomination for election by the Company’s stockholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of either an actual or threatened election contest, including but not limited to a consent solicitation, relating to the election of directors of the Company and whose appointment or election was not approved by at least a majority of the directors of the Company in office immediately before any such contest, or

 

(iii)                          there is consummated a merger or consolidation of the Company with any other business entity, other than (1) a merger or consolidation which would result in the securities of the Company generally entitled to vote in the election of directors of the Company outstanding immediately prior to such merger or consolidation continuing to represent (either by remaining outstanding or by being converted into such securities of the surviving entity or any parent thereof), in combination with the ownership of any trustee or other fiduciary holding such securities under an employee benefit plan of the Company or any Subsidiary of the Company, at least 50.1% of the securities of the Company or such surviving entity or any parent thereof outstanding immediately after such merger or consolidation and generally entitled to vote in the election of directors of the Company or such surviving entity or any parent thereof, or (2) a merger or consolidation effected to implement a recapitalization of the Company (or similar transaction) in which no Person is or becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing 50.1% or more of the then outstanding securities of the Company generally entitled to vote in the election of directors of the Company; or

 

(iv)                         the stockholders of the Company approve a plan of complete liquidation or dissolution of the Company or there is consummated the sale or disposition by the Company of all or substantially all of the Company’s assets, other than a sale or disposition by the Company of all or substantially all of the Company’s assets to an entity where the outstanding securities generally entitled to vote in the election of directors of the Company immediately prior to the sale continue to represent (either by remaining outstanding or by being converted into such securities of the surviving entity or any parent thereof) 50.1% or more of the outstanding securities of such entity generally entitled to vote in the election of directors immediately after such sale; or

 

(v)                            any other event which the Board of Directors declares to be a Change in Control.

 

12
 

 

(j) “  Change in Control Severance Period  ” shall mean the period commencing ninety (90) days prior to the execution of any definitive purchase and sale, merger or other acquisition agreement resulting in a Change in Control through the first anniversary following the closing of such Change in Control, or, in the case of any other type of Change in Control, the period of one (1) year beginning on the date of the occurrence of such Change in Control through the first anniversary thereof.

 

(k) “  Code  ” shall mean the Internal Revenue Code of 1986, as amended from time to time and Regulations issued thereunder.

 

(l) “  Company  ” shall mean  [STR Holdings, Inc.]  , and, except in determining under Section 18(i) hereof whether or not any Change in Control of the Company has occurred, shall include any successor to its business and/or assets.

 

(m) “  Date of Termination  ” shall have the meaning set forth in Section 6(b) of this Agreement.

 

(n) “  Disability  ” shall have the meaning set forth in the Employment Agreement between the Executive and the Company, if any, and otherwise shall be deemed the reason for the termination by the Company of the Executive’s employment, if, as a result of the Executive’s incapacity due to physical or mental illness, the Executive shall have been absent from the full-time performance of the Executive’s duties with the Company for a period of six (6) consecutive months, the Company shall have given the Executive a Notice of Termination for Disability, and, within thirty (30) days after such Notice of Termination is given, the Executive shall not have returned to the full-time performance of the Executive’s duties.

 

(o) “  Exchange Act  ” shall mean the Securities Exchange Act of 1934, as amended from time to time.

 

(p) “  Executive  ” shall mean the individual named in the first paragraph of this Agreement.

 

(q) “  Executive’s Position  ” shall mean the position held by the Executive as set forth in column A of Schedule A.

 

(r) “  General Release”  shall have the meaning set forth in Section 11(b) of this Agreement.

 

(s) “  Good Reason  ” for termination by the Executive of the Executive’s employment shall mean the occurrence (without the Executive’s express written consent) during the Term of this Agreement, of any one of the following acts by the Company, or failures by the Company to act.  As set forth below, subsection (i) contains the elements of Good Reason, and subsection (ii) sets forth certain terms and conditions applicable to termination by the Executive for Good Reason;

 

  (i) (A) (1)  A material diminution in the nature or status of the Executive’s responsibilities from those in effect immediately prior to such diminution resulting from, among other things, (1) the assignment to the Executive of any duties inconsistent with the Executive’s duties and the Executive’s Position, immediately prior to such assignment, or (2) during a Change in Control Severance Period, the failure of the Company to ensure that the Executive maintains substantially the same duties and position during such Change in Control Severance Period, with the Company and each other entity that may then be a direct or indirect parent of the Company owning directly or indirectly a majority of the outstanding capital stock of the Company, as the Executive was assigned or held immediately prior to such Change in Control Severance Period;
       

 

13
 

 

    (B) A material reduction by the Company, during the period of one (1) year immediately prior to the Date of Termination, in either or both of (1) the Executive’s annual base salary (a “Base Salary Reduction”); or (2) the target bonus percentage set forth in the Company’s management incentive plan, in each case as in effect on the date of this Agreement or as the same may be increased from time to time;
       
    (C) The relocation of the Executive’s principal place of employment to a location more than (fifty) 50 miles from the Executive’s principal place of employment immediately prior to such relocation or the Company’s requiring the Executive to be based anywhere other than such principal place of employment (or permitted relocation thereof) except for required travel on the Company’s business to an extent substantially consistent with the Executive’s business travel obligations immediately prior thereto;
       
    (D) The failure by the Company to pay to the Executive any portion of the Executive’s current compensation, or to pay to the Executive any portion of an installment of deferred compensation under any deferred compensation program of the Company, within thirty (30) days of the date such compensation is due;
       
    (E) The failure by the Company to continue in effect any material compensation plan in which the Executive participates immediately prior to such failure which is material to the Executive’s total compensation, unless an equitable arrangement (embodied in an ongoing substitute or alternative plan) has been made with respect to such plan, or the failure by the Company to continue the Executive’s participation therein (or in such substitute or alternative plan) on a basis not materially less favorable, both in terms of the amount or timing of payment of benefits provided and the level of the Executive’s participation relative to other participants, as existed immediately prior to such failure;
       

 

14
 

 

    (F) The failure by the Company to continue to provide the Executive with benefits substantially similar to those enjoyed by the Executive under any of the Company’s benefit plans, including without limitation, life insurance, health and accident, or disability plans in which the Executive was participating immediately prior to such failure, the taking of any other action by the Company which would directly or indirectly materially reduce any of such benefits or deprive the Executive of any material fringe benefit enjoyed by the Executive immediately prior to such action, or the failure by the Company to provide the Executive with the number of paid vacation days to which the Executive is entitled on the basis of years of service with the Company in accordance with the Company’s normal vacation policy in effect at the time of such failure; or
       
    (G) Any material breach by the Company of the Executive’s Employment Agreement.
       
  (ii) (A) For purposes of this Agreement, any purported termination of the Executive’s employment which is not effected pursuant to a Notice of Termination satisfying the requirements of Section 6(a) of this Agreement shall not be effective.
       
    (B) The Executive’s right to terminate the Executive’s employment for Good Reason shall not be affected by the Executive’s incapacity due to physical or mental illness.
       
    (C) For purposes of any determination regarding the existence of Good Reason, any claim by the Executive that Good Reason exists shall be presumed to be correct unless the Company establishes to the Board by clear and convincing evidence that Good Reason does not exist.
       
    (D) Notwithstanding any provision of this Section 18(r) to the contrary, none of the foregoing provisions of this Section 18(r) shall constitute Good Reason unless (A) no later than ninety (90) days following the occurrence of any of the events set forth in Section 18(r)(i) above, the Executive provides written notice to the Company of such event containing a description thereof and stating the subsection of Section 18(r)(i) above under which such event constitutes Good Reason (the “Good Reason Notice”) and the Company shall not have cured such event within thirty (30) days following its receipt of such notice, and (B) no later than one hundred eighty (180) days, but no earlier than thirty (30) days, following the Company’s receipt of such Good Reason Notice, the Executive gives the Company a Notice of Termination satisfying the requirements of Section 6(a) of this Agreement with respect to the event constituting Good Reason described in such Good Reason Notice.
       

 

15
 

 

(t) “  Incumbent Board  ” shall have the meaning set forth in Section 18(h)(ii) of this Agreement.

 

(u) “  Lump Sum Amount  ” shall have the meaning set forth in Section 5(c) of this Agreement.

 

(v) “Notice of Termination  ” shall have the meaning set forth in Section 6(a) of this Agreement.

 

(w) “Periodic Payments”  shall have the meaning set forth in Section 5(b) of this Agreement.

 

(x) “  Person  ” shall have the meaning given in Section 3(a)(9) of the Exchange Act, as modified and used in Sections 13(d) and 14(d) thereof, except that such term shall not include (i) the Company or any of its direct or indirect Subsidiaries, (ii) a trustee or other fiduciary holding securities under an employee benefit plan of the Company, (iii) an underwriter temporarily holding securities pursuant to an offering of such securities, (iv) or a corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions and with substantially the same voting rights as their ownership and voting rights with respect to the Company.

 

(y) “  Pro Rata Bonus  ” shall have the meaning set forth in Section 5(b) of this Agreement.

 

(z) “  Qualifying Severance Payments”  shall mean Severance Payments that, in the aggregate, do not exceed two times the lesser of (i) the Executives annual rate of base salary for the taxable year immediately preceding the year during which the Date of Termination occurs, determined in accordance with Section 1.409A-1(a)(9)(iii)(A)(1) of the Regulations under Code Section 409A, or (ii) the limit under the Code Section 401(a)(17) on compensation under a qualified retirement plan for the year in which the Date of Termination occurs.

 

(aa) “  Qualifying Termination  ” shall have the meaning set forth in Section 5(a) of this Agreement.

 

(bb) “  Severance Payments  ” shall have the meaning set forth in Section 5(a) of this Agreement.

 

(cc) “Specified Employee”  shall have the meaning as defined in Section 409A of the Code and Section 1.409A-1(i) of the Regulations issued under the Code.

 

(dd) “  Subsidiary  ” shall mean any corporation of which the Company owns, directly or indirectly, a majority of securities entitled to vote in the election of directors.

 

16
 

 

(ee) “  Target Bonus  ” shall mean the percentage of the Executive’s annual base salary that is established with respect to the applicable year pursuant to the Company’s management incentive plan (or any successor incentive plan adopted by the Board) calculated as if the performance of the Executive meets the Executive’s Target performance amount with respect to all performance objectives (irrespective of actual performance).

 

(ff) “  Target Bonus Amount  ” shall have the meaning set forth in Section 5(c) of this Agreement.

 

(gg) “  Term  ” shall mean the period of time described in Section 2 of this Agreement.

 

17
 

 

IN WITNESS WHEREOF  , the parties have executed this agreement as of the date and year first above written.

 

    STR HOLDINGS, INC.
     
    By:   
      Name: Alan N. Forman
      Title: Sr. Vice President & General Counsel
     
    THE EXECUTIVE
     
     
     
    Name: Robert Yorgensen
     
    Address: 55 Old Stone Crossing
    West Hartford, CT 06117
     

 

 

18
 

Exhibit A

 

FORM OF AGREEMENT AND GENERAL RELEASE

 

This Agreement and General Release (“Release”) is entered into by and between STR HOLDINGS, INC. (“Company”) and                          (“Executive”) to resolve any and all disputes concerning his employment with Company and his separation from employment on                         . Accordingly, in exchange for the consideration and mutual promises set forth herein, the parties do hereby agree as follows:

 

1.                      Effective close of business on                         , Executive’s employment with Company will terminate, and all salary continuation and benefits will cease other than those to which Executive is entitled in consideration for this Release as set forth in Executive’s Change in Control Agreement with Company (“Agreement”), which is incorporated by reference, and as a matter of law (e.g., COBRA benefits).

 

2.                      In consideration for Executive’s executing this Release of any and all legal claims he might have against the STR Parties (as defined below), subject to the exceptions set forth herein, and the undertakings described herein, and to facilitate his transition to other employment, Company agrees to provide Executive with the compensation and severance payments consideration detailed in Sections 4 and 5 of the Agreement.

 

3.                      Neither Company nor Executive admits any wrongdoing of any kind, and both agree that neither they nor anyone acting on their behalf will disclose this Release, or its terms and conditions. Notwithstanding the foregoing, Executive is not barred from disclosing this Release to his legal, financial and personal advisors or to those persons essential for Executive to (a) implement or enforce his rights under this Release and the Agreement in which the Release is incorporated; (b) defend himself in a lawsuit, investigation or administrative proceeding; (c) file tax returns; or (d) advise a prospective employer, business partner or insurer of the contractual restrictions on his post-Company employment.

 

4.                      In exchange for the undertakings by Company described in the above paragraphs:

 

 

 

a.                                                      Executive, for himself, his heirs, executors, administrators and assigns, does hereby release, acquit and forever discharge Company, its subsidiaries, affiliates and related entities, as well as all of their respective officers, stockholders, stockholder representatives, directors, members, partners, trustees, employees, attorneys, representatives and agents (collectively, the “STR Parties”), from any and all claims, demands, actions, causes of action, liabilities, obligations, covenants, contracts, promises, agreements, controversies, costs, expenses, debts, dues, or attorneys’ fees of every name and nature, whether known or unknown, without limitation, at law, in equity or administrative, against the STR Parties that he may have had, now has or may have against the STR Parties by reason of any matter or thing arising from the beginning of the world to the day and date of this Release, including any claim relating to the termination of his employment with any STR Party. Those claims, demands, liabilities and obligations from which Executive releases the STR Parties include, but are not limited to, any claim, demand or action, known or unknown, arising out of any transaction, act or omission related to Executive’s employment by any STR Party and Executive’s separation from such employment, sounding in tort or contract and/or any cause of action arising under federal, state or local statute or ordinance or common law, including, but not limited to, the federal Age Discrimination In Employment Act of 1967, Title VII of the Civil Rights Act of 1964, as amended, the Americans With Disabilities Act, the Family and Medical Leave Act, the Equal Pay Act, the Worker Adjustment and Retraining Notification Act, the Fair Labor Standards Act, the Connecticut Civil Rights Law, as well as any similar state or local statute(s), in each case as any such law may be amended from time to time and any claims to have been or to be considered as a “whistleblower” or other protected person under Federal or state law, including Section 806 of the Corporate and Criminal Fraud Accountability Act. The foregoing shall, in accordance with applicable law, not prohibit or prevent Executive from filing a charge with the United States Equal Employment Opportunity Commission (“EEOC”) and/or any state or local agency equivalent, and/or prohibit or prevent Executive from participating in any investigation of any charge filed by others, albeit that he understands and agrees that he shall not be entitled to seek monetary compensation for himself from the filing and/or participation in any such charge.  This Release does not apply to:  (i) any exculpatory provision or right to indemnification or contribution under the Company’s Certificate of Incorporation or Bylaws or under any federal or state law, or under any Indemnification Agreement with the Company or related to any directors’ and officers’ insurance policy maintained by the Company for the benefit of its officers and directors; (ii) any rights to the receipt of employee benefits which vested on or prior to the date of this Release; (iii) the right to receive compensation and severance payments consideration detailed in Sections 4 and 5 of the Agreement, the right to reimbursement of expenses under Section 5(g)of the Agreement, and any other rights of Executive under the Agreement which expressly survive termination; (iv) the right to continuation coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act; or (v) any rights of Executive as a stockholder of the Company or attendant to Executive’s ownership of any stock options or other equity securities in the Company or its successors or assigns and any options or warrants related thereto or under any stock option plan or other equity incentive plan of the Company and any award agreements related thereto.

 

b.                                                      Executive expressly acknowledges that his attorney has advised him regarding, and he is familiar with the fact that certain state statutes provide that general releases do not extend to claims that the releaser does not know or suspect to exist in his favor at the time he executes such a release, which if known to him may have materially affected his execution of the release. Being aware of such statutes, Executive hereby expressly waives and relinquishes any rights or benefits he may have under such statutes, as well as any other state or federal statutes or common law principles of similar effect, and hereby acknowledges that no claim or cause of action against any STR Party shall be deemed to be outside the scope of this Release whether mentioned herein or not.

 

 

 

 

c.                                                       Executive hereby acknowledges that he is executing this Release pursuant to the Agreement, and that the compensation and severance consideration to be provided to Executive pursuant to Sections 4 and 5 of the Agreement is in addition to what he would have been entitled to receive in the absence of this Release. Executive hereby acknowledges that he is executing this Release voluntarily and with full knowledge of all relevant information and any and all rights he may have. Executive hereby acknowledges that he has been advised to consult with an independent attorney of his own choosing in connection with this Release to explain to him the legal effect of the terms and conditions of this Release and that Executive has consulted such an attorney for such purpose. Executive acknowledges that he has read this Release in its entirety. Executive further states that he fully understands the terms of this Release and that the only promises made to him in return for signing this Release are stated herein and in the Agreement in which this Release is incorporated.  Executive hereby acknowledges that he is voluntarily and knowingly agreeing to the terms and conditions of this Release without any threats, coercion or duress, whether economic or otherwise, and that Executive agrees to be bound by the terms of this Release. Executive acknowledges that he has been given at least twenty-one (21) days to consider this Release, and that if Executive is age forty (40) or over, Executive understands that he has seven (7) days following his execution of this Release in which to revoke his agreement to comply with this Release by providing written notice of revocation to the Vice President of Human Resources of the Company.

 

d.                                                      Executive further hereby covenants and agrees that this General Release shall be binding in all respects upon himself, his heirs, executors, administrators, assigns and transferees and all persons claiming under them, and shall inure to the benefit of all of the officers, directors, agents, employees, stockholders, members and partners and successors in interest of Company, as well as all parents, subsidiaries, affiliates, related entities and representatives of any of the foregoing persons and entities.

 

e.                                                       Executive agrees that he will not disparage or materially criticize any STR Parties or make or publish any communication that reflects adversely upon any of them, including communications concerning the Company itself and its current or former directors, officers, employees or agents.

 

5.                      If any provision of this Release is found to be invalid, unenforceable or void for any reason, such provision shall be severed from the Release and shall not affect the validity or enforceability of the remaining provisions.  This Release shall be interpreted, enforced and governed by the laws of the State of Connecticut, without regard to the choice of law principles thereof.

 

 

 

 

IN WITNESS WHEREOF, I have signed this General Release this      day of                                                   , 201    .

 

 

    By:   
       
       
    Name:   
       

 

Subscribed and sworn to before me this      day of                     , 201    .

 

 

     
    Notary Public
    My Commission Expires
       

 

 

 

 

 

SCHEDULE A

 

Applicable Multipliers During Severance Periods

 

(A) 
Name/Position
  (B) 
Applicable Multiplier 
(Not During Change 
in Control Severance 
Period)
  (C) 
Applicable Multiplier 
(During Change in 
Control Severance 
Period)
Robert Yorgensen/President & Chief Executive Officer     2.0       2.0  

 

 

 

 

 

 

 

 

Exhibit 10.15

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exhibit 21

 

SUBSIDIARIES OF STR HOLDINGS, INC.

 

Subsidiary

 

State or other
Jurisdiction of
Incorporation

Specialized Technology Resources Espãna S.A. Spain
Specialized Technology Resources, Inc. Delaware
Specialized Technology Resources (Connecticut), LLC Connecticut
Specialized Technology Resources (Hong Kong), Ltd. Hong Kong
Specialized Technology Resources (Malaysia) Sdn. Bhd. Malaysia
10 Water Street, LLC. Connecticut
Specialized Technology Resources India Pvt., Ltd. India
Specialized Technology Resources Solar (Suzhou) Co. Limited China

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-162939 and 333-175020) of STR Holdings, Inc. of our report dated March 9, 2017, relating to the consolidated financial statements and financial statement schedule as of December 31, 2016 and 2015 and for the years then ended, which appears in this annual report on Form 10-K of the Company for the year ended December 31, 2016.

 

/s/ UHY LLP

New York, New York

March 9, 2017

Exhibit 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO

SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a), AS ADOPTED

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Robert S. Yorgensen, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of STR Holdings, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
   
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
     
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
   
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
     
Date: March 9, 2017

/s/ Robert S. Yorgensen

  Name:  Robert S. Yorgensen
  Title: Chairman, President and Chief Executive Officer
(Principal Executive Officer)

Exhibit 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO

SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a), AS ADOPTED

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Thomas D. Vitro, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of STR Holdings, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
   
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
     
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
   
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
     
Date: March 9, 2017

/s/ Thomas D. Vitro

  Name:  Thomas D. Vitro
  Title: Vice President, Chief Financial Officer and Chief
Accounting Officer (Principal Financial Officer and
Principal Accounting Officer)

Exhibit 32.1

 

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Chairman, President and Chief Executive Officer of STR Holdings, Inc. (the “Company”), does hereby certify that to my knowledge:

 

1. the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2016 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
     
2. the information contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2016 fairly presents, in all material respects, the financial condition and results of operations of the Company.
     
Date: March 9, 2017

/s/ Robert S. Yorgensen

  Name:  Robert S. Yorgensen
  Title: Chairman, President and Chief Executive Officer
(Principal Executive Officer)

 

Exhibit 32.2

 

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Vice President and Chief Financial Officer and Chief Accounting Officer of STR Holdings, Inc. (the “Company”), does hereby certify that to my knowledge:

 

1. the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2016 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
     
2. the information contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2016 fairly presents, in all material respects, the financial condition and results of operations of the Company.
     
Date: March 9, 2017

/s/ Thomas D. Vitro

  Name:  Thomas D. Vitro
  Title: Vice President, Chief Financial Officer and
Chief Accounting Officer (Principal Financial
Officer and Principal Accounting Officer)